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Mastitis is one of the most costly diseases to dairy producers around the world with milk 
yield loss being the biggest contributor to economic losses.  The objective of first study 
of this thesis was to determine the impacts of high somatic cell counts on milk yield loss.  
To accomplish this, over one million cow data records were collected from Southeastern 
US dairy herds.  The objective of the second study was to determine optimum treatment 
cost of clinical mastitis by combining two economic modeling approaches used in animal 
health economics.  The last objective of this thesis was to determine how much 
Southeastern US dairy producers are spending to control milk quality on farm and 
determine if they understand how milk quality affects them economically.  This was 
accomplished through a collaborative project within the Southeast Quality Milk 
Initiative.  
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Mastitis is one of the most costly diseases on dairy operations.  Cases of mastitis, 
both clinical (CM) and subclinical (SCM) can have a major impact on dairy farm 
economics.  Decreased milk yield contributes most of the economic losses associated 
with decreased milk quality.  Dairies take different preventative measures, have different 
treatment protocols, and may deal with different pathogen, which causes incidences of 
mastitis to affect dairies differently.  Therefore, understanding the effects of milk quality 
on milk yield, having the ability to calculate losses from mastitis specific to an operation, 
and knowing what is being spent managing milk quality can greatly impact the 
economics of dairy operations and influence decisions made to manage milk quality. 
SOMATIC CELL COUNT AND MILK PRODUCTION 
What are Somatic Cells?   
Somatic cells are important in the role of fighting pathogens in the mammary 
gland.  Three main cells make up most of the white blood cells that respond to invading 
bacteria.  White blood cells include macrophages, lymphocytes, and polymorphonuclear 
neutrophil (PMN) leukocytes (Harmon, 1994).  The PMN are a key defense mechanism 
in the udder, engulfing foreign bacteria.  During a period of inflammation in the udder, 
PMN are the main source of increased somatic cells.  The presence and type of pathogen 
infecting the quarter is the primary factor affecting the somatic cell count (SCC).   
 Although infection status is the main reason for variability in a cow’s SCC, many 
other variables play a smaller role.  Two of them being the age and stage of lactation of 
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the cow (Harmon, 1994).  As a cow ages or as stage of lactation progresses, her SCC 
tends to increase.  However, if the mammary gland is healthy, SCC tends to decrease 
rapidly after calving and age affects are minimal.  
 Stress and season may also factor into SCC (Harmon, 1994).  Heat stress has been 
shown to be associated with elevated SCC of dairy cattle.  When cows are under heat 
stress, herd SCC tends to increase.  This leads to seasonal trends, with a high SCC in the 
summer and a low SCC in the winter.  de Haas et al. (2002) explains that differences in 
infection rates with clinical mastitis are the main reasons for the seasonal trends observed 
in SCC.  Thus, infection status remains the primary factor affecting SCC at the cow and 
herd level. 
Measurement of Somatic Cell Count  
Because many factors are associated with SCC, examining the average lactation 
SCC for a cow may be difficult.  Average lactation data is skewed with the mean being 
higher than the median (Ali and Shook, 1980).  To perform an analysis of variance, data 
must meet certain criteria, one being a normal distribution.  Ali and Shook (1980) 
examined different SCC data could be transformed to meet the analysis parameters.  Until 
the time of the study, the geometric mean was used to transform data.  Ali and Shook 
(1980) determined the log transformation of the data was a sufficient transformation.  
Adding a constant improved the model slightly.  Ali and Shook (1980) concluded that the 
log transformation is preferred because of its convenience and the adaptation of data to 
nearly optimal properties when analyzing SCC.     
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Somatic Cell Count Effects on Milk Production  
Due to the way somatic cells fight an infection, a correlation exists between SCC 
and milk production.  Raubertas and Shook (1982) were one of the first to research the 
idea.  Their model is as follows: 
𝑌𝑖𝑗𝑘 =  𝐿𝑘 + 𝐻𝑖𝑘 + 𝑀𝑙𝑘 + 𝐶𝐿𝑖𝑗𝑘 + 𝑒𝑖𝑗𝑘 , 
Where: 
𝑌𝑖𝑗𝑘 = Actual milk yield of cow j in herd i during lactation k 
𝐿𝑘 =  Effect common to cows in lactation k 
𝐻𝑖𝑘 =  Effect common to cows in herd i during lactation k 
𝑀𝑙𝑘 =  Effect common to cows beginning lactation k in season 1, where the yr was 
broken up into four seasons starting with January 1 – March1 
𝐶𝐿𝑖𝑗𝑘 = Component of yield associated with d in lactation, age at calving, average log 
SCC, and variation in SCC 
𝑒𝑖𝑗𝑘= residual error 
The original model also included a PLijk variable that was associated with the 
previous lactation.  Raubertas and Shook (1982) later dropped this variable from the 
model because only age at calving was a significant factor and age would be highly 
correlated from lactation to lactation.  Variability was also dropped from the model 
because regression coefficients were not significant; suggesting that only the natural 
logarithm SCC was needed.  The model without the previous lactation variable required 
allowed for more data access because of the lack of need for two consecutive lactations 
worth of data per cow.   
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 The overall results from the model suggested that the relationship between 
somatic cell count and milk production is a curvilinear relationship.  Milk production 
decreased at a decreasing rate as SCC increased.  With every 2.7 fold increase in SCC, 
there is a 270 kg decrease in milk production for cows in their third lactation (Raubertas 
and Shook, 1982).   
 Many studies have been formulated similar to the study by Raubertas and Shook 
(1982), (Jones et al., 1984, Bartlett et al., 1990, Deluyker et al., 1993, Miller et al., 2004, 
Hagnestam-Nielsen et al., 2009, Hand et al., 2012).  Bartlett et al. (1990) reported similar 
results to Raubertas and Shook (1982) with 1.18 to 2.37 kg of milk loss per d per unit 
increase in SCC for second and higher parities and 1.17 kg per d per unit increase in 
SCC, respectively. Miller et al. (2004) reported different milk production losses but a 
similar trend, with first parity cows having 50% of the production loss of multiparous 
cows, 125 kg of milk loss per unit increase in SCS and 226 kg of milk loss per lactation 
for first and later parity cows, respectively.   
 Hand et al. (2012) conducted some of the most recent research on the topic and 
added another factor different from that of Raubertas and Shook (1982).  Hand et al. 
(2012) added milking quartile into the model.  By adding milking quartile Hand et al. 
(2012) accounted for differences in milk production.  Cows were assigned a milking 
quartile based on their average test d milk production, milking quartile 1 being the lower 
producing cows and milking quartile 4, the higher producers.  Results for the milking 
quartile 1 cows were similar to that of previous research (Raubertas and Shook, 1982, 
Jones et al., 1984, Miller et al., 2004) with the parity one cows experiencing 50% of the 
milk loss as multiparous cows.  Milking quartiles 2, 3, and 4 differed in results with 
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parity one cows losing 36, 33, and 26% percent less than multiparous cows.  Hand et al. 
(2012) also examined how the number of test days the cow experienced an elevated SCC 
(> 100,000 cells/mL) affected the milk loss in the lactation.  Lactations with 5 or more 
test d with a SCC over 100,000 cells/mL resulted in the highest milk losses. 
Test Day Data vs. Lactation Data  
 Raubertas and Shook (1982) examined how SCC affected the whole lactation 
production while others (Jones et al., 1984, Bartlett et al., 1990, Hand et al., 2012) use 
test d data.  When using test d data, researchers must take into account persistency of 
lactation and how persistency is affected.   
 Pollott (2000) takes a different approach to the lactation curve and examines it 
through a biological standpoint, stating that the programmed cell death of secretory cells 
determines the length of lactation and determines the milk yield during the declining 
phase of the lactation.  Proliferation of the secretory tissue occurs in the gestation period 
of the dairy cow and continues a few weeks into lactation (Knight and Wilde, 1993).  A 
close correlation exists between parenchyma and milk production.  During peak milk 
yield, parenchyma are at their highest number and drop slowly as milk yield decreases, 
though numbers do not return to the original state and increase in the second lactation.  
Growth is also faster in the second lactation.  Cell differentiation is correlated with milk 
production (Knight and Wilde, 1993).  Differentiation starts around seven weeks before 
calving, continues slowly during late gestation, and then increased rapidly between 
calving and peak milk.  
 Sturtevant (1886) was one of the first to look at milk throughout the course of 
lactation and the lactation curve and found that milk production drops by approximately 
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9% each mo. Ludwick and Petersen (1943) explained that three situations affect milk 
yield: maximum initial production, the persistency of milk yield, and the length of the 
production period.  Ludwick and Petersen (1943) determined that four periods gave the 
lactation curve its shape: 1) the first 80 d after peak lactation was a time where the cow 
was under no individual depressing influences, 2) the 80 d time had effects of conception 
and adjustment to pregnancy, 3) time where pregnancy influences production and 
pregnancy, and 4) other adjustments heavily influenced the final 80 d production.  A fifth 
period, after calving to right before peak milk, was insignificant due to the small 
correlation to the overall lactation yield.  Ludwick and Petersen (1943) produced the 
following model allowing different periods of data to be used, instead of the original four 











𝑋𝑛(𝑛 − (𝑛 − 2))
𝑋𝑛−1





P - Persistency 
X- (With the aid of subscripts) designates the production of any particular period 
n- The number of divisions into which the lactation is divided 
 Sargent et al. (1968) and (Hand et al., 2012) explained the test interval method of 
producing a lactation curve and lactation production from individual test d data.  The test 
interval method uses information from two consecutive test d of data.  Calculation of the 
first portion of the test period consisted of the first test period and the second half of the 
test period is from the second test; adding the two, results in the test period yield.  For the 
first test of the lactation, the test period would consist of the d of calving until the test 
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period of the current lactation and the last test period until the cow ended the lactation 
from the previous lactation.  The test d interval has several advantages over the central 
date theory (Sargent et al., 1968):   
1. Permits greater flexibility in the testing schedule without a concurrent loss of 
accuracy. 
2. Permits records to be brought up to date following missed tests and the 
processing of bimonthly records with a minimum of special handling. 
3. Eliminates adjusting records for status changes between the test d and the end 
of the test period, since the two are synonymous. 
4. The basic logic of the method is more easily understood by dairymen, machine 
programmers or anyone not well versed in the subject. 
5. Permits greater flexibility in scheduling surprise tests. 
6. Requires less core storage in the computer.  
Sargent et al. (1968) explains the following example using the test interval method:  
358 d in the 12 test periods, 365/358 = 1.019 
15,699 cow d on test 
1.019 × 15,699 cow d/365 = 43.828 cow years 
227,002 total kg milk 
1.019 × 227,002 kg milk/43.828 cow years = 5,278 kg milk/cow per yr 
In the end, results were very similar to that of the central date theory of 5,279 kg/cow per 
yr.   
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Somatic Cell Count and Milk Dilution 
One factor not considered in any of the models, was the dilution of SCC with 
higher milk production.  Raubertas and Shook (1982) discussed the matter saying that 
SCC changed little for cows from one lactation to the next and by not accounting for 
dilution would lead to little over or underestimation of milk loss.  Hand et al. (2012) 
stated that the dilution effect still has not been quantified. 
 Green et al. (2006) examined the phenomenon of milk production diluting SCC 
using two different models.  The first set of models did not include a dilution factor while 
the second set did.  Using the first set of models a slightly negative, linear correlation 
existed between production and SCC up to a SCC of 300,000 cells/mL, suggesting a 
possibility of a dilution effect.  The second set of models did contain a dilution factor.  
Dilution-adjusted SCC had a better fit to the data than un-adjusted and production 
decreased with every increase in SCC but still a significant drop in production with every 
SCC above 200,000 cells/mL (Green et al., 2006).   
ANIMAL HEALTH ECONOMICS 
Animal health and disease economics is a relatively new and growing research 
idea in animal science.  Health and disease in the dairy industry affect a large spectrum of 
people from society as a whole, down to the individual producer level.  
 Galligan (2006) explained that in order to follow the economic impact of a 
disease, a partial budget must be developed.  Production, reduced slaughter value, higher 
input cost, and loss of future income due to premature culling are all cost parameters that 
need to be included into the partial budget.  A partial budget can be explained with the 
following equation (Galligan, 2006): 
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𝑁𝑀𝐶 = (𝐼𝑅 + 𝐷𝐶) − (𝐷𝑅 + 𝐼𝐶) 
Where: 
NMC = Net marginal change 
IR = Increased revenue 
DC = Decreased cost 
DR = Decreased revenue 
IC = Increased cost 
Two steps need to be taken when constructing a partial budget to determining the 
effects of a disease.  First, any effects on the partial budget need to be measured over the 
same period.  Secondly, discounting accounts for the time when cash flows are 
calculated.  When a lag in time from where a decision occurs and a change in revenue or 
cost occurs, future cash flows presented are discounted to account for the time value of 
money.  To account for the change, the following net present value equation is used 
(Galligan, 2006) :   





NPV = Net present value 
Co  = Cash outflow or inflow during time period 
t = Time period 
Ct = Investment or cash outflow in time period 
r = Discount rate during the time period (opportunity cost) 
 If the NPV is equal to zero, the investment has the same value as the discount 
rate.  If NPV is > 0, the producer should invest because the financial gains are greater 
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than the discount rate.  When the NPV is zero, the producer should not invest (Galligan, 
2006). 
 In animal agriculture, it is common to compare investments at different periods.  
In order to examine the NPV for a period of time, an annuity factor is used.  The 
following is the equation to calculate the annuity: (Galligan, 2006)   
𝐶𝐴𝑛𝑛𝑢𝑖𝑡𝑦 =  
𝑁𝑃𝑉
1




t = Time periods 
CAnnuity = Constant cash flow for t periods 
NPV = Net present value over t periods 
r = Discount rate 
 
Factors Affecting Cost  
  A case of mastitis affects the economic well-being of a farm in many different 
ways.  Costs associated with mastitis include: milk production losses, milk composition 
changes, drugs, discarded milk, veterinary services, labor, product quality, materials and 
investments, diagnostics, increased risk of other diseases, culling, and reduced slaughter 
value (Allore and Erb, 1998, Halasa et al., 2007).   
Production Loss. Decreased milk production due to the infection in the mammary 
gland is the largest contributor to economic impact of mastitis.  Research by Schepers 
and Dijkhuizen (1991) indicates that 70% and 100% of the money loss because of milk 
loss for CM and SCM, respectively.  The same study found that milk loss ranged from 
267 to1,277 kg per CM case.  Mastitis affects cows in different ways.  For instance, a CM 
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case often affects cows differently depending on their parity.  Primiparous cows lost 164 
kg of milk while multiparous cows lost 253 kg (Bar et al., 2007).  Multiple cases in the 
same lactation also influence milk production.  Cows in their first lactation lost an 
additional 198 kg of milk if within two mo of the original infection their second CM case 
occurred where older cows lost 238 kg with their second case and 216 kg with their third 
CM case (Bar et al., 2007).  Production losses also depend on when the cow contracts 
mastitis during her lactation.  Even when SCC are the same, daily milk losses are higher 
during later lactation than they are in early lactation (Seegers et al., 2003).  Huijps et al. 
(2008) examined when intramammary infections take place in a cow’s lactation and 
found that 30% of the clinical cases of mastitis occur in the first mo of lactation.  The 
percent of cases then dropped every mo until 4% of the cases occurred in the ninth mo of 
the lactation (Huijps et al., 2008).  Having more than one case of mastitis in a lactation 
hurts milk production even more because milk production never completely recovers 
from a case of mastitis during the lactation (St Rose et al., 2003).     
The infecting pathogen can also have an impact on the production losses 
throughout the lactation.  Gröhn et al. (2004) suggested that Klebsiella had an increased 
milk loss compared to all other pathogens because of the consistent milk loss throughout 
the lactation.  Primiparous cows infected with Klebsiella experienced large daily milk 
production losses the week after diagnosis, followed by a rebounding period, but still 
experienced losses only to have large losses later in lactation. 
Drug and Veterinary Costs.  Veterinarian costs have been estimated to account 
for 19 to 27% of the total costs of a clinical case of mastitis (Sadeghi-Sefidmazgi et al., 
2011).  Economic loss due to a case of mastitis has a positive linear relationship with vet 
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costs (Halasa et al., 2007).  Huijps et al. (2008) estimated that 5% of all clinical mastitis 
cases would require a visit from a veterinarian and depending on whether the cow needs 
treatment or not, the cost of the vet visit could go up.  Estimated costs of a visit from a 
veterinarian that required treatment were $237 US dollars (USD) per clinical case 
(Heikkila et al., 2012).  United States based models often do not include veterinary costs, 
arguing that most mastitis treatments are done by farm staff (Pinzon-Sanchez et al., 2011)       
      Labor Costs.  The easiest way to estimate the labor cost associated with mastitis 
is to take the additional amount of time spent with a clinical case multiplied by the hourly 
wage (Halasa et al., 2007).  Additional time covers the time to treat, sorting time, or any 
other time spent monitoring a cow with mastitis.  Estimates for the additional time spent 
with a clinical mastitis case vary.  Halasa et al. (2007) estimated that only 45 extra min 
are spent with a cow with clinical mastitis, whereas Heikkila et al. (2012) estimated that 
an additional two hours was needed for treatment and care of cows with clinical mastitis 
cases.  Another factor to consider is opportunity costs of labor; time spent treating and 
caring for clinical cows could be spent doing other tasks around the farm (Halasa et al., 
2007). 
 Product Quality.  Milk quality itself also has a role in the economics of mastitis.  
Milk processors require a SCC limit from their producers.  If over that limit, farmers get a 
deduction in their paycheck.  If their SCC is lower they get a premium for having higher 
quality milk (Halasa et al., 2007).  Deductions or premiums depend on the processor.  
Having a high SCC also results in lower fat and protein content that could make farmers 
miss receiving premiums for components.  Valeeva et al. (2007) determined that farmers 
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are more motivated by having deductions made from their milk check for having poor 
quality milk than they are by receiving premiums for high quality milk. 
 Culling Costs.  Premature culling is one of the highest estimated costs of a 
clinical case of mastitis (Halasa et al., 2007).  Bar et al. (2007) found that 8% of CM 
cases end with a cull.  The cost also depends on the timing of culling.  Heikkila et al. 
(2012) estimated the costs that were associated with culling a cow too early.  Culling a 
cow early, increased the cost of a case of mastitis by 20%.  The drop in milk production 
by having a replacement heifer instead is the main reason for the additional costs.  
Heikkila et al. (2012) determined the optimal culling time for Holsteins that were healthy 
or had had three or four clinical cases was the sixth lactation, compared to the fifth 
lactation for cows experiencing their first or second clinical mastitis case.  For cows that 
had only had one or two cases, the best time to cull was at the end of their fifth lactation.  
If cows were culled earlier than the optimal culling period the cost of the clinical mastitis 
case went up 30%.             
TREATMENT OPTIONS 
 Steeneveld et al. (2011a) examined five different treatment methods, a standard 3-
d intramammary; an extended 5-d intramammary; a combination 3-d intramammary and 
a systemic; a combination 3-d intramammary, a systemic, and a 1-d non-steroidal anti-
inflammatory drug; and a combination extended 5-d intramammary and a systemic, with 
average cost being: $224, $247, $253, $260, and $275 per mastitis case, respectively.  
The costs of treatment were attributed to the following reasons: pathogen distribution, the 
probability of culling a cow, the amount of milk production loss, the costs for culling, the 
costs for milk production losses, costs for discarded milk, costs for labor.  In the study, 
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they evaluated how cows would respond to the five different treatment regimens.  
Overall, based on assumptions made in the study, treating cows based on infecting 
pathogen was beneficial.  They did find that antimicrobial treatment resulted in fewer 
culled cows, fewer clinical mastitis cases treated with extended therapy, and fewer flare-
ups.   
 Shim et al. (2004) found that both a treatment with antibiotics and a supportive 
treatment were beneficial.  Supportive treatments can consist of anything from oxytocin 
at milking, extra milkings, and anti-inflammatory drugs.  Using antibiotic and supportive 
therapies together lead to higher cure rates, lower recurrence rates, and less severe 
mastitis cases.   
 Allore and Erb (1998) found that success of treatment method was variable.  A 
lactation therapy and a dry cow treatment gave the least variable clinical mastitis cure 
results.  Lactation therapy alone had the greatest variability and was the least beneficial 
when used alone.  Prevention and dry cow therapy yielded the greatest benefits.  
Dry Cow Treatment  
 Dry cow treatment (DCT) is very common among dairy farmers around the 
world; 75% to 99% of dairy farmers use a dry cow treatment in their dairy herds (Robert 
et al., 2006).  This has become a very timely topic recently, due to the concern over 
antimicrobial resistance.   
Dry cow therapy is used with two goals in mind: 1) eliminate any intramammary 
infections when drying a cow off and 2) prevent new infections during the dry period.  
Three different factors affect the cost of mastitis during the dry period.  Those factors are: 
risk of contracting a new infection during the dry period, spontaneous cure, and the cost 
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of antibiotic treatment (Huijps and Hogeveen, 2007a).  Huijps and Hogeveen (2007b) 
examined the costs of blanket DCT, selective DCT, and no DCT of cows with an 
intramammary infection at dry off.  Costs between the different DCT included the costs 
of treatment, the costs associated with a CM case after calving, and the costs associated 
with milk production loss in the next lactation from the intramammary infection at dry 
off.  When determining the costs of the three DCT regimens, the costs associated with 
CM accounted for 82% of the costs of DCT in those cows that were not dry treated.  
When using a blanket dry treatment, treatment accounted for 65% of the costs and 
clinical mastitis only accounted for 27% of the costs of mastitis.  The overall cost of each 
of the different treatment types was also determined.  Selective DCT, on average was the 
cheapest, but the costs varied more compared to a blanket treatment.  Not treating the 
cows at all, on average, ended up being the most expensive ($ 19.46 USD/cow) and 
varied the most in cost compared to the other two treatment types, $16.84 and $14.81 
USD for blanket and selective dry cow treatment, respectively.   
Berry and Hillerton (2002) examined four different dairy herds comparing 
selective treatment with a blanket dry cow treatment.  Two of the herds belonged to the 
Institute of Animal Health and the others were two herds that were transitioning from 
conventional farms to organic.  Out of 16 cows that had an infection at dry off that went 
untreated, 10 of the cows calved in with an infection of the same pathogen.  Two of the 
cows had also contracted a Streptococcus uberis infection.  In the group of untreated 
Institute of Animal Health cows, 70% of quarters infected with Corynebacterium species, 
which were infected at calving.  This was 46.2% of quarters in organic herds.  The study 
showed that dry cow therapy reduced that rate of getting a new intramammary infection 
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by 80%.  They also found that cows with a dry period of longer than 16 weeks had a 
higher infection rate than cows that had a normal dry period (6 to 10 weeks.) 
Berry and Hillerton (2007) conducted a study to assess how treating cows with a 
teat sealant would differ from cows that did not receive a teat sealant treatment in terms 
of intramammary infections.  Infection rates differed as cows calved; 62 cows and 93 
quarters had become infected in the cows that did not receive a treatment, compared to 21 
cows and 27 quarters in cows, that received a teat sealant treatment.  Six cows in the non-
treated group were infected with CM, while 0 cows receiving the treatment had clinical 
mastitis during the dry period.  Treating resulted in nearly 80% fewer new Streptococcus 
uberis infections and 70% fewer new Staphylococcus aureus infections at calving. 
Overall, treating led to 70% less infections.  
Pathogen Prevalence  
 Pathogen type also has an effect on the cost of a case of mastitis (Pinzon-Sanchez 
et al., 2011, Steeneveld et al., 2011b, Down et al., 2013).  Different pathogen types are 
more common, more persistent, passed from cow to cow, and require more drugs or a 
higher cost drug in order to treat.  Steeneveld et al. (2011b) concluded that Staph aureus 
was the most expensive pathogen to treat when examining the cost of   Streptococcus 
dysgalactiae or uberis, Staphylococcus aureus, and E. coli, with a variety of different 
treatment options.      
The Cost of Mastitis 
Mastitis costs United States producers 1.2 to 1.7 billion dollars annually, which is 
6% of their value of production (Shim et al., 2004).  The average cost for a case of 
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mastitis produced from economic models range from $179 to $426 dollars depending on 
the cow’s stage of lactation (Bar et al., 2008b, Huijps et al., 2008, Liang et al., 2016). 
Effects of Milk Price 
Milk price has a major impact on how much a case of mastitis will cost a 
producer.  If the milk price changes 20%, either up or down, the cost of a case of mastitis 
increased anywhere from 10% to 18% if the milk price increased; the higher the milk 
price the higher the cost of a CM case.  The cost of mastitis decreased 10% to 17% if the 
milk price decreased 20% (Bar et al., 2007, Heikkila et al., 2012).   
MASTITIS PREVENTION 
Environmental factors are increasingly contributing to the cause of mastitis on 
dairy operations and the cow’s environment is one thing that farmers can control.  
Keeping cows clean and dry is the consistent practice that farmers can do to help manage 
the environmental pathogens that may come in contact with the mammary gland.  A 
positive relationship exists between udder cleanliness and udder health.  For udder 
cleanliness scores of 1, 2, 3, and 4, the percent of intramammary infections are 7.7%, 
10%, 10.6%, and 13.5% respectively.  Udders that scored a 3 or 4, were 1.5 times as 
likely to be infected with environmental pathogens (Schreiner and Ruegg, 2003).  Post 
dipping is also a major benefit to fighting off new infections (Pyorala, 2002).  It can 
reduce new infections by up to 50%.  Additional costs would be for labor, fuel for 
equipment to clean stalls, flaming udders, and the cost of post-milking teat disinfectant.  
These additional management practices would see a return on investment through 




 The development of models helps determine the different variables that play a 
significant role in the cost of a case of mastitis.  Dijkhuizen (1991) explained two basic 
ways of modeling economic data, positive and normative.  The positive approach uses 
data collected from a field study.  Normative modeling takes into account proven facts 
about mastitis, veterinary science, and about the farm or cow.  Dijkhuizen (1991) lists 
different models to determine the economic impact of an animal disease.  Different 
models included cost-benefit, decision analysis, dynamic programing, factor analysis, 
Markov chains, path analysis, system simulation, and stochastic simulations.  Bennett 
(1992) also added network analysis as a modeling option. 
 Cost-benefit analysis determines the profitability of a decision or product 
over a long period.  Results from the analysis are displayed as either a 
NPV or a ratio of present benefits to present costs.  Common uses of cost-
benefit analysis include society decisions or nationwide control programs.  
Decision Analysis involves making a decision too complex to be made by 
the human mind (Dijkhuizen, 1991).  Not only does decision analysis 
consider the economics of a decision but also the risk and uncertainty 
associated with a decision (Bennett, 1992). 
Dynamic Programing is a group of mathematical techniques that have no 
standard formulation.  The program examines decisions over time.  
Because there is no standard formulation, variables can be changed at any 
time in the model.  Dynamic programming is most commonly used in 
making culling decisions (Dijkhuizen, 1991, Bennett, 1992). 
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Factor Analysis is a common statistical method to take a large number of 
variables and combine them into a small number of mutually independent 
and hypothetical variables.  The variables show variation in the variable of 
interest.  Factor analysis is used to account for covariance in observed 
variables (Dijkhuizen, 1991).           
Markov Chains measure the change of a system over a number of repeated 
trials.  A system can range anywhere from a single cow to the whole farm.  
Markov chains take into account many different variables that can change 
with each repetition of the trial (Dijkhuizen, 1991).   
Path Analysis makes it possible to determine the effects of relationships 
on complex situations (Dijkhuizen, 1991).  The model interprets different 
relationships and has been used to determine the cause and effects of 
animal diseases (Dijkhuizen, 1991). 
System Simulations model real life situations over time.  The model moves 
a herd or animal through time and changes management decisions or 
events along the way.  Results from the model are marginal rather than 
fixed values (Dijkhuizen, 1991). 
Bennett (1992)  discussed that when choosing a model there are five different 
considerations to keep in mind: 1) the problem being modeled, 2) the complexity of 
systems involved, 3) information available, 4) the users of the model and preferences of 
the creator or user, and 5) the resources available.  In order to accomplish these 
considerations, modeling methods may be used together.    
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One of the most common model types used in animal disease economics is 
stochastic modeling (Ostergaard et al., 2005, Huijps and Hogeveen, 2007a, Huijps et al., 
2008).  Stochastic modeling is a commonly used finance tool when one or more variables 
are random, allowing the model to predict outcomes for a wide variety of situations.  
Another common model is dynamic programming (Rajala-Schultz et al., 1999, Bar et al., 
2008b, Heikkila et al., 2012).  The dynamic programming model takes a complex 
problem and breaks it down into layers of simple problems.        
 A wide variety of treatment options for mastitis, including dry cow treatments, 
has been looked at in the literature (Shim et al., 2004, Pinzon-Sanchez et al., 2011, 
Steeneveld et al., 2011a).  Different treatment options ranged from length of antibiotic 
therapies (Pinzon-Sanchez et al., 2011) to using a supportive therapy in addition to 
antibiotic therapy (Shim et al., 2004, Steeneveld et al., 2011b).  Pinzon-Sanchez et al. 
(2011) examined four different treatment options for CM including a 2-d, 5-d, 8-d 
treatment, as well as no treatment and concluded that the economics of treatment duration 
depended on infecting pathogen.  Cost due to mastitis ranged from $25 per case (with no 
intramammary antibiotic used) to $212 per case (8-d intramammary therapy).  Shim et al. 
(2004) concluded that supportive therapy alone, lead to increased losses from clinical 
mastitis compared to using both an antibiotic treatment and supportive therapy together.  
Steeneveld et al. (2011a) reported an increased average cost of a mastitis case when 
supportive therapy was used. 
 Many models also included infection pathogen as a variable (Deluyker et al., 
1993, Allore and Erb, 1998, Halasa et al., 2009b).  Halasa et al. (2009b) developed an 
economic model that compared the economic burdens that come with different 
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pathogens.  Contagious pathogens were evaluated using a Reed-Frost model because they 
are spread by contact from cow to cow.  A Reed-Frost model assumes that the ability of 
the pathogen to be spread is dependent on the number of infected cows (Becker, 1989, 
Zadoks et al., 2001).  Environmental pathogens were described using a Greenwood 
model because once the pathogen is present in the environment the probability of a cow 
getting infected is dependent on the number of cows with an intramammary infection 
(Becker, 1989).     
 Two different models are common when determining the cost of culling.  One is 
using the retention payoff method (RPO) (Bar et al., 2008b) and another using the 
optimal value function (Heikkila et al., 2012).  The RPO is the profit expected from a 
cow that stays throughout her optimal lifespan compared to her replacement.  The 
optimal value function takes into account the discounted return from a cow and her 
replacement, stating that the current state of the animal is going to have an effect on 
future lactations.   
 Other models took a decision tree approach (Pinzon-Sanchez et al., 2011, 
Steeneveld et al., 2011b, Down et al., 2013).  These models take the approach of treating 
a specific cow for a case of mastitis.  Two of the studies, (Steeneveld et al., 2011b, Down 
et al., 2013), use a stochastic Monte Carlo simulation model to calculate the cost of 
mastitis with different treatment regimens.  The model consisted of three different steps.  
One being each simulation process ended with a cow with a case of clinical mastitis.  The 
second step consisted of treating the case of clinical mastitis.  This was simulated using 6 
different treatment practices.  The final step was to calculate the costs associated with all 
6 treatments for that case of mastitis.  The model also included the causal pathogen, 
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which was determined using a discrete probability distribution, and a simulation of 
follow up treatments.  The cost of the mastitis case was calculated for the original clinical 
mastitis case, any follow up treatments, recurrence cases, milk production losses, and 
finally the cost of culling the cow.  Culling cost was calculated using retention payoff 
with specific cow factors.  The overall model had three options for a case of mastitis.  
Those included a bacterial and clinical cure, no bacterial cure but a clinical cure and a no 
cure.  The bacterial and clinical cure followed with either the end of the cow’s lactation 
or culling.  No cure led to an extended treatment which either ended with an end of 
lactation, cull, drying off the quarter, or a treatment of a second case of mastitis.   
A clinical cure led to the end of the lactation, culling of the cow, or a second case 
of mastitis.  The second case of mastitis had the same options as the first, which could all 
lead to a third case of mastitis.  After the third case, the cow completed the lactation or 
culling occurred.  Down et al. (2013) added another factor into the model and that was 
transmission rate, believing that transmission rate is another cost factor in the case of 
mastitis.  So, if a cow infects her herdmates, the cost of their cases of mastitis adds to the 
original case.  Down et al. (2013) found that the transmission rate had the greatest 
influence on the case of mastitis no matter the treatment protocol.  In an example 
scenario, an increase in the transmission rate from 0.13 to 0.25 new cases for a 14-d 
period would increase the cost of clinical mastitis by 60%.       
Pinzon-Sanchez et al. (2011) took another approach to a decision tree.  Their 
model added a culture variable.  The first decision of the model contained three 
outcomes: either no culturing, on farm culturing but waiting 24 hours to treat, or on farm 
culturing and treating right away.  Results from culturing consisted of gram-negative, 
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gram-positive, or no growth.  After culture results, the model was set up similarly to 
Down et al. (2013) and (Steeneveld et al., 2011a).  Pinzon-Sanchez et al. (2011)  included 
the following variables in the cost of a case of mastitis: milk production loss, discarded 
milk, diagnosis, initial treatment, additional treatment, premature culling, losing the 
quarter infected, and recurrence.  Like Down et al. (2013) a transmission cost was also 
included.  The model by Pinzon-Sanchez et al. (2011) only accounted for the 
transmission of S. aureus and assumed that with every unsuccessful cure, the mastitis 
case spread to 0.25 more cows.   
DECISION SUPPORT TOOLS IN AGRICULTURE 
 Making decisions on a farm can be a very complicated process.  Even though the 
economic welfare of the operation is very important, not all decisions are based on 
economic analysis alone (Kristensen and Jørgensen, 1998, Willock et al., 1999).  
Personal factors, external farm factors, attitudes towards farming, and objectives in 
farming are the main decision drivers for dairy producers (Willock et al., 1999).  Willock 
et al. (1999) explained these examples further and examined the relationships between 
them by surveying producers on farming attitude, objectives, and behavior.  Highly 
correlated factors on decision-making consisted of: environmental impact, openness of 
the producer, stress with goal achievement, legislation, and pessimism.  Moderate 
correlations were: intensive production goals with quality of life environmentally 
oriented with sustainability and off farm work objectives.  Financial risk had a moderate 
correlation with extraversion, openness, and agreeableness of producers.  A small 
correlation existed between business development and success of farming, achievement, 
sustainability, quality of life, status, and success.  Willock et al. (1999) stated that two 
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things could be taken away from the correlations: 1) there are attitude, objective, and 
behavior associations with domains of farming concerns, such as production and 
sustainability, and 2) some attitudes, such as achievement and openness, might drive 
more than one objective and behavior domain in farming.   
 Kristensen and Jørgensen (1998) concluded that four things must be known in 
order to make a rational decision: 1) the present state of the animal or farm, 2) the 
relationship between factors used and the resulting production given the present state, 3) 
personal preferences of the farmer, and 4) any legal, economic, physical, or personal 
restrictions.  Uncertainty also complicates the decision making process, for example, the 
probability that a drug will cure a mastitis case.   
All of the reasons listed can make a decision very difficult for the producer.  The 
standard answer has been to get expert help.  However, it can be hard for experts to give 
farm specific recommendations because preferences and situations vary from farm to 
farm.  Experts also have a hard time calculating uncertainty.  By developing a model for 
decision support, individualism and complexity of each farm and the problem of interest 
can be accounted for (Kristensen and Jørgensen, 1998).  
 Cox (1996) described decision support tools (DST) as ways for researchers to 
make their data usable to farmers and producers.  McCown (2002) examined the use of 
DST in the agriculture industry.  Decision support tools can be broken up into six 
different categories based on their function: Function 1, relating to a property in a certain 
management system, nutrition in dairy cattle.  The second function expands on the 
program by giving it rules, which is function 3, or mathematical models, function 4.  
Function 5 uses risk assessment to provide a “best management practice,” and function 6, 
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performing a what-if analysis.  Not all DST models contain all 6 functions (McCown, 
2002).   
 McCown (2002) argues that there are seven points to take away from DST 
research: 
 1.  Implementing them on farm is difficult.  Thus agreeing with Cox (1996). 
 2.  The use of DST has shifted from making decisions to aiding decisions of 
producers. 
 3.  Farmers try to get the results from the DST with little use and after initial 
benefit there was little use of the DST.   
 4.  Most tools show no reason for continued use after initial benefit. 
 5.  Producers are not programmers; the tools need to have an easy to use interface.  
There needs to be some type of service to help learn how to use the tool. 
 6.  Having producers help with the development of DST will not lead to more use 
by producers. 
 7.  Decision Support Tools are begin used more by consultants in benefit of the 
producers. 
  Implementing a DST on farms is one of the biggest challenges faced by 
developers (Cox, 1996, McCown, 2002).  Many different factors, relating to the seven 
points above, determine the use of a tool by producers.  The purpose of the DST must be 
relatable to producers and help them reach goals of their operation.  The decisions of the 
tools must alleviate or aid in solving a problem that the producer has.  Just as important 
as the information that feeds the DST is the interface.  The tools must be simple to 
understand and to use.        
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 McCown (2002) explained in certain situations DST have been or will be useful 
to the producer.  The main use for a tool should be to help eliminate uncertainty.  For 
example, when making a management change, as a producer enters unfamiliar territory, a 
DST can help guide them.  Another use is to help simplify complex data.  Tools can store 
complex data and make it readily available and useable to producers.  Decisions on farms 
are often complicated and intertwined in which DST can account for different outcomes 
and possibilities providing a producer with a guided decision.  McCown (2002) argues 
that two other reasons producers have adapted the use of decision support technologies is 
when there is a problem that they need guidance solving or when trying to meet 
regulations. 
 McCown (2002) states three things that both developers and producers need to 
think about when it comes to DST.  Developers need to focus on making models realistic 
representations of farming, make the software easy to use, and make the tool easily 
accessible to make it more attractive to producers.  Producers need to ask: Does the DST 
help them with management or problems they are currently experiencing, is the DST 
relevant to their operation, and finally can the DST support local data or data from their 
operation. 
UNDERSTANDING OF MANAGEMENT COSTS 
 When calculating the cost of a high SCC, mastitis or any disease there are two 
aspects of the cost: the cost due to production loss and the cost associated with the 
treatment of the disease.  Milk production loss, due to the decreased milk production 
from having a high SCC or mastitis and to having to discard the milk due to 
contamination, is the loss of concern to a dairy.  In some cases, there may be gains from 
27 
 
the disease, for example, a decrease in milk production lead to less feed consumption.  In 
this case, reduced feed cost is subtracted from cost of lost milk production.  Expenses of 
treating a case are often straight forward, the cost of drugs or veterinary visits, but the 
expenses of prevention are hidden.  Cost of vaccinations, dry-cow treatment, or teat 
sealants are foreseeable, but other costs, such as bedding, maintenance of housing area, 
pre-dip, post-dip, and feed additives, are considered standard costs.  Some producers tend 
to control treatment costs while others tend to control prevention costs.  What a producer 
should be examining is the ‘marginal criterion.’  Meaning, when spending another dollar 
on prevention, how much will it save in treatment.  If treatment costs are lower, more 
should be spent on prevention, if there is no change the extra costs are not worth it.  
When a dollar towards prevention saves a dollar in treatment, this is referred to as the 
“optimum position” (McInerney et al., 1992), point M in Figure 1.1.  When examining an 
optimum SCC, once cost for prevention methods and treatments have increased to the 
point where there is no additional output in milk production or bonuses from the 
cooperative, the optimal SCC has been reached. 
 Hogeveen et al. (2011) researched this theory from McInerney et al. (1992) with a 
case of mastitis, comparing expenditures and losses.  If there were no expenditures, there 
was a max in losses and if no losses, a max in expenditures.  A value was calculated for 
each loss and expenditure that would typically go into treating a case of mastitis.  For 
example, losses may include: loss of milk production or increased treatment cost due to a 
case of mastitis.  In order for expenditures to be cost effective, expenditures must cost 
less than the losses that were avoided from having the expense.  Six expenses are cost 
effective for producers to implement in their operations.  Those six include from greatest 
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effect to least: blanket dry cow therapy, keeping cows standing after milking, back 
flushing the milking unit after milking a cow with CM, having a treatment protocol, and 
having milkers wear gloves.  By implementing these practices, producers can save 
anywhere from $9.00 to $41.00 per cow.  The practices with the lowest net benefit are 
back flushing a unit after milking a cow with SCM and milking cows with SCM last.  
 Barkema et al. (1998b) determined how management practices differed from high, 
medium, and low bulk milk somatic cell count (BMSCC) records, determining that 
management practices can have an effect on BMSCC.  The most influential factors were: 
post milking teat disinfection, duration of treatment on a CM case, and no drying after a 
wet pre-milking treatment.  Low BMSCC herd paid extra attention to dry cow therapy, 
hygiene, and nutrition.   
SUMMARY 
 Evaluating the cost of mastitis cases is very important to the dairy industry, with 
mastitis being one of the most costly diseases in the industry.  Not only is it important to 
calculate the direct cost of mastitis: drug cost, veterinarian fees, culling, and labor but 
also the indirect costs due to lost milk production and lost premiums.  Many of the 
models calculating milk loss associated with poor milk quality are out dated and milk 
production of dairy cattle has increased.  Recent studies have shown higher losses than 
the standard still used in the industry today.  Producers need to find the right balance of 
costs due to losses and trying to prevent mastitis cases.  Many of the costs associated with 
prevention are often over looked because they are considered standard costs but these 
must also be taken into account. 
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 Many producers are unsure or have the wrong estimate of what a case of mastitis 
costs them (Hogeveen et al., 2011).  Decision Support Tools may be of benefit.  A DST 
can calculate the cost of mastitis for a farm by allowing a producer to enter farm specific 
inputs.  Tools can also be developed to educate producers on how milk quality on their 
operation is affecting them economically.  A developer of the DST must make the tool 
easy to use, easily accessible, and realistic to the farming operation.   
 This thesis contains three objectives.  The first is to calculate the milk production 
loss with an increase in somatic cell count adapting the model used by with current 
production data.  The second is to use the new data to determine economically optimum 
treatment decisions for mastitis cases.  The final objective is to determine what producers 
are spending on mastitis management and treatment and evaluate their understanding of 
the cost of mastitis.       
30 
 
Figure 1.1.  The relationship between output losses (L) and control expenditures (E), 
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Mastitis is one of the most costly diseases in the dairy industry.  The largest 
contributor to the mastitis costs is lost milk production (Shim et al., 2004).  The costs 
associated with mastitis can be reduced with prevention and early detection.  Subclinical 
mastitis can be detected by examining and testing somatic cell counts (SCC) in milk.  
The presence of somatic cells in the mammary gland is due to an inflammatory 
response.  When the mammary gland becomes infected with bacteria, somatic cells 
respond in order to eliminate the bacteria and help in the healing process.  Three main 
cells make up most of the white blood cells that respond to an infection.  White blood 
cells include macrophages, lymphocytes, and polymorphonuclear neutrophil (PMN) 
leukocytes (Harmon, 1994).  The PMN are a key defense mechanism in the udder, 
engulfing foreign bacteria.  During a period of inflammation in the udder, PMN are the 
main source of an increased SCC but SCC can remain high after an infection, depending 
on the infecting pathogen or stage of lactation. 
Average lactation SCC is skewed with the mean being higher than the median 
(Ali and Shook, 1980).  To conduct an analysis of variance, three limits need to be met: 
1) the data must be collected randomly from a normal population 2) the sampled 
population must have equal variances 3) the effects of the factors must be additive (Ali 
and Shook, 1980).  Transforming SCC data can correct these limitations.   
 Ali and Shook (1980) examined different ways SCC data can be transformed to 
overcome the analysis limits and determined the log transformation was an effective 
transformation.  Results from the study were used in further analyses to calculate somatic 
cell score (SCS) (Wiggans and Shook, 1987): 
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𝑆𝐶𝑆 =  𝑙𝑜𝑔2 (
𝑆𝐶𝐶
100
) + 3 
 Raubertas and Shook (1982) completed one of the first studies to examine the 
effects of log SCC on 305 d lactation milk yield, determining that with an increase of one 
unit of SCS, 135 ± 20 kg and 270 ± 30 kg of milk were lost in the first and later 
lactations, respectively.  Hand et al. (2012) more recently examined the effects of SCS on 
milk production, modeling the effects differently, determining the effect of test-day (TD) 
SCS on test-day milk yield.  Hand et al. (2012) also accounted for different production 
levels of dairy cattle, categorizing production levels into high, medium, and low and 
adding production level as a variable in the model.  In this research, SCS had a greater 
impact on milk production but followed the same trend of multiparous losing about 50% 
more milk throughout the lactation than primiparous cows (Hand et al., 2012).  Hand et 
al. (2012) suggested that differences in results for previous literature may be because of 
differences in geographic location or analysis or modeling techniques.  Results from 
Raubertas and Shook (1982) are the most widely used and accepted in the dairy industry. 
The objective of the current study was to use the log transformation of SCC, 
displayed as SCS, to determine its effect on milk production in dairy cattle in 
southeastern United States.  Data in the current analysis were cleaned and analyzed as 
closely as possible to Raubertas and Shook (1982).  Other objectives included 1) to 
describe the effect of TD SCS on TD milk yield, 2) to describe the first test-day SCS 
effect on 305 d lactation milk yield, 3) to describe the effect of calving season on milk 
yield and SCS, and 4) to describe the relationship between SCS and DIM.   
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MATERIALS AND METHODS 
Dairy Records Management Systems (DRMS) (Dairy Records Management 
Systems, Raleigh, NC) data were collected from 6 different states (Tennessee, Kentucky, 
Virginia, Georgia, Florida, and Mississippi) involved in the Southeast Quality Milk 
Initiative project.  .  The original data consisted of over 1.5 lactation records from the 6 
states from 2007 to 2016.  To be included in all further analyses Holstein cow lactations 
needed to have a lactation length between 240 and 365 days.  Raubertas and Shook 
(1982) included cows with a lactation length between 240 and 305 days, but stated that 
this might have excluded higher producing cows that would have a longer lactation.  
Ludwick and Petersen (1943) explained that length of lactation did have an effect on milk 
yield.  Because of the statement made by Raubertas and Shook (1982), the current 
analysis included cows with lactation length of 365 d instead of 305 d from previous 
models.  The data sets were analyzed similarly with our model including the same 
variables recorded by Raubertas and Shook (1982) and by analyzing 305 d milk yield.   
To also be included in the analysis: cows had to be within two standard deviations 
of the average age at calving of all cows included in the data set, and have at least four 
test dates within a lactation.  Age was calculated, in months, from the data by taking the 
cow’s calving date for the lactation of interest minus her birthdate.  Inclusion in the data 
set also required cows to have an average milk yield under the first percentile of the 
lactation population’s yield.  Only cows from herds with at least 5 cows meeting these 
requirements were included in the final data set.  Three models were used to model 
different effects of SCS on milk production.  The model included lactation average SCS 
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on total 305 d milk production, TD SCS on TD milk yield, and the lactation’s first test 
(FT) SCS effect on total milk yield.   
The Effect of Lactation SCS on 305 d Milk Yield 
 Datasets were separated by lactation, so that parities 1 to 4 were analyzed 
separately.  Calving seasons were separated into the seasons of the year, Winter 
(December 21 to March 19), Spring (March 20 to June 20), Summer (June 21 to 
September 21), and Fall (September 22 to December 20), based on calving date.  
Division of SCS into groups allowed for analysis of interactions between SCS and other 
independent variables on milk yield.  Somatic cell score groups consisted of group 1 (0 < 
SCS ≤ 1), group 2 (1 < SCS ≤ 2), group 3 (2 < SCS ≤ 3), group 4 (3 < SCS ≤ 4), group 
5(4 < SCS ≤ 5), group 6 (5 < SCS ≤ 6), group 7 (6 < SCS ≤ 7), group 8 (8 < SCS ≤ 9), 
and group 9 (9 < SCS).  When examining the effect of TD SCS on TD milk yield and FT 
on 305 d milk yield a tenth SCS group was created (9 < SCS ≤ 10).  Somatic cell score 
group then replaced the variable of SCS in Models 2.1, 2.2, and 2.3 when examining 
interactions with categorical variables.  The MEANS procedure in SAS was used to 
calculate averages of lactation length, age, 305 d milk yield, and SCS for each parity 1 to 
4.  Seasonal SCS trends were also examined using the MEANS procedure in SAS.  
Model 2.1 was analyzed using the GLM procedure in SAS 9.4 (SAS Inc., Cary, NC).    
Model 2.1: GLM model used to determine the effect of lactation average SCS on 305 d 
milk yield.  




Yijklm = 305 d lactation milk yield 
Hi = effect of the ith herd 
M j= effect of jth calving season 
Dk  = effect of the kth days the cow was in lactation 
Al = effect of the lth age at calving 
Sm = effect of mth SCS 
Ɛijklmn  = residual error 
The Effect of Test-Day SCS on Test-Day Milk Yield 
If a cow did not have at least four TD, all TD records from that cow were 
removed from the data set.  Cow’s DIM were grouped every 30 d of lactation to provide a 
stage of lactation.  Stage of lactation 1 included DIM 1 to 30 and stage increments 
increased every 30 d to DIM 331 to 365 representing stage of lactation 12.  To compare 
the interaction of SCS and categorical variables and their effects on milk yield, SCS 
group replaced SCS in Model 2.2.  Parities 1, 2, 3 and 4 were analyzed separately.  The 
MEANS procedure in SAS was used to examine averages of age, TD SCS, TD milk 
yield, and lactation length for each lactation.  The MEANS procedure was also used to 
examine trends between calving season and TD SCS and trends between stage of 
lactation and TD SCS.  Model 2.2 was used to determine the effect of TD SCS on TD 
milk yield using the HPMIXED procedure of SAS 9.4.   
Model 2.2:  HPMIXED model used to determine the effect of TD SCS on TD milk yield. 
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𝑌𝑖𝑗𝑗𝑘𝑙𝑚𝑛 = 𝐻𝑖 + 𝐶𝐽(𝑖) + 𝐷𝑘 + 𝑀𝑙 + 𝐴𝑚 + 𝑆𝑛 + 𝜀𝑖𝑗𝑘𝑙𝑚𝑛 
Where: 
Yijklmn = test-day milk yield 
Hi = effect of the ith herd 
Cj(i) = effect of jth cow in ith herd 
Dk  = effect of the kth stage of lactation 
Ml = effect of lth calving month 
Am = effect of the mth age at calving 
Sn = effect of nth SCS 
Ɛijklmn  = residual error 
The Effect of First-Test SCS on Lactation Milk Yield 
The FT dataset included an additional variable being the previous lactations last-
test (LT) SCS.  Parities 1, 2, 3, and 4 were analyzed separately.  Parity 1 data set did not 
include the LT SCS from the previous lactation because they were currently in their first 
lactation.  Both LT SCS and current lactations FT SCS were grouped and replaced the 
SCS variable in the model to examine interaction effects.  The MEANS procedure in 
SAS was used to examine averages of age, TD SCS, TD milk yield, and lactation length 
for each lactation.  The MEANS procedure was also used to examine trends between 
calving season and FT and LT SCS.  Model 2.3 used the GLM procedure in SAS 9.4 to 
test the effect of the FT SCS on 305 d milk yield. 
Model 2.3: GLM model for the effect of the FT SCS on 305 d milk yield. 




Yijklmno = 305 dmilk yield 
Hi = effect of the ith herd 
Cj(i) = effect of jth cow in ith herd 
Dk  = effect of the kth length of lactation 
Ml = effect of lth calving season 
Am = effect of the mth age at calving 
Sn = effect of nth first test SCS 
Po = effect of oth SCS of last test of previous lactation 
Ɛijklmno  = residual error 
RESULTS AND DISCUSSION 
The Effect of Lactation SCS on 305 d Milk Yield 
Each data set for parities 1 through 4 consisted of 163,081; 129,798; 81,121; and 
44,317 cows, respectively.  First lactation animals averaged lower milk yield and a lower 
SCS than older lactations, and fourth lactation cows averaged the highest milk production 
and SCS (Table 2.1).  Of the cows 85.36%, 84.35%, 77.56%, and 72.16% for lactations 
1, 2, 3, and 4, respectively had a lactation average SCS less than 4, which is considered a 
healthy mammary gland (Dohoo and Leslie, 1991).   
Regression coefficients for SCS on 305 d milk yield were negative for each 
parity, with parity 1 having the lowest coefficient and parity 2 having the highest, 
meaning an increase in SCS has the greatest effect in parity 2 cows.  Table 2.3 contains 
the regression statistics for Model 2.1.  All coefficients in the model were highly 
significant (P < 0.001).  For each 1 mo increase in age at calving, cows produced 51.06 ± 
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1.70, 62.35 ± 1.37, 29.62 ± 1.44, and 11.34 ± 1.68 kg more milk per 305 d lactation for 
parities 1, 2, 3, and 4, respectively.  Raubertas and Shook (1982) presented similar results 
with age affecting parity 2 cows the most and parity 4 cows the least.  As lactation length 
increased by one day, 305 d milk yield increased by 16.60 ± 0.12, 21.57 ± 0.15, 22.59 ± 
0.22, and 21.99 ± 0.27 kg of milk over the course of a lactation for parities 1, 2, 3, and 4, 
respectively.  An increase in 305 d milk yield is to be expected, as cows with longer 
lactations would produce more milk throughout the lactation (Ludwick and Petersen, 
1943). 
As SCS increased by one unit, 305 d milk yield decreased by 106.50 ± 2.47, 
222.22 ± 3.25, 204.31 ± 4.01, and 197.70 ± 5.26 kg for parities 1, 2, 3, and 4, 
respectively.  When SCS were distributed into the SCS groups, as group number 
increased 305 d milk yield decreased (P < 0.05).  Results from the study were similar to, 
but slightly less than, Raubertas and Shook (1982).  Somatic cell score regression 
coefficient results for parity 1 were about 50% of the later lactations regressions.  
Raubertas and Shook (1982) reported losses of 134 ± 805 kg of milk with an increase in 
log SCC for primiparous cows, and an average loss of 260 ± 648 kg per unit increase in 
log SCC for multiparous cows.  Effects of SCS on 305 d milk production were also 
similar to Miller et al. (2004).  Miller et al. (2004) presented a lactation milk loss of 125 
kg per increase in SCS for parity 1 cows and 226 kg for later parity cows.  Laevens et al. 
(1997)  presented no differences in SCC between parities when the mammary gland was 
considered healthy, but in the current analysis, milk losses occurred between all SCS 
groups.   
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Milk loss is experienced because of the infection in the mammary gland and the 
effects of bacteria on mammary epithelial tissue (Zhao and Lacasse, 2008).  If bacteria 
levels in the gland rise high enough, damage to the mammary epithelium occurs.  
Somatic cell count increases as the duration of the infection increases and as the infection 
persists, more damage to the tissue occurs and structure of the alveoli is compromised 
(Zhao and Lacasse, 2008).  Least squares means for 305 d yield associated with each SCS 
group are presented in Table 2.5.  With each increase in a SCS group, milk yield 
decreased.  However, unlike past research (Raubertas and Shook, 1982, Bartlett et al., 
1990, Hand et al., 2012) the relationship between a change in SCS and milk yield is non-
linear.  The decrease in milk yield between SCS group 4 and 5 (SCS range: 3.1 to 5.0) 
was not significant (P > 0.05) across all parities.  As SCS range groups increased, 305d 
milk yield tended to decrease, with the most drastic losses occurring between SCS groups 
8 and 9. 
Somatic cell scores tended to differ between calving seasons.  Primiparous cows 
that calved in the spring tended to have higher lactation average SCS than primiparous 
cows that calved in any other season (Table 2.2).  Multiparous cows that calved in the 
summer tended to have higher lactation average SCS than those that calved in other 
seasons.  Olde Riekerink et al. (2007) found that season had a significant impact on bulk 
tank SCC and individual SCC but concluded that season was not the sole reason for 
changes in SCC.  Changes in SCC are due to changes in infection rate and pathogen 
prevalence.  Olde Riekerink et al. (2007) suggested that increased risk of clinical mastitis 
and changes in pathogen prevalence that are associated with changing seasons were 
reasons for changes in SCC.  Smith et al. (1985) concluded that increased intramammary 
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infection could be due to varying bacteria loads in bedding material with changes of 
season.  
Least square means for 305 d milk yield compared to SCS group and calving 
season are presented in Table 2.6.  Calving season was also a significant (P < 0.001) 
predictor of 305 d milk yield of dairy cattle.  Cows that calved in the fall produced more 
(P < 0.05) milk throughout their lactation than cows that calved in any other season.  
Descriptive statistics for 305 d milk yield by calving seasons are reported in Table 2.4.  
The relationship between SCS group and season did have a significant impact (P < 
0.0001) on 305 d milk yield.  Cows that calved in the fall or winter tended to have the 
highest milk production regardless of lactation or SCS group, where calving in the spring 
or summer led to the lowest milk yield throughout the lactation.  Decreased milk 
production for cows calving in the summer months can be due to the decreased DMI and 
physiological changes that occur when a cow experiences heat stress (West, 2003).  
Calving season had more of an impact on lactation milk yield when SCS groups were 
lower.  As SCS increased, seasonal differences (P < 0.05) became less.  The lack of 
impact of season was more evident for cows in their first or second parities.   
The Effect of Test-Day SCS on Test-Day Milk Yield 
Parities 1, 2, 3, and 4 consisted of 1,221,407; 941,507; 595,191; and 318,706 TD 
records respectively.  Averages for daily milk production followed similar trends to 
lactation averages with parity 1 producing the lowest and parity 4 the highest.  Daily SCS 
trends were the same, with parity 1 scoring the lowest and parity 4 the highest in TD 
SCS.  Most of the cows in each parity, 81.16%, 79.02%, 73.08%, and 68.64% for parities 
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1, 2, 3, and 4 respectively, averaged a TD SCS ≤ 4.  Table 2.7 displays average TD milk 
yield, TD SCS, and age for each parity.   
Parity 1 resulted in the lowest regression coefficient and parity 2 the highest 
followed by parities 3 and 4, respectively.  With each unit increase in TD SCS, TD milk 
yield decreased by 1.04 ± 0.01, 1.96 ± 0.01, 1.92 ± 0.01, and 1.86 ± 0.01 kg for parity 1, 
2, 3, and 4, respectively.  Regression results of the impact of TD SCS and age on TD 
milk yield are presented in Table 2.10.  All variables were highly significant (P < 0.001).   
Results for TD milk losses are similar to those published in other studies.  Jones et 
al. (1984) reported a milk loss between 0.36 and 1.03 kg of milk/d with a one unit 
increase in linear SCC depending on herd production.  Bartlett et al. (1990) reported an 
average milk loss of 1.17 kg/d for any cow with a SCS > 0.  In more recent studies, Dürr 
et al. (2008) reported a milk loss between 0.49 and 0.52 kg for first parity cows and 
losses of 0.88 to 1.80 with a one point increase in SCS for second and later parity cows.  
Hand et al. (2012) accounted for production levels when modeling the effect of SCS on 
milk loss.  Daily milk loss ranged from 0.35 to 4.70 kg of milk per cow per day.  
By examining least squares means of milk yield for the different stages of 
lactation, the persistency of lactation for each parity can be determined (Table 2.11).  
Parity 1 milk yield persisted longer than parities 2, 3, and 4.  Milk yield peaked for 
parities 2, 3, and 4 in the second stage of lactation (DIM 31 to 60) and during the third 
stage (DIM 61 to 90) for parity 1.  Additionally, yields dropped below the first stage milk 
yield during the sixth stage of lactation for parities 2, 3, and 4.  Test-day milk yields did 
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not drop below the first stage of lactation’s production level until stage of lactation 10 for 
primiparous cows.   
Somatic cell scores also tended to change with stage of lactation.  All parities 
tended to have a higher SCS in the first stage of lactation.  However, in the second stage, 
parities 2, 3, and 4 experienced the lowest SCS of the lactation.  Parity 1 experienced the 
lowest TD SCS during the fifth stage of lactation.  As lactation progressed, all lactations 
experienced an increase in TD SCS.  During stage of lactation 7, multiparous cows’ TD 
SCS rose above the first stage of lactation’s TD SCS and experienced the highest TD 
SCS during the last stage of lactation.  Primiparous cows’ TD SCS never rose above the 
first stage of lactations TD SCS.  Ng-Kwai-Hang et al. (1984) and Laevens et al. (1997) 
presented similar results with a high SCS right after calving (30 DIM) and an increase 
toward the end of lactation.  The distribution of TD SCS by stage of lactation is presented 
for the current analysis in Table 2.9.  de Haas et al. (2002) concluded that infection status 
largely affects the lactation curve for SCC, stating lactation curves of uninfected cows 
tended to drop shortly after the beginning of the lactation while SCC remained high in 
infected quarters.  Smith et al. (1985)  reported higher IMM infection rates within the 
first 76 DIM which would account for a higher SCC, because SCC are an inflammation 
response (Kehrli and Shuster, 1994).    
Descriptive statistics of average SCS by calving season are located in Table 2.8.  
Cows that calved in fall had a lower TD SCS on average.  Multiparous cows that calved 
in the summer tended to have a higher TD SCS throughout the lactation.  Primiparous 
cows that calved in the spring had a higher TD SCS throughout the lactation.  Calving 
season had a significant effect on TD milk yield.  Much like the pattern of 305 d milk 
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yield, cows calving in the Fall and Winter had a higher TD milk yield than those calving 
in the Spring or Summer (Table 2.12).  Halasa et al. (2009) concluded that calving season 
did not significantly affect TD milk yield.  Hand et al. (2012) grouped months into cool 
and warm seasons and found that season did not have a significant impact on daily milk 
yield.  In the current analysis, the relationship between TD SCS group and calving season 
did significantly affect TD milk yield.  No matter the SCS group, cows that calved in the 
fall tended to have a higher TD milk yield average.  However, unlike lactation milk yield, 
less of a pattern was established between season and SCS groups (Table 2.13).  More 
significant differences (P < 0.05) were experienced with a higher SCS than when 
examining lactation milk yields.  Though others have examined the effect of SCS on TD 
milk yield with the effect of season (Jones et al., 1984, Halasa et al., 2009, Hand et al., 
2012), none, to the authors’ knowledge have examined the relationship of SCS and 
calving season.   
The Effect of First Test-Day SCS on Lactation Milk Yield 
 Parities 1, 2, 3, and 4 consisted of 158,616; 63,549; 56,142; and 32,947 cows, 
respectively.  Cow numbers are smaller for multiparous data sets because cows were 
required to have a LT SCS.  Table 2.14 displays descriptive statistics for 305 d milk 
yield, FT SCS, LT SCS, lactation length and age.  Total milk yield increased with every 
lactation.  First-test SCS was highest in fourth parity cows followed by first, third, and 
second parities.  Previous lactation’s last test SCS was lowest in second parity cows 
followed by third and fourth parities.  The average SCS decreased from LT to FT. 
 As FT SCS increased by one unit, 305 d milk yield decreased by 77.48 ± 1.85, 
107.24 ± 3.35, 99.58 ± 3.38, and 111.77 ± 4.45 kg for parities 1, 2, 3, and 4 respectively.  
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Regression coefficients for FT SCS, LT SCS, age, and lactation length are presented in 
Table 2.15.  When breaking SCS into groups, as group number increased with higher 
SCS, milk yield decreased (P < 0.05).  Least squares means for 305 d milk production 
associated with each group are displayed in Table 2.18.  Milk losses ranged from 40.57 
kg between SCS groups 3 and 4 for fourth parity cows to losses of 245.68 kg per lactation 
between SCS groups 4 and 5 for cows in their fourth parity.  Losses ranged widely 
between SCS groups and across parity; losses between SCS groups 1 and 2 for 
primiparous cows were 63.92 kg while losses between SCS groups 4 and 5 for second 
parity cows was 198.78 kg over the lactation.  The largest losses tended to be between 
SCS groups 9 and 10 for all lactations.  Results are consistent with past research.  Coffey 
et al. (1986) found first lactation cows experienced milk losses of about 400 kg when 
SCS raised from < 1 to between 1 and 2 and then another 400 kg when SCS raised from 
between a 2 and 4 to > 4.  Losses were similar for later parities except when SCS 
increased from between 2 and 4 to > 4, losses were less than 100 kg throughout the 
lactation.  De Vliegher et al. (2005) concluded that losses were 119 kg over the course of 
the lactation for a primiparous cow with a SCC over 500,000 cells/mL compared to a 
primiparous cow with a FT SCC under 500,000 cells/mL. 
 First-test SCS tended to change with calving season.  Calving in the summer led 
to a higher average FT SCS for all parities.  Primiparous cows that calved in the fall 
tended to have the lowest FT SCS when compared to other first lactation cows, while 
multiparous cows that calved in the winter had the lowest SCS.  Descriptive statistics of 
FT SCS by calving season are located in Table 2.16.  Cows that calved in the fall 
produced more (P < 0.05) milk than their herdmates for parities 1, 3, and 4 (Table 2.17).  
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Second parity cows produced the most milk when calving in the winter.  For parities 2, 3, 
and 4, calving in the summer resulted in lower milk yield (P < 0.05).  Primiparous cows 
that calved in the summer or spring produced less (P < 0.05) throughout a 305 d lactation.  
Season has affected both SCS and milk yield in past research (Ng-Kwai-Hang et al., 
1984, Coffey et al., 1986, De Vliegher et al., 2005).  Ng-Kwai-Hang et al. (1984) 
reported highest milk yield and lowest SCS in June, but suggested that this was when 
cows in the study were at peak production.  Differences may also be due to management 
styles of dairy farms.  Ng-Kwai-Hang et al. (1984) explained that keeping cows inside 
during the winter could result in higher mastitis rates.  De Vliegher et al. (2005) 
presented similar results as the current analysis with small differences in TD milk yield 
and the highest production in winter months.   
Unlike other analyses, the current analysis examined the interaction between SCS 
group and calving season.  The interaction of FT SCS group and calving season affected 
(P < 0.05) lactation milk yield.  Much like the lactation average SCS, the effect season 
became insignificant, as SCS groups were higher, for first and second lactation cows 
(Table 2.19).  Results tended to follow the same pattern of season, with Fall and Winter 
being different (P < 0.05) than Spring and Summer regardless of SCS group, especially 
in parities 3 and 4.   
Like with the other modeling methods, lactation average SCS and TD SCS, these 
results suggest that with an increasing SCS, calving season becomes less of a factor in 
milk yield.  Therefore, SCS need to be managed throughout lactation no matter calving 
season.  Cows in the highest SCS group that calved in the Winter or Fall had similar milk 
production to cows with a low SCS calving in the Spring or Summer.  These seasonal 
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differences may provide opportunities for dairy producers to manage cows that 
consistently have a high SCS.          
CONCLUSIONS 
  The effect of SCS on milk yield has been modeled many different ways and in 
different regions over the past 30 years.  The results from Raubertas and Shook (1982) 
are widely accepted by the industry, which was the reason the current model and data sets 
were adapted so closely to theirs.  Milk production loss, whether examined daily or by 
lactation, continues to be a factor in the industry today.  The cost associated with the loss 
of milk yield is the largest economic contributor to poor milk quality (Swinkels et al., 
2005, Pinzon-Sanchez et al., 2011, Steeneveld et al., 2011).  Even though the percent of 
milk yield lost with each increase in SCS has changed minimally, milk production loss is 
still a major factor that dairy operation management needs to address.   
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Table 2.1.  Mean and standard deviations of 305 d milk yield, lactation length, SCS, and age along with the number of cows and herds 
collected from Dairy Records Management Systems from 2009 to 2016.  Cows included Holsteins from any herd size from dairy 
farms enrolled in the Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 Parity 
Variable 1 2 3 4 
305 d milk yield (kg)1 8,785 ± 1,788 9,971 ± 2,169 10,398 ± 2,291 10, 452 ± 2,333 
Lactation length (d)2 312 ± 28 310 ± 29 310 ± 30 310 ± 31 
SCS3 2.43 ± 1.44 2.58 ± 1.43 2.92 ± 1.54 3.15 ± 1.63 
Age at calving (mo)4 25 ± 2 38 ± 3 52 ± 4 65 ± 5 
Number of cows5 163,081 129,798 81,121 44,317 
Number of herds6 1,038 1,027 973 899 
1Average 305 d milk yield ± standard deviation by parity 
2Avergage lactation length in d ± standard deviation by parity 
3Average lactation SCS ± standard deviation by parity 
4Average age at calving in mo ± standard deviation by parity 
5Number of TD records included in each parity’s data set 





Table 2.2.  Mean and standard deviations of lactation average SCS by calving season for 
parities 1, 2, 3, and 4 of cows enrolled in the Dairy Herd Information program from 2009 
to 2016.  Cows included Holsteins from any herd size from dairy farms enrolled in the 
Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, 
and Mississippi. 
 Parity 
Season  1 2 3 4 
Spring 2.57 ± 1.46 2.63 ± 1.42 2.93 ± 1.51 3.16 ± 1.59 
Summer 2.49 ± 1.42 2.69 ± 1.42 3.01 ± 1.50 3.24 ± 1.58 
Fall 2.27 ± 1.41 2.51 ± 1.43 2.86 ± 1.55 3.09 ± 1.65 
Winter 2.44 ± 1.47 2.52 ± 1.44 2.88 ± 1.59 3.13 ± 1.69 
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Table 2.3  Regression coefficients for the effects of lactation length, age, and SCS on 305 
d milk yield (kg)4 for parities 1, 2, 3, and 4 cows.  Cows included Holsteins from any 
herd size from dairy farms enrolled in the Dairy Herd Improvement program in 
Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 Parity 
Variable* 1 2 3 4 
SCS1 -106.50 ± 2.47 -222.22 ± 3.25 -204.31 ± 4.01 -197.70 ± 5.26 
Lactation length 
(d)2 
16.60 ± 0.12 21.57 ± 0.15 22.59 ± 0.20 21.99 ± 0.27 
Age at calving 
(mo)3 
51.06 ± 1.70 62.35 ± 1.37 29.62 ± 1.44 11.34 ± 1.68 
*All variables were highly significant (P < 0.0001) 
1Regression coefficients ± standard error for increase in SCS effects on total milk yield 
by parity 
2Regression coefficients ± standard error for each increase in the lactation length in d 
effects on total milk yield by parity  
3Regression coefficients ± standard error for each increase in age at calving in mo effects 
on total milk yield by parity 
4Collected from Dairy Records Management Systems (Dairy Records Management 
Systems, Raleigh, NC) from 2009 to 2016 
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Table 2.4.  Least squares means (± SE) 305 d milk yield (kg)1 for parities 1, 2, 3, and 4 
cows that calved in the spring, summer, fall and winter from 2009 to 2016.  Cows 
included Holsteins from any herd size from dairy farms enrolled in the Dairy Herd 
Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, and 
Mississippi. 
 Parity 
Season 1 2 3 4 
Spring 7,896 ± 11a 8,959 ± 14a 9,385 ± 21a 9,539 ± 29b 
Summer 7,881 ± 10a 8,774 ± 12b 9,259 ± 15b 9,345 ± 21c 
Fall 8,036 ± 10b 9,092 ± 12c 9,715 ± 14c 9,906 ± 18a 
Winter 7,961 ± 10c 9,166 ± 13d 9,741 ± 16c 9,926 ± 22a 
 a, b, c Significantly different 305 d milk yield between seasons within parity.   
1Collected from Dairy Records Management Systems (Dairy Records Management 




Table 2.5.  Least squares means (± SE) of 305 d milk yield (kg)1 associated with a SCS 
grouping2 for parity 1, 2, 3, and 4 cows.  Cows included Holsteins from any herd size 
from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, 
Kentucky, Virginia, Georgia, Florida, and Mississippi. 
  Parity 
Number SCS Range 1 2 3 4 
1 0.0 to 1.0 8,225 ± 12a 9,612 ± 16a 10,258 ± 25a 10,454 ± 37a 
2 1.1 to 2.0 7,998 ± 10b 9,234 ± 12b 9,814 ± 15b 10,026 ± 22b 
3 2.1 to 3.0 7,857 ± 10c 8,866 ± 12c 9,483 ± 15c 9,662 ± 21c 
4 3.1 to 3.0 7,836 ± 11cd 8,708 ± 14d 9,285 ± 17d 9,502 ± 23d 
5 4.1 to 5.0 7,815 ± 14d 8,682 ± 17d 9,283 ± 20d 9,483 ± 20d 
6 5.1 to 6.0 7,712 ± 18e 8,572 ± 23e 9,170 ± 25e 9,351 ± 32e 
7 6.1 to 7.0 7,475 ± 29f 8,369 ± 34f 8,975 ± 36f 9,166 ± 42f 
8 7.1 to 8.0 7,190 ± 64g 7,912 ± 64g 8,665 ± 66g 8,742 ± 78g 
9 8.1 to 10.0 6,755 ± 203h 7,376 ± 194h 8,204 ± 172h 8,106 ± 219h 
a, b, c, d, e Significantly different 305 d milk yield between seasons within lactation.  
1Collected from Dairy Records Management Systems (Dairy Records Management 
Systems, Raleigh, NC) from 2009 to 2016 
22SCS group determined by SCS, split into 5 groups to provide even distribution of cows 





Table 2.6.  Least squares means (± SE) for 305 d milk yield (kg)1 associated with SCS group2 and season of the year for parity 1, 2, 3, 
and 4 cows.  Cows included Holsteins from any herd size from dairy farms enrolled in the Dairy Herd Improvement program in 
Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
   Parity 
SCS Group SCS Range  Season 1 2 3 4 
1 0.0 to 1.0 
Spring 8,152 ± 22a 9,607 ± 35a 10,138 ± 62a         10,397 ± 92a  
Summer 8,185 ± 19a 9,448 ± 26b 10,098 ± 42a         10,343 ± 66a 
Fall 8,320 ± 16b 9,685 ± 23ac 10,479 ± 34b         10,635 ± 48b  
Winter 8,241 ± 19c 9,709 ± 27c 10,317 ± 43c         10,443 ± 63a  
2 1.1 to 2.0 
Spring 7,948 ± 16a 9,153 ± 22a 9,674 ± 33a           9,883 ± 50a  
Summer 7,964 ± 19a 9,039 ± 18b 9,620 ± 24a           9,762 ± 35b  
Fall 8,082 ± 13b 9,372 ± 17c 9,997 ± 22b         10,218 ± 31c  
Winter 8,010 ± 14c 9,370 ± 18c 9,968 ± 25b         10,242 ± 36c  
3 2.1 to 3.0 
Spring 7,835 ± 17a 8,843 ± 28a 9,346 ± 31a           9,493 ± 46a 
Summer 7,798 ± 15a 8,635 ± 17b 9,218 ± 22b           9,329 ± 32b  
Fall 7,955 ± 15a 8,918 ± 18c 9,658 ± 22c           9,895 ± 31c  
Winter 7,848 ± 16a 9,069 ± 20d 9,708 ± 26d           9,934 ± 37c  
4 3.1 to 4.0 
Spring 7,788 ± 20a 8,716 ± 38a 9,128 ± 38a           9,326 ± 52a 
Summer 7,798 ± 18a 8,478 ± 21b 8,979 ± 25a           9,174 ± 35a 
Fall 7,929 ± 19a 8,773 ± 22a 9,467 ± 26b           9,729 ± 34b 
Winter 7,899 ± 20a 8,865 ± 25c 9,567 ± 32c           9,780 ± 42b 
5 4.1 to 5.0 
Spring 7,769 ± 23a 8,647 ± 38a 9,148 ± 48a           9,367 ± 63a 
Summer 7,665 ± 23a 8,401 ± 27b 8,989 ± 31a           9,036 ± 41b  
Fall 7,933 ± 25a 8,772 ± 29c 9,441 ± 31b           9,702 ± 40c 
Winter 7,864 ± 24a 8,910 ± 33d 9,557 ±39c           9,832 ± 50d 
6 5.1 to 6.0 
Spring 7,654 ± 34a 8,549 ± 50a 9,079 ± 63a           9,258 ± 79a  
Summer 7,647 ± 68a 8,282 ± 38a 8,820 ± 41a           8,954 ± 51b 
Fall 7,833 ± 34a 8,708 ± 39b 9,384 ± 40b           9,628 ± 48c 




Table 2.6 (continued) 
 
   Parity 
SCS Group SCS Range  Season 1 2 3 4 
7 6.1 to 7.0 Spring 7,434 ± 56a 8,197 ± 77a 8,833 ± 91a           9,169 ± 108a  
  Summer 7,420 ± 54a 8,144 ± 59a 8,611 ± 61a           8,782 ± 73b 
  Fall 7,523 ± 57a 8,537 ± 61a 9,171 ± 59b           9,310 ± 67c 
  Winter 7,527 ± 54a 8,597 ± 66a 9,286 ± 66b           9,404 ± 77c 
8 7.1 to 8.0 Spring 7,058 ± 133a 7,681 ± 150a 8,844 ± 164a           8,593 ± 208a  
  Summer  7,027 ± 133a 7,607 ± 124a 8,119 ± 122b           8,275 ± 134a 
  Fall 7,523 ± 123a 8,048 ± 113a 8,700 ± 113a           9,110 ± 130b 
  Winter 7,316 ± 113a 8,313 ± 120a 8,999 ± 116a           8,989 ± 134b 
9 8.1 to 10.0 Spring 6,888 ± 557a 7,508 ± 457a 7,397 ± 380a           8,075 ± 540a 
  Summer 6,494 ± 397b 6,704 ± 363b 8,525 ± 371b           7,699 ± 472a 
  Fall 6,759 ± 331a 7,422 ± 344a 8,428 ± 294b           8,451 ± 329a 
  Winter 6,891 ± 292a 7,871 ± 372a 8,468 ± 326b           8,199 ± 374a 
a, b, c, d Significantly different 305 d milk yield  within lactation and somatic cell score group 
1Collected from Dairy Records Management Systems (Dairy Records Management Systems, Raleigh, NC) from 2009 to 2016 




Table 2.7.  Test-day (TD) averages for milk yield, SCS, and age at calving for parities 1, 
2, 3, and 4, along with the number of TD records6 and herds included in each parities data 
set.  Cows included Holsteins from any herd size from dairy farms enrolled in the Dairy 
Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, and 
Mississippi. 
 Parity 
Variable 1 2 3 4 
TD milk (kg)1 29.75 ± 7.28 33.54 ± 10.12 34.73 ± 11.36 35.02 ± 11.39 
TD SCS2 2.41 ± 1.89 2.56 ± 1.93 2.91 ± 2.06 3.12 ± 2.13 
Age at calving (mo)3  25.07 ± 2.36 38.77 ± 3.58 52.13 ± 4.40 65.50 ± 5.20 
TD4 1,333,977 1,054,585 664,708 358,927 
Herds5  1,036 1,026 970 895 
1Average TD milk yield ± standard deviation by parity 
2Average TD SCS ± standard deviation by parity 
3Average age at calving in mo ± standard deviation by parity 
4Number of TD records included in each parity’s data set 
5Number of herds included in each parity’s data set 
6Collected from Dairy Records Management Systems (Dairy Records Management 





Table 2.8.  Means (± SD) of test-day SCS by calving season for parities 1, 2, 3, and 4 of 
cows enrolled in the Dairy Herd Information program from 2009 to 2016.  Cows included 
Holsteins from any herd size from dairy farms enrolled in the Dairy Herd Improvement 
program in Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 Parity 
Season 1 2 3 4 
Spring 2.54 ± 1.90 2.60 ± 1.93 2.89 ± 2.03 3.12 ± 2.11 
Summer 2.47 ± 1.86 2.66 ± 1.88 2.98 ± 1.97 3.21 ± 2.05 
Fall 2.25 ± 1.87 2.48 ± 1.92 2.83 ± 2.06 3.06 ± 2.15 
Winter 2.41 ± 1.94 2.48 ± 1.99 2.83 ± 2.15 3.09 ± 2.25 
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Table 2.9.  Means (± SD) of test-day SCS by DIM group for parities 1, 2, 3, and 4 of cows enrolled in the Dairy Herd Information 
program from 2009 to 2016.  Lactation length ranged from 240 to 365 days.  Cows included Holsteins from any herd size from dairy 
farms enrolled in the Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
  Parity 
Stage of Lactation1 DIM Range 1 2 3 4 
1 1 to 30 3.10 ± 1.92 2.56 ± 1.95 2.87 ± 2.08 3.17 ± 2.16 
2 31 to 60 2.40 ± 1.88 2.09 ± 1.99 2.39 ± 2.15 2.68 ± 2.25 
3 61 to 90 2.28 ± 1.87 2.12 ± 1.99 2.43 ± 2.17 2.68 ± 2.29 
4 91 to 120 2.29 ± 1.88 2.24 ± 1.97 2.52 ± 2.13 2.78 ± 2.24 
5 121 to 150 2.27 ± 1.88 2.35 ± 1.94 2.65 ± 2.09 2.87 ± 2.19 
6 151 to 180 2.28 ± 1.89 2.47 ± 1.91 2.80 ± 2.04 3.00 ± 2.13 
7 181 to 210 2.31 ± 1.89 2.63 ± 1.88 2.97 ± 1.98 3.18 ± 2.09 
8 211 to 240 2.35 ± 1.89 2.81 ± 1.85 3.15 ± 1.93 3.35 ± 2.00 
9 241 to 270 2.38 ± 1.87 2.95 ± 1.79 3.31 ± 1.85 3.52 ± 1.92 
10 271 to 300 2.46 ± 1.86 3.09 ± 1.74 3.48 ± 1.77 3.68 ± 1.85 
11 301 to 330 2.58 ± 1.85 3.24 ± 1.70 3.64 ± 1.72 3.88±  1.79 
12 331 to 365 2.69 ± 1.85 3.38 ± 1.67 3.83 ± 1.70 4.06 ± 1.72 




Table 2.10.  Regression coefficients for the effects of age and SCS on TD milk yield (kg) 
for parity 1, 2, 3, and 4 cows enrolled in the Dairy Herd Information program from 2009 
to 2016.  Cows included Holsteins from any herd size from dairy farms enrolled in the 
Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, 
and Mississippi. 
 Parity 
Variable*  1 2 3 4 
 TD SCS1 -0.42 ± 0.003 -0.83 ± 0.004 -0.82 ± 0.005 -0.80 ± 0.007 
Age at calving (mo)2 0.18 ± 0.003 0.23 ± 0.002 0.12 ± 0.002 0.06 ± 0.003 
*Variables highly significant (P < 0.0001) 
1Regression coefficients ± standard error for increase in SCS effects on TD milk yield by 
parity 
2Regression coefficients ± standard error for each increase in age at calving in mo effects 






Table 2.11.  Least Squares Means (±SE) for the effects of stage of lactation on test-day milk yield (kg) for parity 1, 2, 3, and 4 cows 
enrolled in the Dairy Herd Information program from 2009 to 2016.  Lactation length ranged from 240 to 365 days.  Cows included 
Holsteins from any herd size from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, 
Georgia, Florida, and Mississippi. 
  Parity 
Stage of Lactation1 DIM Range 1 2 3 4 
1 1 to 30 24.61 ± 0.02a 30.42 ± 0.06a  32.61 ± 0.07a 33.26 ± 0.09a 
2 31 to 60 28.83 ± 0.02b 35.23 ± 0.07b 38.04 ± 0.07b 38.86 ± 0.09b 
3 61 to 90 29.65 ± 0.02c 34.42 ± 0.07c 37.42 ± 0.08c 38.37 ± 0.09c 
4 91 to 120 29.22 ± 0.02d 32.75 ± 0.07d 35.49 ± 0.08d 36.30 ± 0.09d 
5 121 to 150 28.79 ± 0.02b 31.14 ± 0.07e 33.56 ± 0.08e 34.30 ± 0.09e 
6 151 to 180 28.09 ± 0.02e 29.25 ± 0.07f 31.28 ± 0.07f 32.02 ± 0.09f 
7 181 to 210 27.22 ± 0.02f 27.28 ± 0.06g 29.01 ± 0.07g 29.72 ± 0.09g 
8 211 to 240 26.25 ± 0.02g 24.93 ± 0.06h 26.36 ± 0.07h 27.05 ± 0.08h 
9 241 to 270 25.05 ± 0.02h 22.86 ± 0.06i 23.87 ± 0.07i 24.31 ± 0.09i 
10 271 to 300 23.71 ± 0.02i 20.66 ± 0.07j 21.54 ± 0.08j 21.90 ± 0.10j 
11 301 to 330 22.60 ± 0.03j 19.07 ± 0.09k 19.76 ± 0.10k 19.88 ± 0.12k 
12 331 to 365 21.49 ± 0.04k 17.70 ± 0.14l 18.21 ± 0.15l 17.97 ± 0.20l 
a, b, c, d, e, f, g, h, i, j, k Significantly different (P < 0.05) within parity 





Table 2.12.  Least squares means (± SE) of 305 d milk yield (kg)1 associated with a SCS 
grouping2 for parity 1, 2, 3, and 4 cows.  Cows included Holsteins from any herd size 
from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, 
Kentucky, Virginia, Georgia, Florida, and Mississippi. 
  Parity 
Number SCS Range 1 2 3 4 
1 0.0 to 1.0 27.44 ± 0.02a 31.53 ± 0.03a 33.43 ± 0.05a 33.94 ± 0.07a 
2 1.1 to 2.0 26.50 ± 0.02b 29.88 ± 0.03b 31.85 ± 0.04b 32.35 ± 0.05b 
3 2.1 to 3.0 25.99 ± 0.02c 28.48 ± 0.02c 30.32 ± 0.03c  30.99 ± 0.04c  
4 3.1 to 3.0 25.65 ± 0.02d 27.33 ± 0.03d 29.07 ± 0.03d 29.93 ± 0.04d 
5 4.1 to 5.0 25.57 ± 0.02e 26.81 ± 0.03e 28.56 ± 0.04e 29.32 ± 0.05e 
6 5.1 to 6.0 25.47 ± 0.03f 26.88 ± 0.04e 28.56 ± 0.04e 29.19 ± 0.06e 
7 6.1 to 7.0 25.01 ± 0.04g 26.91 ± 0.05e 28.46 ± 0.06e 28.93 ± 0.07f 
8 7.1 to 8.0 24.42 ± 0.05h 26.22 ± 0.06f 28.13 ± 0.08f 28.36 ± 0.10g 
9 8.1 to 9.0 23.12 ± 0.07i 24.82 ± 0.09g 26.68 ± 0.11g 27.08 ± 0.13h 
10 9.1 to 10.0 21.16 ± 0.15j 22.57 ± 0.18h 24.22 ± 0.19h 24.88 ± 0.23i 
a, b, c, d, e, f, g, h, i, j Significantly different 305 d milk yield between seasons within parity.  
1Collected from Dairy Records Management Systems (Dairy Records Management 
Systems, Raleigh, NC) from 2009 to 2016 
22SCS group determined by SCS, split into 5 groups to provide even distribution of cows 
in each group 
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Table 2.13.  Least squares means of test-day milk yield for parity 1, 2, 3, and 4 cows that 
calved in the spring, summer, fall, and winter1.  Cows included Holsteins from any herd 
size from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, 
Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 
a, b, c, d Comparisons significantly different (P < 0.0001) within parity 
1Collected from Dairy Records Management Systems (Dairy Records Management 






Season 1 2 3 4 
Spring 26.46 ± 0.02a 27.39 ± 0.04a 29.42 ± 0.04a 30.04 ± 0.05a 
Summer 26.29 ± 0.02ab 27.07 ± 0.05b 28.60 ± 0.06b 29.25 ± 0.08b 
Fall 26.18 ± 0.02c 26.62 ± 0.04c 28.20 ± 0.05c 28.65 ± 0.06c 
Winter 26.24 ± 0.02ad 27.50 ± 0.04d 29.50 ± 0.05c 30.04 ± 0.06c 
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Table 2.14.  Least squares means of the interaction between test-day SCS2 and calving season and their effects on test-day milk yield 
(kg)1 for parities 1, 2, 3, and 4.  Cows included Holsteins from any herd size from dairy farms enrolled in the Dairy Herd Improvement 
program in Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
   Parity 
SCS Group SCS Range  Season 1 2 3 4 
1 0.0 to 1.0 
Spring 27.30 ± 0.03a 31.40 ± 0.04a 32.93 ± 0.07a 33.48 ± 0.11a 
Summer 27.47 ± 0.03b 30.73 ± 0.04b 32.51 ± 0.06b 32.92 ± 0.09b 
Fall 27.65 ± 0.02c 31.86 ± 0.04c 34.08 ± 0.05c 34.61 ± 0.08c 
Winter 27.35 ± 0.02a 32.13 ± 0.04d 34.17 ± 0.06c 34.74 ± 0.09c 
2 1.1 to 2.0 
Spring 26.52 ± 0.03a 29.96 ± 0.04a 34.61 ± 0.07a 31.99 ± 0.10a 
Summer 26.38 ± 0.03b 29.30 ± 0.03b 31.24 ± 0.05b 31.53 ± 0.07b 
Fall 26.66 ± 0.03c 29.97 ± 0.03a 32.18 ± 0.05c 32.84 ± 0.07c 
Winter 26.44 ± 0.03b 30.30 ± 0.04c 32.37 ± 0.06d 33.06 ± 0.08d 
3 2.1 to 3.0 
Spring 26.07 ± 0.03a 28.73 ± 0.04a 30.12 ± 0.06a 30.82 ± 0.09a 
Summer 25.82 ± 0.03b 28.05 ± 0.03b 29.74 ± 0.04b 30.18 ± 0.06b 
Fall 26.11 ± 0.03a 28.44 ± 0.03c 30.63 ± 0.04c 31.41 ± 0.06c 
Winter 25.94 ± 0.03c 28.70 ± 0.04a 30.78 ± 0.05d 31.56 ± 0.08c 
4 3.1 to 4.0 
Spring 25.75 ± 0.03a 27.44 ± 0.05a 28.73 ± 0.07a 29.66 ± 0.09a 
Summer 25.45 ± 0.03b 26.93 ± 0.04b 28.52 ± 0.05b 29.07 ± 0.06b 
Fall 25.77 ± 0.03a 27.37 ± 0.04a 29.53 ± 0.05c 30.55 ± 0.06c 
Winter 25.62 ± 0.03c 27.57 ± 0.05c 29.52 ± 0.06c 30.46 ± 0.08c 
5 4.1 to 5.0 
Spring 25.62 ± 0.04a 26.75 ± 0.06a 28.02 ± 0.08a 28.88 ± 0.11a 
Summer 25.37 ± 0.04b 26.44 ± 0.04b 27.98 ± 0.05a 28.50 ± 0.07b 
Fall 25.70 ± 0.04ac 26.95 ± 0.05c 29.20 ± 0.05b 30.00 ± 0.08c 
Winter 25.59 ± 0.04ad 27.10 ±0.05d 29.06 ± 0.07b 29.89 ± 0.09c 
6 5.1 to 6.0 
Spring 25.35 ± 0.05a 26.80 ± 0.08a 28.18 ± 0.10a 28.76 ± 0.13a 
Summer 25.37 ± 0.05ab 26.31 ± 0.06b 27.94 ± 0.07b 28.17 ± 0.09b 
Fall 25.69 ± 0.05c 27.20 ± 0.06c 29.21 ± 0.07c 30.05 ± 0.08c 




Table 2.14 (continued) 
 
   Parity 
SCS Group SCS Range  Season 1 2 3 4 
7 6.1 to 7.0 
Spring 24.84 ± 0.07a 26.80 ± 0.10a 28.18 ± 0.13a 28.78 ± 0.17a 
Summer 24.81 ± 0.06a 26.23 ± 0.07b 27.63 ± 0.09b 27.89 ± 0.11b 
Fall 25.30 ± 0.06b 27.32 ± 0.08c 28.99 ± 0.08c 29.52 ± 0.10c 
Winter 25.09 ± 0.06c 27.27 ±0.08c 29.04 ± 0.10c 29.52 ± 0.12c 
8 7.1 to 8.0 
Spring 24.45 ± 0.09a 26.12 ± 0.13a 28.00 ± 0.17a 28.20 ± 0.22a 
Summer 24.23 ± 0.09ab 25.60 ± 0.10b 27.17 ± 0.12b 27.23 ± 0.15b 
Fall 24.61 ± 0.09ac 26.49 ± 0.10c 28.45 ± 0.11c 28.84 ± 0.14c 
Winter 24.36 ± 0.09ab 26.66 ±0.11c 28.90 ± 0.13d 29.14 ± 0.16c 
9 8.1 to 9.0 
Spring 22.82 ± 0.15a 24.81 ± 0.20a 26.47 ± 0.24a 26.82 ± 0.30a 
Summer 23.20 ± 0.13b 24.41 ± 0.15ab 25.85 ± 0.17b 26.48 ± 0.21a 
Fall 23.38 ± 0.13bc 24.91 ± 0.15ac 27.22 ± 0.16c 27.51 ± 0.19c 
Winter 23.09 ± 0.13abc 25.16 ±0.16ac 27.19 ± 0.18c 27.52 ± 0.21c 
10 9.1 to 10.0 
Spring 20.86 ± 0.30a 21.84 ± 0.39a 23.76 ± 0.44a 25.11 ± 0.54a 
Summer 20.94 ± 0.27a 22.15 ± 0.32ab 23.35 ± 0.33ab 24.57 ± 0.40a 
Fall 21.58 ± 0.27a 23.36 ± 0.31c 24.67 ± 0.32ac 25.06 ± 0.38a 
Winter 21.25 ± 0.27a 22.92 ± 0.33bc 25.10 ± 0.33ac 24.76 ± 0.38a 
a, b, c, d,  Significantly different (P < 0.05) within parity and somatic cell score group 
1Collected from Dairy Records Management Systems (Dairy Records Management Systems, Raleigh, NC) from 2009 to 2016 




Table 2.15.  Lactation averages for 305 d milk yield, first-test (FT) SCS for the current lactation, last test (LT) SCS for the 
previous lactation, age, and lactation length by lactation.  Collected from Dairy Records Management Systems (Dairy Records 
Management Systems, Raleigh, NC) from 2009 to 2016.  Cows included Holsteins from any herd size from dairy farms 
enrolled in the Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 Parity 
Variable 18 2 3 4 
Milk (kg)1 8,781 ± 1,788 9,956 ± 2079 10,466 ± 2,262 10,529 ± 2,323 
FT SCS2 2.93 ± 1.96 2.34 ± 1.93 2.69 ± 2.10 3.01 ± 2.20 
LT SCS3 - 2.52 ± 1.85 3.03 ± 1.76 3.39 ± 1.74 
Lactation length (d)4 312 ± 28 309 ± 30 309 ± 29 309 ± 31 
Age at calving (mo)5 25 ± 2 37 ± 2 51 ± 3 64 ± 5 
Cows6 158,616 63,549 56,142 32,947 
Herds7 1,034 928 899 847 
1Average 305 d milk yield ± standard deviation by parity 
2Average FT TD SCS ± standard deviation by parity 
3Avergae LT SCS from the previous lactation ± standard deviation by parity 
4Average lactation length in d  ± standard deviation by parity 
5Average age at calving in mo ± standard deviation by parity  
6Number of cows included in each parity’s data set 
7Number of herds included in each parity’s data set 






Table 2.16.  Regression coefficients for the effects of lactation length, age, first test (FT) 
SCS, and previous lactation last test (LT) SCS on 305 d milk yield for parity 1, 2, 3, and 
4 cows.  Collected from Dairy Records Management Systems (Dairy Records 
Management Systems, Raleigh, NC) from 2009 to 2016.  Cows included Holsteins from 
any herd size from dairy farms enrolled in the Dairy Herd Improvement program in 
Tennessee, Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 Parity 
Variable* 11 2 3 4 
FT SCS -77.48 ± 1.85 -107.24 ± 3.35 -99.58 ± 3.48 -111.77 ± 4.45 
LT SCS - -17.90 ± 3.48 -59.27 ± 4.14 -62.33 ± 5.64 
Age (mo) 50.48 ± 1.72 48.31 ± 2.58  25.49 ± 1.95 12.25 ± 2.11 
Lactation length (d) 16.71 ± 0.12 21.98 ± 0.21 22.78 ± 0.23 22.19 ± 0.31 
*Variables were highly significant (P < 0.0001) 




Table 2.17.  Means (± SD) of first test SCS by calving season for parities 1, 2, 3, and 4 
for cows calving between 2009 to 2016.  Cows included Holsteins from any herd size 
from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, 
Kentucky, Virginia, Georgia, Florida, and Mississippi. 
 Parity 
Season 1 2 3 4 
Spring 3.05 ± 1.94 2.26 ± 1.93 2.52 ± 2.07 2.86 ± 2.20 
Summer 3.09 ± 1.95 2.57 ± 1.97 2.93 ± 2.10 3.26 ± 2.18 
Fall 2.71 ± 1.92 2.29 ± 1.88 2.66 ± 2.06 2.99 ± 2.18 
Winter 2.90 ± 1.98 2.15 ± 1.91 2.49 ± 2.13 2.77 ± 2.24 
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Table 2.18.  Least squares mean 305 d milk yield (kg) for parity 1, 2, 3, and 4 Holstein 
cows that calved in the spring, summer, fall and winter for cows calving between 2009 to 
2016.  Cows included Holsteins from any herd size from dairy farms enrolled in the 
Dairy Herd Improvement program in Tennessee, Kentucky, Virginia, Georgia, Florida, 
and Mississippi. 
 Parity 
Season 1 2 3 4 
Spring 7,877 ± 11a 8,847 ± 23a 9,337 ± 25a 9,554 ± 31b 
Summer 7,880 ± 10a 8,753 ± 20b 9,245 ± 20b 9,396 ± 24c 
Fall 8,026 ± 10b 9,043 ± 20c 9,703 ± 20c 9,953 ± 24a 
Winter 7,946 ± 10c 9,062 ± 21c 9,694 ± 21c 9,942 ± 27a 





Table 2.19.  Least squares means of 305 d milk yield (kg)1 associated with a FT SCS grouping2 for parity 1, 2, 3, and 4 cows.  Cows 
included Holsteins from any herd size from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, Kentucky, 
Virginia, Georgia, Florida, and Mississippi. 
  Parity 
SCS Group SCS Range 1 2 3 4 
1 0.0 to 1.0 8,111 ± 12a 9,196 ± 20a 9,792 ± 22a 10,079 ± 28a 
2 1.1 to 2.0 8,033 ± 11b 8,984 ± 21b 9,582 ± 23b 9,830 ± 30b 
3 2.1 to 3.0 7,962 ± 11c 8,837 ± 22c 9,467 ± 24c 9,707 ± 30c 
4 3.1 to 4.0 7,884 ± 11d 8,813 ± 25c 9,372 ± 26d 9,654 ± 32c 
5 4.1 to 5.0 7,822 ± 13e 8,714 ± 28d 9,319 ± 29de 9,547 ± 36d 
6 5.1 to 6.0 7,778 ± 15f 8,628 ± 34e 9,271 ± 33ef 9,472 ± 40d 
7 6.1 to 7.0 7,663 ± 19g 8,566 ± 41ef 9,210 ± 40f 9,332 ± 49e 
8 7.1 to 8.0 7,577 ± 24h 8,447 ± 52f 9,085 ± 50g 9,256 ± 59e 
9 8.1 to 9.0 7,420 ± 33i 8,253 ± 74g 8,872 ± 67h 9,167 ± 79ef 
10 9.1 to 10.0 7,157 ± 64j 8,111 ± 138g 8,534 ± 125i 8,921 ± 137ef 
a, b, c, d, e, f, g, h, i, j Significantly different (P < 0.05) within parity. 
1Collected from Dairy Records Management Systems (Dairy Records Management Systems, Raleigh, NC) from 2009 to 2016 






Table 2.20.  Least squares means for 305 d milk yield (kg)1 associated with SCS group2 and season of the year for parities 1, 2, 3, and 
4.  Cows included Holsteins from any herd size from dairy farms enrolled in the Dairy Herd Improvement program in Tennessee, 
Kentucky, Virginia, Georgia, Florida, and Mississippi. 
   Parity 
SCS Group SCS Range  Season 1 2 3 4 
1 0.0 to 1.0 
Spring 8,002 ± 21a 9,076 ± 32a 9,643 ± 39a 9,926 ± 56a 
Summer 8,063 ± 19b 9,061± 28a 9,566 ± 32a 9,813 ± 45a 
Fall 8,234 ± 16c 9,359 ± 26b 10,030 ± 29b 10,376 ± 39b 
Winter 8,143 ± 18d 9,287 ± 27c 9,931 ± 32c 10,202 ± 43b 
2 1.1 to 2.0 
Spring 7,950 ± 19a 8,888 ± 36a 9,407 ± 44a 9,622 ± 63a 
Summer 7,991 ± 17b 8,811 ± 29a 9,360 ± 33a 9,520 ± 45a 
Fall 8,141 ± 16c 9,118 ± 28a 9,782 ± 31b 10,107 ± 42b 
  Winter 8,048 ± 17d 9,119 ± 31a 9,778 ± 36b 10,070 ± 49b 
3 2.1 to 3.0 
Spring 7,925 ± 18a 8,718 ± 41a 9,322 ± 48a 9,533 ± 68a 
Summer 7,873 ± 16b 8,683 ± 31a 9,178 ± 34a 9,349 ± 45a 
Fall 8,068 ± 16c 8,955 ± 31a 9,662 ± 32b 9,890 ± 41b 
  Winter 7,983 ± 17d 8,990 ± 35a 9,705 ± 40b 10,056 ± 54b 
4 3.1 to 4.0 
Spring 7,861 ± 20a 8,811 ± 50a 9,182 ± 57ab 9,475 ± 73a 
Summer 7,839 ± 17a 8,631 ± 34a 9,111 ± 36a 9,331 ± 47a 
Fall 7,949 ± 18b 8,856 ± 36a 9,577 ± 37b 9,865 ± 46b 
  Winter 7,887 ± 19c 8,955 ± 43a 9,618 ± 47b 9,946 ± 61b 
5 4.1 to 5.0 
Spring 7,770 ± 24a 8,685 ± 60a 9,123 ± 67a 9,382 ± 83ab 
Summer 7,790 ± 20a 8,517 ± 40ab 9,073 ± 41a 9,256 ± 51b 
Fall 7,876 ± 22b 8,763 ± 45a 9,550 ± 43b 9,811 ± 52a 
  Winter 7,852 ± 23b 8,889 ± 53a 9,530 ± 57b 9,741 ± 67a 
6 5.1 to 6.0 
Spring 7,740 ± 29a 8,733 ± 76a 9,219 ± 79a 9,405 ± 97ab 
Summer 7,742 ± 25a 8,336 ± 50b 9,017 ± 47b 9,166 ± 58a 
Fall 7,861 ± 28b 8,677 ± 53a 9,424 ± 51a 9,675 ± 58b 




Table 2.20 (continued) 
 
   Parity 
SCS Group SCS Range  Season 1 2 3 4 
7 6.1 to 7.0 
Spring 7,620 ± 36a 8,538 ± 93ab 9,104 ± 98a 9,204 ± 121a 
Summer 7,617 ± 32a 8,280 ± 63a 8,915 ± 59a 8,989 ± 71a 
Fall 7,743 ± 35b 8,732 ± 70b 9,376 ± 62b 9,612 ± 70b 
Winter 7,671 ± 35b 8,715 ± 81b 9,446 ± 77b 9,524 ± 98ab 
8 7.1 to 8.0 
Spring 7,587 ± 50a 8,424 ± 124a 8,897 ± 129a 9,183 ± 155ab 
Summer 7,525 ± 42a 8,311 ± 80a 8,834 ± 78a 8,950 ± 92b 
Fall 7,645 ± 47a 8,519 ± 90a 9,272 ± 80b 9,370 ± 91a 
Winter 7,550 ± 45a 8,534 ± 104a 9,337 ± 93b 9,521 ± 110a 
9 8.1 to 9.0 
Spring 7,375 ± 68a 8,147 ± 175a 8,536 ± 169ab 9,088 ± 209ab 
Summer 7,384 ± 61a 8,102 ± 116a 8,724 ± 104a 8,769 ± 120b 
Fall 7,489 ± 64a 8,164 ± 141a 9,093 ± 113b 9,226 ± 121ab 
Winter 7,431 ± 61a 8,598 ± 144a 9,133 ± 130b 9,585 ± 151a 
10 9.1 to 10.0 
Spring 7,191 ± 149a 7,957 ± 293ab 8,148 ± 324a 8,526 ± 323a 
Summer 6,946 ± 110b 7,856 ± 234ab 8,295 ± 196a 8,765 ± 252ab 
Fall 7,459 ± 133b 8,630 ± 278a 9,168 ± 231b 9,324 ± 248b 
Winter 7,034 ± 116ab 7,999 ± 287b 8,524 ± 228a 9,070 ± 261ab 
a, b, c, d Significantly different 305 d milk yield  within parity and somatic cell score group 
1Collected from Dairy Records Management Systems (Dairy Records Management Systems, Raleigh, NC) from 2009 to 2016.   






3. CHAPTER THREE 
 
The use of a stochastic decision tree model to determine optimal economic treatment 
decisions by causative mastitis pathogen 
 
D.T. Nolan and J.M. Bewley 
 








Mastitis is one of the most common and costly diseases in the dairy industry.  
Costs associated with an intramammary infection (IMI) include milk production losses, 
milk composition changes, drugs, discarded milk, veterinary services, labor, decreased 
product quality, materials and investments, diagnostics, culling, and reduced slaughter 
value (Allore and Erb, 1998, Halasa et al., 2007).  Because each mastitis cost category is 
highly variable, determining the economic impact of a mastitis case can be difficult.   
Developing economic models helps researchers and dairy producers understand 
the complexity of mastitis costs.  Stochastic modeling, a type of system simulation 
analysis, is one of the most common modeling strategies (Ostergaard et al., 2005, Huijps 
and Hogeveen, 2007b, Huijps et al., 2008).  Stochastic models are used when one or more 
variables are random, accounting for variability.    
Decision tree analysis is one of the most common models used in decision 
analysis (Dijkhuizen and Morris, 1997) but is not common in disease modeling.  A 
decision tree is a graphical representation of actions and their alternatives available to the 
decision maker when faced with multiple situations.  Each step of the decision tree model 
is derived from choices or chances.  A choice is a decision to make and a chance 
considers the probability that a situation will happen.  When modeling the cost of 
mastitis, an example of a choice would be whether or not to culture.  Curing a clinical 
mastitis (CM) case would be an example of a chance and the probability of the chance is 
considered in the economic outcome of the mastitis case (Dijkhuizen and Morris, 1997). 
 The objective of this study was to model the cost of a mastitis case by combining 




stochastic.  Making the input variables to the decision tree model stochastic allowed the 
current model to account for the variability in results common in dairy production and 
peer-reviewed literature.  A secondary objective was to determine economically optimal 
treatment decisions for different mastitis causing pathogens using decision tree results. 
MATERIALS AND METHODS 
Stochastic Model  
 The base model for the current analysis was first developed by Bewley et al. 
(2010), and further refined by Liang et al. (2017)  The model was developed in Microsoft 
Excel (Microsoft, Seattle, WA) with the @Risk 7.0 (Palisade Corporation, Ithaca, NY) 
add-in.  Herd and cow modules of the model (Bewley et al., 2010) considered the effects 
of a clinical mastitis case for an average cow in the herd.  Key variables on a herd and 
cow level were modeled stochastically.  However, the base model was deterministic, 
modeling daily factors of the average cow’s life.  
The herd demographic module simulated the average life of a cow in the herd 
over a ten-year period.  Industry averages were set as defaults in the herd module with 
flexibility for producers to enter farm specific data, allowing the model to be used as a 
decision support tool.  Herd averages were collected from peer reviewed literature or 
Dairy Records Management System (2016, Dairy Records Management Systems, 
Raleigh, NC) data.  Values used to model herd demographics are displayed in Appendix 
Table 0.1.   
Two major assumptions were made in the development of the herd module of the 
model.  First, the model does not account for seasonal calving; meaning even distribution 




at the end of the year the herd size was above the maximum desired number of cows, 
heifers were sold.  If herd size was less than desirable, replacement heifers were 
purchased (Bewley et al., 2010).   
The second phase of the model simulated an average cow from the herd analysis 
(Bewley et al., 2010).  Simulation occurred for each d of the cow’s life for six parities.  
Variables changed to simulate management factors, biological changes of the cow, and 
changes in market prices.  Biological changes modeled included age at first calving, 
calving interval, the length of the dry period, parity length, daily milk yield, and DIM at 
conception.  Milk production, retention pay off (RPO), and cost of d open (CDO) were 
used in the decision tree analysis to determine the cost of CM.  Average cow data used in 
stochastic analysis are located in Appendix Table 0.2.  
Market Prices 
 Market prices for milk price, corn price, soybean price, alfalfa price, replacement 
heifer price, and slaughter price were all collected from historical data (Liang et al., 
2017).  Prices were collected from Gould and Bozic (2016) from yr 1971 to 2016.  As 
previously described by Bewley et al. (2010) and Liang et al. (2017), historical prices 
were used to create predicted market prices for the yr of 2016.  To make market effects 
more realistic, a correlation matrix between all six variables was applied to the model to 
account for one variable’s market effects on the other.  Prices from 2006 to 2015 were 
used to calculate RPO, CDO, and 2016 market conditions.  Market conditions used in the 




Retention Pay-off  
 Retention pay-off (RPO), a common way to determine the optimum time of 
culling dairy cattle (Bar et al., 2008a, Bewley et al., 2010), is the total profit expected 
from keeping a cow until the optimum time of culling compared to the profits expected 
from her replacement (Dijkhuizen and Morris, 1997).  The optimum moment of 
replacement is when the current cow’s future marginal revenue is the same as her 
replacement resulting in a RPO value of 0.  Two components are included in calculating 
the RPO.  First, marginal net revenue, is calculated using Formula 3.1. 
Formula 3.1: The marginal net revenue milking a cow one additional d.  Adapted from 
Groenendaal et al. (2004), Bewley et al. (2010), and Liang et al. (2017). 
𝑀𝑁𝑅𝑖 = 𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑚𝑖𝑙𝑘, 𝑖 +  𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑐𝑎𝑙𝑓, 𝑖 +  𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑠𝑙𝑎𝑢𝑔ℎ𝑡𝑒𝑟, 𝑖 
− 𝐶𝑜𝑠𝑡𝑓𝑒𝑒𝑑, 𝑖 −  𝐶𝑜𝑠𝑡𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑑𝑖𝑠𝑝𝑜𝑠𝑎𝑙, 𝑖 −  𝐶𝑜𝑠𝑡𝑣𝑒𝑡𝑒𝑟𝑖𝑛𝑎𝑟𝑖𝑎𝑛, 𝑖
−  𝐶𝑜𝑠𝑡𝑏𝑟𝑒𝑒𝑑𝑖𝑛𝑔, 𝑖 
Where, 
MNR=Marginal net revenue, 
Revenue milk,i=Pricemilk× Daily milk production, 
Revenuecalf,i=0 or calf value (only at calving),  
Revenueslaughter,i=Priceslaughter × (body wieghti-body weighti-1), 
Costfeed,i=Pricefeed × DMIi, 




Costveterinarian,i=Average daily routine veterinarian cost 
Costbreeding,i=0 or daily breeding costs (after voluntary waiting period). 
 The second value used in calculating RPO is the maximal annuity net revenue 
(ANRmax).  The ANRmax describes the value of a replacement animal.  Formula 3.2 
calculates ANRmax. 
Formula 3.2: The average net revenue of the replacement cow.  Adopted from 
Groenendaal et al. (2004), Bewley et al. (2010), and Liang et al. (2017). 
𝐴𝑁𝑅𝑖 =  
𝑟 ∗ [∑1










ANRi = Average net revenue for replacement cow at d i 
P1 = Probability of surviving until the end of d i 
Mi = length of period i (d) 
Retention payoff is the sum of the differences between daily ANRmax and daily 
NPR until optimal replacement.  Retention pay-off is calculated in Formula 3.3. 
Formula 3.3: The retention pay-off value of the infected cow, the d of diagnosed 
infection Groenendaal et al. (2004), Bewley et al. (2010), and Liang et al. (2017). 
𝑅𝑃𝑂𝑖 =
∑𝑖+1







RPOi = Retention pay-off value of the present cow in d i 
ANRmax = Maximal ANR value of the replacement cow 
Pj = Probability of surviving until the end of d j 
ORM = Optimal replacement moment (d) 
All variables used in the calculation of RPO were stochastic.  The RPO value 
represented the cost of culling as a treatment choice for a case of CM.  See Figure 3.1.   
Cost of Days Open 
 The current model reflected the effect of a CM case on reproduction by 
calculating the cost associated with an increase in d open.  The cost of d open (CDO) 
represents the cost associated with delaying pregnancy because of a mastitis infection and 
was calculated for each of the six parities simulated in the model.  The cost of additional 
d open is the difference in the RPO value the first d of parity (FDRPO) between an 
average cow in the herd and a cow with CM (Liang et al., 2017) and was added to the 
cost of the original case of mastitis.  Cost of d open is calculated in Formula 3.4. 
Formula 3.4:  The cost of d open for a cow with a IMI  Groenendaal et al. (2004), 
Bewley et al. (2010), and Liang et al. (2017). 
𝐶𝐷𝑂𝑘,𝑙 =  𝐹𝐷𝑅𝑃𝑂𝑎𝑣𝑒𝑟𝑎𝑔𝑒,𝑙 −  𝐹𝐷𝑅𝑃𝑂𝑘,𝑙 
Where, 
CDOk,l = cost of extended d open due to CM in parity l, 




FDRPOk,l  = RPO on the first DIM for a cow infected with CM in parity  
Mastitis Specific Assumptions 
Pathogen Data.  The first decision in the current model of a mastitis case was 
whether the mastitis case was cultured to determine the infecting pathogen.  If not, 
mastitis pathogen became a chance and a probability that the pathogen in question was 
the infecting pathogen was provided.  To determine pathogen prevalence, data was 
collected from the University of Kentucky Veterinary Diagnostic Laboratory (University 
of Kentucky, Lexington, KY), Virginia Tech Mastitis and Immunology Laboratory, 
(Virginia Tech, Blacksburg, VA), and peer-reviewed literature (Wilson et al., 1997, 
Makovec and Ruegg, 2003, Pitkala et al., 2004, Roberson et al., 2004, Tenhagen et al., 
2006, Olde Riekerink et al., 2008).  Culture results from quarter milk samples from the 
University of Kentucky and Virginia Tech labs were collected from 2010 to 2015.  The 
FREQ procedure in SAS 9.3 (SAS Institute, Carry, NC) was used to determine the 
prevalence of University of Kentucky pathogen data.  The results of this analysis along 
with culture data from Virginia Tech are depicted in Table 3.1.  Table 3.2 displays final 
pathogens and prevalence percentages used for the stochastic analysis.  Prevalence for 
each pathogen was fit to a PERT distribution to determine a range of values for stochastic 
analysis using the @Risk add-in in Microsoft Excel.  A PERT distribution, a type of Beta 
distbribution, was formed from the minimum, mode, and maximum probability that an 
event takes place.  The distribution is less sensitive to the minimum and maximum values 




Cure Rates  Field cure rates for specific mastitis pathogens were collected from 
peer-reviewed literature (Owens et al., 1997a, Wilson et al., 1999, Oliver et al., 2003, 
Oliver et al., 2004, Roberson et al., 2004, Deluyker et al., 2005, van den Borne et al., 
2010, Steeneveld et al., 2011b).  Cure rates were analyzed for the highest, average, and 
lowest cure probabilities for each pathogen, given the treatment type used in the analysis.  
A PERT distribution was then fit to the data, making cure rate a stochastic variable.  Cure 
rates used in the analysis are depicted in Table 3.3.  Authors assumed that no differences 
in cure rates between first and later parity cows.           
Recurrence Rates  The current model simulated the possibility of a mastitis case 
recurring up to two times, for a total of three clinical mastitis cases, over the course of a 
lactation.  Recurrence rates were obtained from Wenz et al. (2005) and were dependent 
on the cure status of the IMI.  If the CM case was cured, recurrence rates were 3.9%, 
5.6%, and 4.7% for gram negative, gram positive, and other bacteria, respectively.  For 
uncured cases, recurrence rates were 15.8%, 23.1%, and 19.5%, for gram negative, gram 
positive, and other bacteria, respectively.  Recurrent cases took place 30 d after the case 
before it.  After the first clinical mastitis case (CM1), a second case (CM2) could occur 
30 d later, and a third case (CM3) 60 days later.  In order to make the current model 
comparable to peer reviewed models (Swinkels et al., 2005a, Pinzon-Sanchez et al., 2011, 
Steeneveld et al., 2011a) authors assumed that if a cow became infected with CM3 she 




Milk Production Loss.  Production loss was calculated using daily milk loss 
values from each pathogen reported by Grohn et al. (2004).  Authors assumed that daily 
milk losses were the same for a week long period (Grohn et al., 2004).  Most pathogens 
caused milk production losses 4 weeks before diagnosis and up to eleven weeks after 
diagnosis (Tables 3.4 and 3.5).  Treatment of cases occurred on the d of diagnosis.  
Therefore, if diagnosis occurred on the third DIM, the first week following the treatment 
consisted of DIM 4 to DIM 11.  If a cow had more than 71 d (Grohn et al., 2004) left in 
milk after diagnosis, authors assumed that milk losses per day reported by Grohn et al. 
(2004) for d ≥ 71 persisted for the rest of the cow’s parity.  A PERT Alt distribution was 
fit to the milk loss average and 95% confidence interval reported by Grohn et al. (2004) 
making milk loss a stochastic value.  A PERT Alt distribution is similar to a PERT 
distribution but rather than using the minimum and maximum as distribution variables, 
the 95% confidence interval around the mean is used.  Milk losses associated with CM2 
(Tables 3.6 and 3.7) were calculated in the same manner (Schukken et al., 2009).  
Production losses were multiplied by the stochastic milk price and divided by 100 to 
obtain a monetary value for milk loss. 
Cost of Antibiotic Therapy.  Discarded milk and drug costs constituted the costs 
associated with antibiotic treatment of a CM case.  Authors assumed diagnosis and 
treatments occurred during the last milking of the d and treatments were given twice a d.  
Therefore, discarding of milk started the d after treatment.  A PERT distribution was fit 
to antibiotic treatment costs per tube (Table 3.8) making the variable stochastic to 




To make the current model comparable to peer-reviewed models, discarding of 
milk occurred for the duration of the treatment period and 3 d after the treatment period 
(Swinkels et al., 2005b, Pinzon-Sanchez et al., 2011, Steeneveld et al., 2011a).  
Therefore, producers discarded milk for 5, 8, and 11 d for 2-d, 5-d, and 8-d mastitis 
treatments, respectively.  Authors assumed that discarded milk was fed to calves and 
costs were compared to feeding calves milk replacer to determine if there was a cost 
savings from feeding discarded milk.  The amount of milk replacer fed per calf per d was 
accounted for stochastically.  To account for traditional and accelerated feeding programs 
a PERT distribution was fit to the amount of milk replacer being fed to calves per d, with 
the minimum and maximum of the distribution falling between 0.454 kg (traditional 
program) and 1.13 kg (accelerated program).  A PERT distribution was also fit to the cost 
of a 22.68 kg bag of milk replacer, making the variable stochastic to account for the 
variation of cost between milk replacer brands.  The minimum and maximum of the 
distribution were $60.00 to $90.00 per bag.  Assuming an 8-week weaning age, 16 calves 
were fed milk 3.9 kg of milk per day (Appendix Table 0.1).  Authors assumed that only 
milk from cows with a IMI would be fed to calves.  Incidence rates included in the model 
were 12%, 20%, and 20% for parities 1, 2, and ≥ 3, respectively (Liang et al., 2017).  To 
calculate total costs alleviated by feeding discarded milk the sums of Formula 3.5 and 3.6 
were added together. 









MD$ = The cost of milk discarded alleviated by feeding discarded milk to calves 
M = Amount of milk needed to feed 16 non-weaned claves 
C = Number of cows infected with mastitis 
MP = Milk price under 2016 market conditions 
Formula 3.6.  The cost of milk replacer alleviated by feeding discarded milk to calves. 





MR$ = The cost of milk replacer alleviated by feeding discarded milk to calves 
C = Cost spent on milk replacer per d when feeding 16 calves milk replacer 
M = Amount of milk needed by 16 calves fed discarded milk 
P = Amount of discarded milk provided by one cow infected with mastitis  
Transmission of Staphylococcus aureus Mastitis.  Transmission rates of S. 
aureus mastitis were collected from Swinkels et al. (2005b) and fit to a PERT distribution 
to make the variables stochastic.  Preliminary simulations were run to account for an 
average cost of S. aureus mastitis for multiparous and primiparous cows.  To obtain a 
total cost of transmission, average costs of S. aureus mastitis from the preliminary 
analysis were multiplied by transmission and prevalence rates derived from stochastic 
simulation (Pinzon-Sanchez et al., 2011).  The average cost of transmission was $43.13 
and $31.16 for primiparous and multiparous cows, respectively.  If a cow experienced 




Other Costs.  Other costs included in the model were the costs of culturing and 
labor associated with treating a case of mastitis.  Culture costs (Table 3.8) were collected 
from peer-reviewed literature (Swinkels et al., 2005b, Pinzon-Sanchez et al., 2011) and a 
PERT distribution was fit to the data to make the cost of culturing a stochastic variable.  
Labor costs were collected from peer reviewed literature (Huijps et al., 2008, Pinzon-
Sanchez et al., 2011) and fit to a PERT distribution making the value stochastic (Table 
3.8). 
Decision Tree Model 
 The decision tree model was developed using a Microsoft Excel (Microsoft, 
Seattle, WA) add-in, Precision Tree (Palisade Corporation, Ithaca, NY).  Precision Tree 
analyzes every tree branch and calculates either least or highest cost decisions depending 
on the desired analysis.  As the software analyzes each branch, it accounts for the 
probability of each situation’s outcome to determine the costs associated with that 
branch.  Choices and chances determined the outcome of the cost of a case of CM.  
Choices consisted of whether to culture to determine an infecting pathogen and different 
treatment options.  Treatment choices were no treatment (NT), a 2, 5, or 8-d 
intramammary (IMM) antibiotic treatment, and culling.  Chances consisted of probability 
of cure and probability of recurrence.  If the producer chose not to culture, infecting 
pathogen was also considered a chance as the model accounted for the probability of the 
pathogens being in the infecting pathogen.  Figure 3.1 depicts a model of the decision 
tree used in the analysis.  Squares represented choices a producer would make, while 
circles represented chances of a specific outcome.  Common formulas used in the 




fits in the model.  The model then solved the decision tree by working backward to obtain 
the minimum cost of a case of mastitis given the probabilities associated with chances 
and cost associated with choices using the following formulas.   
Formula 3.7: The cost associated with milk loss from a given pathogen type.  
Represented as node #3 in Figure 3.1. 
𝑀𝐿$ = ((𝑊 ∗ 7 ∗ 𝑆𝑀𝐿1) ∗ 𝑆𝑀𝑃)/100  
Where: 
ML$ = Cost associated with milk loss due to a CM case 
W = Number of weeks in the parity experiencing milk loss 
SML = Stochastic milk loss due to a specific pathogen 
1See Tables 3.4 and 3.5 for CM1 and Tables 3.6 and 3.7 for CM2 
SMP = Stochastic milk price ($/cwt) 
 
 
Formula 3.8: The cost associated with a 2-d IMM antibiotic treatment.  Represented as 
node #4 in Figure 3.1.  









T = Cost per antibiotic tube.  See Table 3.8 
5MP = Simulated milk production for the 5 d following d of diagnosis 
SMP = Stochastic milk price ($/cwt) 
 
Formula 3.9: The cost associated with a 5-d IMM antibiotic treatment.  Represented as 
node #5 in Figure 3.1. 





5T$ =5-d IMM antibiotic treatment Costs  
T = Cost per antibiotic tube.  See Table 3.8 
8MP = Simulated milk production for the 8 d following d of diagnosis 
SMP = Stochastic milk price ($/cwt) 
Formula 3.10: The cost associated with an 8-d IMM antibiotic treatment.  Represented 
as node #6 in Figure 3.1. 





8T$ =8-d IMM antibiotic treatment Costs  




11MP = Simulated milk production for the 11 d following d of diagnosis 
SMP = Stochastic milk price ($/cwt) 
Formula 3.11: The cost associated with culling a cow with CM.  Represented as node #7 
in Figure 3.1. 
𝐶$ = 𝑅𝑃𝑂 − 𝑀𝐿$1 
Where: 
C$ = The cost of culling a cow with CM 
RPO = Retention pay-off: see Formula 3.3 
ML$1 = The cost of milk loss after the d of diagnosis 
Simulation  
 Simulations were run to calculate the costs of CM under multiple situations with 
stochastic variables.  Using Precision Tree, the lowest cost treatment schemes were 
modeled for the six parities analyzed.  Costs for parities ≥ 3 were averaged.  Ten-
thousand iterations were analyzed along with Latin Hypercube sampling.  A static seed of 
31,517 was used to ensure all simulations provided repeatable results.  After each 
simulation, an optimum decision analysis determined the lowest costs options for 
treatment by choosing branch decisions that led to the least cost outcomes.  To obtain the 
frequency that options were optimal to others, every iteration of all treatment options 
were compared.  Iterations were counted when the cost of a treatment was lower than the 
treatment option it was being compared to and then summed to determine how often a 




RESULTS AND DISCUSSION 
General Costs  
Costs of treating a case of mastitis included drugs, labor, extended days open, 
milk yield loss, and milk discarded from antibiotic treatment.  No matter the treatment 
decision made by a producer mastitis costs will always consist of milk yield loss before 
diagnosis, milk yield loss after diagnosis (unless the cow is culled), increased CDO, 
labor, and the costs of transmission (when infected with S. aureus).  By making the 
optimal treatment decision producers can alleviate the costs of RPO, milk discard, and 
the costs of antibiotic treatment.  Drug costs were $13.79 ± 2.07, $34.47 ± 5.17, and 
$55.16 ± 8.27 for 2-d, 5-d, and 8-d treatment regimens, respectively, with an overall 
range between $7.60 and $87.74.  The average cost of treatment labor was $13.75 
ranging from $7.78 to $21.82.  Milk discarded from treatment ranged from -$218.02 for a 
primiparous cow being treated for CM2 using an 8-d regimen to $316.07 for a 
multiparous cow being treated for CM1 with an 8-d treatment therapy (Table 3.9).  
Authors assumed that discarded milk would be fed to calves.  Feeding discarded milk to 
calves alleviated approximately $12.82 ± $2.22 per day across all parities when compared 
to feeding all calves milk replacer.  Appendix Table 0.4 displays costs associated with 
discarding milk before accounting for feeding milk to calves.  Cost of days open per CM 
case ranged from -$0.62 to $79.52 with an average cost of $3.86.  Culling costs varied by 
parity and recurrence of clinical mastitis case.  Retention pay-off values increased as 
parity number increased and tended to decrease as cows experienced a second and third 




Milk losses contributed the highest costs associated with a case of mastitis and 
were influenced by the infecting pathogen (Gröhn et al., 2004, Schukken et al., 2009).  
Tables 3.11 displays the costs associated with milk losses from different pathogens.  
Because milk loss had such a high effect on costs and because pathogen types responded 
to treatment regimens differently, pathogen type had an effect on the overall cost of a 
mastitis case.  Tables displaying average treatment costs and optimum treatment 
frequencies by pathogen are located in the Appendix (Appendix Tables 0.5 to 0.20).   
Simulation results of the different treatment types were analyzed in two different 
ways.  The first analysis was completed by averaging the costs across all 10,000 
iterations of a simulation and comparing the averages for the different treatment types to 
determine which treatment resulted in the lowest cost.  The second analysis was 
completed by considering each of the 10,000 iterations of a simulation separately.  One at 
a time, treatments within an iteration were compared to one another to determine which 
had a lower cost.  Treatments with the highest percent of iterations with the lowest costs 
were deemed the optimum treatment decision.  These analyses were completed for each 
pathogen type.  Results of both analyses are found in the secondary subheadings 
“Average Treatment Costs” and “Optimum Treatment Comparisons” under each 
pathogen’s subheading.  
Overall, when examined across all pathogen possibilities, culling resulted in the 
lowest average cost ($180.97) of any treatment for parity 1 cows, while NT resulted in 
the lowest cost option for parity 2 and ≥ 3 cows (Table 3.12) when averaged over all 
iterations.  No treatment followed by culling if the cow experienced CM2 was the lowest 




for CM1 being 82 d, by CM2 the infected cow would be later in parity and beyond peak 
milk, making her RPO value lower.  Culling was usually the economically optimal 
decision for first parity cows, where 69% of iterations (compared to NT) had a lower cost 
for CM1.  When determining the optimum replacement policy, Kalantari et al. (2010) 
concluded second parity cows have a decreased risk of culling because of increased 
production.  The increased production levels among multiparous cows are a possible 
reason for the difference in optimum treatment decisions among parities.  Culling was 
also the optimal treatment decision (51%) compared to NT, the second most optimal for 
second parity cows.  No treatment was a more economical option than culling for 57% of 
iterations of parity ≥ 3.  Results would suggest that dairy producers over spend when 
treating with antibiotics, especially in primiparous cows.  In older animals, a 2-d 
treatment, NT, and culling were all economically optimal decisions (Table 3.13).  This 
was not expected, as different pathogen types affect the mammary gland differently and 
react to antibiotic treatment differently.  For example, S. aureus produces several 
virulence factors that inhibit both the mammary immune system and antibiotic therapies 
from curing an IMI (Zecconi et al., 2006).  These characteristics allow S. aureus to wall 
itself off in the mammary gland and lyse host immune cells leading to low cure rates (Sol 
et al., 1997).  However, other pathogens like E. coli have high self-cure rates. 
Staphylococcus aureus        
Average Treatment Costs.  The cost of milk loss from S. aureus for CM1 was 
$284.84, $237.47, and $230.82 for parities 1, 2, and ≥ 3, respectively and $380.27, 
$235.61, and $228.72 for parities 1, 2, ≥ 3, respectively for CM2 (Table 3.11).  




cows to $31.61 for multiparous cows.  In previous research, the cost of transmission had 
been modeled in different ways.  Down et al. (2013) assumed the infected cow transmits 
S. aureus to other cows and the mastitis case costs associated with transmission are the 
same as the original case of mastitis.  The cost of transmission had also been calculated 
by multiplying the cost of a S. aureus mastitis case by the probability the infected cow 
transmitted her mastitis case to another cow (Swinkels et al., 2005b, Pinzon-Sanchez et 
al., 2011).  Pinzon-Sanchez et al. (2011) used the cost of a 5-d treatment regimen as a 
cost of mastitis for the new case.  Swinkels et al. (2005b) used a different cost associated 
with a 2-d, 5-d, and 8-d treatment.  In the current analysis, a preliminary simulation was 
run to obtain the average cost of a case of S. aureus mastitis under optimum treatment 
decisions.  To calculate the cost of transmission in the current analysis, the average cost 
under optimum treatment was used, taking into consideration the probabilities of all 
treatment options. 
A wide range of treatment costs existed between initial treatments and treatment 
combinations.  When examining the 2-d treatment options, a 2-d treatment followed by 
culling the cow tended to have the lowest overall cost if a producer was going to treat the 
case of mastitis with a 2-d regimen initially.  This combination was lower than a 2-d 
treatment alone.  Though the RPO of the cow was higher at the time of second infection, 
this combination was true for all other treatment options (5-d, 8-d, NT).  Average costs of 
all treatment options are displayed in Appendix Table 0.5.  The combination of treatment 
followed by culling may be the best option for treatment if the producer decided to treat 
initially.  By culling CM2, producers are not experiencing the economic loss from 




discarded milk and drug costs from a second treatment period.  Overall, culling a cow 
infected with S. aureus at the time of infection was associated with lowest average cost 
for all parities.   
Optimum Treatment Comparisons.  Though culling was the lowest treatment 
cost on average, culling was not always the optimum treatment decision (Appendix Table 
0.6).  During the first parity, culling not being the optimum treatment was rare, but as the 
cow entered second and greater parities, the effects of treatment options on the cost of the 
mastitis case became more variable.  A 2-d treatment cost less than culling in 24% and 
33% of iterations for parity 2 and ≥ 3 parities, respectively.  However, these instances 
decreased to 11% and 19% when choosing a 2-d treatment over culling for CM2.  Five 
and 8-d treatments were rarely optimal when compared to culling.  Only 24% of 
iterations was it optimal to use a 5-d treatment regimen compared to culling a cow with ≥ 
3 parities.  When comparing NT of S. aureus to culling, NT was optimal 11% and 21% of 
iterations when in the second parity for CM1 and 18% and 31% when ≥ 3 parities for 
CM1 and CM2, respectively. 
A 2-d treatment was optimal in 3% to 4% of iterations compared to NT depending 
on parity.  Treatment of any kind may not be an optimal option because of the little effect 
treatment had on cure (5%) of the mastitis case, suggesting the extra drug costs and losses 
due to discarded milk are not worth the treatment of S. aureus (Swinkels et al., 2005b, 
Pinzon-Sanchez et al., 2011).  These results suggest that, except for CM1 for primiparous 
cows, culling is the optimum treatment option.  Producers should not treat primiparous 
cows when infected in with the first case.  However, throughout all parities culling was 




treatment with little cure success paired with increased costs due to transmission to other 
cows, outweighed the benefits of the cow remaining in the herd. 
Streptococcus uberis and Streptococcus dysgalactiae 
Average Treatment Costs.  Unlike other studies (Swinkels et al., 2005b, Pinzon-
Sanchez et al., 2011, Steeneveld et al., 2011a) S. uberis and S. dysgalactiae were 
modeled separately.  One limitation however, was milk production loss was considered 
the same for both bacteria types (Grohn et al., 2004).  Milk loss for each pathogen costed 
$81.14, $225.90, and $220.25 for parities 1, 2, and ≥ 3, respectively during CM1 and 
$201.11, $231.38, and $225.41 for parities 1, 2, and ≥ 3, respectively during CM2 (Table 
3.11).  Though milk losses were the same, costs of treatments were different because of 
the effects of treatment on probability of cure, with S. dysgalactiae having slightly higher 
cure rates. 
No treatment had the lowest average treatment cost with culling second, followed 
closely by a 2-d treatment.  Unlike, S. aureus there was a benefit to each treatment.  Costs 
for 2-d, 5-d, and 8-d treatments are lower than the combination of treatment of CM1 and 
culling of CM2, suggesting treatment of these pathogens with antibiotics, at times was 
economically feasible (Appendix Table 0.7 and 0.09). 
Optimum Treatment Comparisons.  Though NT had the lowest average cost of 
mastitis treatment of S. uberis and S. dysgalactiae across all iterations, culling was the 
optimum option about 58% of the iterations when a cow was in her second parity, 
followed by about 45% and 48% of iterations for parities 1 and ≥ 3, respectively for both 




43%, 30%, and 40% of iterations for parity 1, 2, and ≥ 3 respectively for both pathogens.  
A 5-d treatment was more economical to culling in 35%, 23%, and 32% of iterations for 
parities 1, 2, and ≥ 3, respectively, for CM1.  An 8-d treatment was the economically 
optimum in 30%, 17%, and 24% of iterations for parities 1, 2, ≥ 3, respectively, 
compared to culling for CM1 (Appendix Tables 0.8 and 0.10).  Results suggest that with 
both pathogens, NT and culling are the best treatment options.   However, not commonly 
an optimum decision, antibiotic treatment for primiparous cows was often more 
economically effective when treating S. dysgalactiae and S. uberis than other pathogens.  
These results suggest the importance of culturing cases of mastitis. 
Escherichia Coli 
Average Treatment Costs.  The cost of milk loss associated with E. coli mastitis 
averaged $255.96, $129.08, and $125.76 for parity 1, 2, and ≥ 3, respectively, for CM1 
(Table 3.11).  Costs of $557.16, $169.59, and $165.84 were associated with the milk loss 
of parity 1, 2, and ≥ 3, respectively for CM2.  E. coli had a greater effect on milk 
production in primiparous cows than multiparous cows (Gröhn et al., 2004, Schukken et 
al., 2009), resulting in higher costs due to decreased milk yield in the first parity.   
The lowest average treatment option for a case of E. coli mastitis was to cull, 
followed by NT (Appendix Table 0.11).  The best treatment option for a CM case that 
recurs to a second case was a combination of a 2-d treatment for CM1 followed by 
culling CM2.  After initial treatment of CM1, culling always had the lowest average cost 
for CM2.  This suggests the RPO value at the time of CM2 was lower than the ongoing 




Optimum Treatment Comparisons.  Though culling resulted in the lowest 
average cost of any treatment option, antibiotic treatment had times in which the costs 
were lower, especially as the cow entered multiple parities.  When treating CM1, costs 
were lower in 8%, 36%, and 44% of iterations for parities 1, 2, and ≥ 3, respectively, 
when averaged across 2-d, 5-d, and 8-d treatments.  When comparing culling to NT, NT 
was the optimal treatment option in 14%, 54%, and 62% of the iterations for parities 1, 2, 
and ≥ 3, respectively for when examining CM1.  These dropped for CM2 to 1%, 43%, 
and 53% for parities 1, 2, and ≥ 3, respectively.  Results suggest that when faced with an 
E. Coli mastitis case, NT is the optimal treatment decision.  A 2-d IMM treatment should 
be considered before culling, but culling was often the most optimal treatment decision 
compared to 5-d or 8-d antibiotic treatments. 
Coagulase Negative Streptococci 
Average Treatment Costs.  Milk loss from CNS was greater in primiparous 
compared to multiparous cows (Gröhn et al., 2004, Schukken et al., 2009) for both CM1 
and CM2.  Costs ranged from $441.33 for primiparous cows with their second infection 
to $138.36 for a ≥ 3 parity cow experiencing her second infection (Table 3.11).  The cost 
of milk loss was always higher for CM2 compared to CM1.  Decreasing milk yield costs 
included $335.38, $142.08, and $138.36 for parities 1, 2, and ≥ 3, respectively for CM1 
and $441.33, $168.89, and $164.71 for parities 1, 2, and ≥ 3, respectively for CM2. 
The treatment regimen with the lowest average cost was a combination treatment 
of NT for CM1, followed by culling CM2 for multiparous cows (Appendix Table 0.13).  
Culling was the best option for primiparous cows, suggesting the RPO value was lower 




lowest average cost suggests that antibiotic treatment may not be economically viable 
compared to NT and for CM2, RPO values are lower than the extended costs of milk loss 
or CM3 costs.  The second-best treatment option was a combination of NT for CM1 and 
again for CM2, suggesting the cost of treatment and economic loss because of milk 
discard did not provide enough of an economic incentive to treat. 
Optimum Treatment Comparisons.  Not treating a cow infected with CNS was 
economically optimal compared to 2-d, 5-d, and 8-d treatments in 97%, 96%, and 96% of 
iterations for parities 1, 2, and ≥ 3 during the first CM case.  Like other pathogens, 
treatment provided more of an economic incentive compared to culling at times.  
However, unlike others, large differences occurred between CM1 and CM2 and between 
parities (Appendix Table 0.14).  A 2-d treatment was the optimum treatment option in 
8%, 55%, and 62% of iterations compared to culling for parities 1, 2, and ≥ 3 
respectively.  When comparing a 5-d treatment versus culling, 5-d treatment was the 
optimal in 7%, 48%, and 55% of iterations when treating CM1 for parities 1, 2, and ≥ 3, 
respectively.  Eight-d treatments were optimal in 5%, 40%, and 48% of CM1 treatments 
compared to culling for parities 1, 2, ≥ 3 respectively.  The probability of an antibiotic 
treatment being an economically optimal for CM2 largely decreased.  When comparing a 
2-d treatment to culling for CM2, 2-d treatments were economically optimal in 10%, 
35%, and 42% of iterations for parities 1, 2, and ≥ 3, respectively.  Optimization of a 5-d 
and 8-d treatment dropped compared to culling for CM2 with a 5-d treatment being 
optimal in 5%, 8%, and 11% of iterations for parities 1, 2, and ≥ 3, respectively.  An 8-d 
treatment was optimal in 3%, 2%, and 2% of iterations for parities 1, 2, and ≥ 3, 




71% of iterations when treating CM1 and in 40%, 65%, and 70% of iterations when 
treating CM2 for parities 1, 2, ≥ 3, respectively.  Results suggest that when faced with a 
mastitis case caused by CNS, NT is the most economical treatment option.  Antibiotic 
should be considered for multiparous cows compared to culling, as antibiotic treatment 
was economically beneficial for approximately 50% of CM1 cases.  
Klebsiella 
Average Treatment Costs.  A Klebsiella infection led to more milk loss than any 
other infecting pathogen, especially in primiparous cows (Gröhn et al., 2004).  Average 
costs due to milk loss ranged from $112.45 for a cow experiencing CM1 in parity ≥ 3 to 
$922.82 for a primiparous cow experiencing CM2 (Table 3.11).  Gröhn et al. (2004) 
suggested that Klebsiella had an increased milk loss compared to all other pathogens 
because of its effect on milk production throughout the parity.  Primiparous cows infected 
with Klebsiella experienced large daily milk production losses the week after diagnosis, 
followed by a rebounding period, only to have large losses later in parity.   
The large milk production losses experienced by primiparous cows may be the 
reason culling had the lowest average treatment cost when in the first parity.  No 
treatment had the lowest average cost as the cow was in later parities, suggesting the 
costs and economic losses associated with antibiotic treatment are not worth the benefits 
of higher cure rates.  If CM2 was experienced, the lowest average cost treatment 
combination was NT followed by culling across each parity.  Culling when infected with 
CM2 could be the result of high costs of milk loss that would persist throughout the rest 




Optimum Treatment Comparisons.  No treatment was the optimum treatment in 
95% to 98% of iterations when compared to 2-d, 5-d, and 8-d treatments for both CM1 
and CM2 (Appendix Table 0.16).  When compared to culling, NT was the optimum 
decision when in the first parity only in 3% of iterations for CM1 and 1% of iterations for 
CM2 compared to 65% and 35% of iterations for CM1 and 71% and 47% of iterations for 
CM2 when cows were in parities 2 and ≥ 3, respectively.  At times, antibiotic treatment 
costed less than culling.  Two-d treatments were an optimal choice compared to culling in 
2%, 55%, and 62% of iterations for parities 1, 2, ≥ 3, respectively for CM1.  A 5-d 
treatment was optimal compared to culling in 2%, 47%, and 55% of CM1 cases for 
parities 1, 2, and ≥ 3, respectively and 8-d treatments were only optimal 2%, 40%, and 
47% of CM1 cases compared to culling of parities 1, 2, ≥ 3, respectively.  The probability 
of antibiotic treatment being the optimal treatment of CM2 decreased to a maximum of 
only 33% of iterations for a ≥ 3 parity cow treated for 2-d.  Culling consistently being the 
optimal treatment option when in the first parity provides further evidence that RPO 
value of the cow was lower than the cost of lost milk production throughout the parity.  
Optimum treatment results suggest that not treating Klebsiella is the most economical 
treatment decision for dairy producers.  A 2-d and 5-d antibiotic treatment was 
economical compared to culling more times than not, but when considering an 8-d 
intramammary treatment cow production records should be considered.  
Minor Pathogens 
Average Treatment Costs.  The costs of mastitis associated with minor pathogens 
had rarely been modeled in past research.  Authors felt that including it the current 




results (Makovec and Ruegg, 2003, Tenhagen et al., 2006, Olde Riekerink et al., 2008) 
and thus was important for producers to understand the costs of treatment regimens.  
These minor pathogens also caused milk loss when they infect the mammary gland.  The 
cost due to milk loss from minor pathogens is the highest in multiparous cows than any 
other pathogens (Table 3.11). 
Culling cows infected with a minor pathogen in the first parity resulted in the 
lowest average treatment cost (Appendix Table 0.17).  No treatment resulted in the 
lowest average treatment cost for later parities.  The difference in treatment options might 
be because of first parity cows experience more milk production loss from minor 
pathogens than later parity cows (Gröhn et al., 2004).  No treatment followed by culling 
resulted in the lowest average cost if cows experienced a CM2, suggesting RPO values 
were lower than the economic losses associated with milk loss throughout the remainder 
of the parity. 
Optimum Treatment Comparisons.  Optimum treatment decisions are closely 
related to the average costs of each treatment.  When compared to antibiotic treatment, 
NT was more optimal in 95% to 98% of iterations (Appendix Table 0.18).  When 
compared to culling, NT was the optimum treatment in 13%, 51%, and 60% of iterations 
for parities 1, 2, and ≥ 3 respectively for CM1 and in 3%, 20%, and 32% of iterations for 
parities 1, 2, ≥ 3, respectively for CM2.  A 2-d antibiotic treatment was an optimum 
option compared to culling in 10%, 41%, and 50% of iterations for parities 1, 2, and ≥ 3, 
respectively during CM1.  A 5-d treatment was optimal for 8%, 33%, and 42% of CM1 
cases for parities 1, 2, and ≥ 3, respectively when compared to culling and a 8-d treatment 




compared to culling during CM1.  Like other pathogens, the percent of cases that were 
optimum to treat for CM2 decreased suggesting RPO values later in parity are lower than 
the cost associated with treatment.  Results suggest that NT was the optimum treatment 
for a mastitis case caused by a minor pathogen in most situations.  Antibiotic treatment 
for multiparous cows should be a consideration to producers before culling a cow with a 
IMI.     
No Pathogen Present 
Average Treatment Costs.  The most common culture result is often no pathogen 
(Makovec and Ruegg, 2003, Tenhagen et al., 2006, Olde Riekerink et al., 2008) which 
can mean that cow’s immune system had cleared the pathogen from the mammary gland 
or a low number of colonies were present in the milk sample.  Even when no pathogen 
was present when culturing, milk loss still occurs.  Table 3.11 presents the cost associated 
with milk loss from a negative culture sample.  Like all other pathogens, no pathogen 
present had the greatest effect on primiparous cows.  No pathogen is second highest 
(Klebsiella) for primiparous cows when comparing pathogens.  However, for multiparous 
cows, no pathogen present had the lowest economic effect when comparing to other 
pathogens.   
Like minor pathogens, when culture results come back negative the lowest 
average treatment cost was culling for primiparous cows and NT for multiparous cows 
during CM1 (Appendix Table 0.19).  For parity 1, the second lowest average was NT.  
For second parity cows, the second lowest was a 2-d mastitis treatment, followed by a 5-
d, suggesting that the costs associated with 2-d and 5-d treatments are lower than the 




compared to culling for parity ≥ 3 cows when treating CM1.  For CM2 the combination 
of NT for CM1 followed by culling for CM2 was the lowest treatment combination for 
all parities.   
Optimum Treatment Comparisons.  No treatment when compared to 2-d, 5-d, 
and 8-d treatments was optimal for 95% to 98% of iterations (Appendix Table 0.20).  
When compared to culling, NT was the optimal option in 3%, 64%, and 71% of iterations 
when treating CM1 for parities 1, 2, and ≥ 3, respectively.  When comparing treatments 
to culling, 2-d treatments were optimal in 2%, 55%, 62% of iterations, 5-d treatments 
were optimal in 2%, 47%, and 55% of iterations, and 8-d treatment were optimal in 2%, 
40%, and 47% of iterations for parities 1, 2, and ≥ 3, respectively.  When comparing NT 
to culling, NT was the best choice in 3%, 64%, and 71%of iterations for parities 1, 2, and 
≥ 3, respectively during CM1.  As cows experienced CM2, the proportion of cases that 
were optimally treated by NT compared to culling was nearly cut in half for multiparous 
cows.  These optimum treatment results suggest that when faced with a mastitis case that 
producers are unsure of the infecting pathogen, the most economical treatment decision 
would be not to treat the mastitis case.  Secondary decisions would include culling for 
primiparous cows and antibiotic treatment for multiparous cows.   
Overall Clinical Mastitis Cost 
The average cost of clinical mastitis cases under optimal decisions are displayed 
in Table 3.14.  Overall costs of case of mastitis were similar to those presented by Shim 
et al. (2004), Pinzon-Sanchez et al. (2011), and Steeneveld et al. (2011a).  Knowing the 
causative pathogen, by culturing the case of mastitis led to a lower overall cost of the 




the use of on farm culturing led to a lower overall economic impact of a mastitis case by 
allowing for more informed treatment decisions.  Though culturing led to a lower overall 
cost, it did not reduce costs associated with a case of mastitis. 
Figure 3.2 displays variables that had the greatest influence over the overall cost 
of the case of mastitis when cows were in the first parity.  With a baseline cost of 
$164.60, RPO during CM1 had the greatest effect of the overall cost of mastitis.  
Depending on RPO during the first clinical mastitis case, the average cost of the case of 
mastitis ranged from $11.52 to $429.15.  The RPO value during CM2 was the second 
most influential variable.  Heikkila et al. (2012) indicated a high variability in the cost of 
CM due to culling by stating that pre-mature culling accounted for 23% of the overall 
cost of the case of mastitis.  However, unlike Steeneveld et al. (2011a), Heikkila et al. 
(2012) concluded culling a cow with CM can be an optimal decision.  Current results 
may differ because of the modeling of a US system and market effects of 2016 (Liang et 
al., 2017).  Days in milk when diagnosed followed RPO value as the next most influential 
variable. 
Other models either did not determine or had a static d of infection (DOI) (Bar et 
al., 2008a, Halasa et al., 2009b, Pinzon-Sanchez et al., 2011).  In the current model, d of 
infection affected the overall mean of the cost of clinical mastitis from $30.16 to $390.80 
in the first parity.  Day in milk at the time of infection should be considered for future 
analyses because of the effect of DIM on milk yield and RPO.  Though not considered in 





Milk loss associated with differing pathogen types also accounted for variance in 
the overall mean of mastitis costs, with the economic losses associated with milk loss 
from a CNS infection contributing most of the variance when > 1 parity (Figures 3.3 and 
3.4).  Milk loss was followed by RPO values and DOI for both parities 2 and ≥ 3.  The 
cost of discarded milk associated with antibiotic treatment also had a large effect in the 
overall cost mean for multiparous cows.  Halasa et al. (2010) added, depending on milk 
yield of the cow, the costs of discarded milk largely contribute to the variability of 
clinical and subclinical mastitis costs.   
Model Strengths and Limitations 
Estimates for the costs of mastitis have been modeled many different ways and 
results are largely variable.  Developing a model aids in determining the effects of 
treatments (Pinzon-Sanchez et al., 2011, Steeneveld et al., 2011a), culling costs (Bar et 
al., 2008a), and transmission of pathogens (Down et al., 2013) on overall cost of mastitis.  
Two common model types have been used to model the cost of mastitis 1) stochastic 
modeling (Ostergaard et al., 2005, Steeneveld et al., 2011a) and 2) decision tree analysis 
(Pinzon-Sanchez et al., 2011).  Authors used the current model to combine the two 
modeling approaches by modeling every day of a cow’s life and determining the 
economic cost if the cow were infected with mastitis by a variety of pathogens.  The 
stochastic modeling approach allowed the modelers to account for variability of results 
found in peer reviewed literature, cow variables, market values, and the variables 
associated with mastitis pathogens (production loss, cures rates, and recurrence rates).  
The decision tree model allowed for a decision process that may be too difficult for the 




1997).  To determine optimal outcomes, the current model analyzed the least cost paths 
through the decision tree starting with the decision of whether or not to culture mastitis 
cases.  The combining of the two models allowed the researchers to account for how life 
changes of a cow affect optimal treatment decisions of mastitis cases. 
Though not an objective of the study, by including culturing as a choice in the 
model, researchers were able to determine culturing as economically beneficial to the 
overall cost of mastitis, agreeing with Pinzon-Sanchez et al. (2011).  Adding culturing as 
a factor in future analyses may be a way to reiterate the economic benefit of culturing to 
producers. 
Few economic models included pathogen specific effects of mastitis (Halasa et 
al., 2009b, Pinzon-Sanchez et al., 2011, Steeneveld et al., 2011a).  When modeling 
different pathogens, stochastic modeling became especially important because it allowed 
the authors to use information from multiple sources.  The effect different pathogens have 
on milk loss has been rarely examined, Gröhn et al. (2004) being one of the only studies 
and the most commonly used in economic modeling.  Effects of recurring cases of 
mastitis have often been modeled using results from Schukken et al. (2009).  However, 
results presented by Schukken et al. (2009) are broken into bacteria type rather than 
specific pathogen.  To have comparable results with other economic models, both results 
from Gröhn et al. (2004) and Schukken et al. (2009) were used in the current analysis. 
In addition, to make results comparable a 2-d, 5-d, 8-d, NT, and culling treatment 
protocol were used (Swinkels et al., 2005b, Pinzon-Sanchez et al., 2011).  For antibiotic 




et al., 2005b, Pinzon-Sanchez et al., 2011).  Rollin et al. (2015)  considered feeding 
discarded milk to calves and concluded that when non-saleable milk was discarded rather 
than fed to calves, non-saleable milk accounts for 22% of the total cost of a mastitis case 
and adds $92 to a case of mastitis.  In the current analysis, an average of $12.43 was 
alleviated from the cost of milk discard per day by feeding discarded milk to calves.  
Because the cost of discarding milk accounted for a high variability in the overall mean 
of mastitis costs, inclusion of feeding discarded milk to calves could make treatment with 
antibiotics a more viable option.   
Unlike Swinkels et al. (2005b), Pinzon-Sanchez et al. (2011), and Steeneveld et 
al. (2011a) recurrence rates in the current model were based off pathogen type and cure 
status, instead of cure status alone (Pinzon-Sanchez et al., 2011).  However, the current 
model did not account for parity when modeling recurrence rate (Pinzon-Sanchez et al., 
2011), due to lack of sufficient data.  
The calculation of RPO considers that when a cow is culled, an equal replacement 
is available within the herd or can be purchased but does not consider cash flow 
considerations.  Eventually, if enough cows are being culled from the herd, there is not 
enough cash flow to buy replacements.  This was not considered in the current analysis 
because only one cow was being modeled but authors caution that not every cows with a 
case of mastitis should be culled because of lack of cash flow consideration.  Heikkila et 
al. (2012) argued that RPO was not the proper way of accounting for the cost of culling 
when determining the cost of a mastitis case.  However, like Steeneveld et al. (2011a),  
Swinkels et al. (2005b), and Liang et al. (2017), RPO was used as a culling cost in the 




money to spend on treatment of an animal.  Because the current model was trying to 
determine optimum treatment decision, authors found RPO the most suitable modeling 
option.  Steeneveld et al. (2011a) concluded that culling costs were highly dependent on 
milk production, pregnancy status, and parity, which agree with the current analysis as 
culling was often more costly for later parities when cows yielded higher milk 
production.   
The current model was developed for a US system and like Pinzon-Sanchez et al. 
(2011) and Bar et al. (2008b) veterinarian costs were not accounted for.  Authors felt that 
models developed outside the US had inflated veterinarian costs due to different 
management practices and regulations.  Farm staff generally treats non-severe mastitis 
cases in the US (Pinzon-Sanchez et al., 2011). 
CONCLUSIONS 
The current study was used to model the cost of a clinical mastitis case under 
2016 market conditions using a stochastic model to simulate the daily life of a dairy cow 
on a average US dairy operation.  A decision tree model was then used to determine 
optimum treatment for a variety of mastitis pathogens.  Culturing mastitis cases before 
treating was an optimal decision as it leads to a lower overall cost of mastitis.  Knowing 
the affecting pathogen can lead to a more responsible use of antibiotics and lower overall 
cost incurred for a mastitis case.  Often, the most economical option was not to treat 
mastitis no matter the pathogen types.  If infected with S. aureus, culling was the 
optimum decision.  A 2-d antibiotic treatment was economical for all other pathogens 




complex, a decision tree analysis allows for the modeling of decisions that would be 
made on dairy farms. 
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Table 3.1.  Bacteria type and frequency results for clinical mastitis samples submitted to 
the University of Kentucky Veterinary Diagnostic Laboratory and Virginia Tech Mastitis 
and Immunology Laboratory from June 2010 to June 2015. 
 University of Kentucky Virginia Tech 
Bacteria Type Frequency Percent Frequency Percent 
No growth 34 13.88% 5,822 55.68% 
Minor Pathogens1 124 51% 2100 20% 
Escherichia coli 21 8.57% 231 2.21% 
Streptococcus uberis 18 7.35% 15 0.14% 
Staphylococcus aureus 15 6.12% 493 4.71% 
Streptococcus dysgalactiae 15 6.12% 135 1.29% 
Klebsiella pneumoniae 12 4.90% 154 1.47% 
CNS 6 2.45% 1,127 10.78% 
1Minor pathogens included a total of 29 different culture results including nonpathogenic 
bacteria, overgrown by saprophytes, contaminated, Enterococcus faecalis, 
Arcanobacterium pyogenes, Corynebacterium species, Enterobacter cloacae, Minimal 
Inhibitory Concentration, Acinetobacter baumannii, Bacillus species, Enterobacter 
species, Moraxella species, Neisseria species, Proteus vulgaris, Serratia marcescens, 
Staphylococcus intermedius, Yeast, Staphylococcus hyicus, unknown microorganism, 
Pseudomonas, Mold, Coryneform, gram negative pathogen, Prototheca, Proteus, 





Table 3.2.  Mastitis pathogen prevalence rates collected from peer reviewed literature.  Prevalence rates were fit into a PERT 
distribution and a 10,000 iteration simulation was conducted to estimate pathogen prevalence rates for when no culture was chosen in 
a stochastic decision tree model. 
Bacteria Type Average 5% 95% Reference 
Staphylococcus aureus 5.83% 9.70% 2.90% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
Streptococcus uberis 6.07% 29.10% 0.14% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
Streptococcus dysgalactiae 1.80% 4.00% 0.05% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
CNS 8.46% 16.61% 1.52% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
Escherichia coli 6.26% 19.40% 0.40% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
Klebsiella 3.72% 14.60% 0.20% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
Other 30.23% 9.56% 2.43% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 
2004, Roberson et al., 2004, Olde Riekerink et al., 2008) 
No Pathogen 36.89% 62.38% 8.61% 
(Wilson et al., 1997, Makovec and Ruegg, 2003, Pitkala et al., 






Table 3.3.  Cure rates for mastitis cases treated with a 2-d, 5-d, 8-d or a no treatment regimen for common mastitis causing pathogens 
in the United States.  Cure rates were collected from peer-reviewed literature and then fit into a PERT distribution and a 10,000-
iteration simulation was conducted to estimate pathogen cure rates 
Bacteria 2D 5D 8D Untreated References 
Staphylococcus aureus 31% 32% 65% 27% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
Streptococcus uberis 61% 64% 82% 35% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
Streptococcus dysgalactiae 69% 84% 88% 58% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
CNS 70% 78% 81% 44% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
Escherichia coli 87% 91% 92% 78% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
Klebsiella 50% 57% 75% 22% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
Other 81% 84% 87% 64% 
(Owens et al., 1997b, Oliver et al., 2003, Oliver et al., 2004, 
Roberson et al., 2004, Deluyker et al., 2005, Galligan, 2006, 
van den Borne et al., 2010, Steeneveld et al., 2011a) 
No Pathogen 50% 71% 84% 29% 
(Owens et al., 1997b, Wilson et al., 1999, Oliver et al., 2003, 
Oliver et al., 2004, Roberson et al., 2004, Deluyker et al., 
2005, Galligan, 2006, van den Borne et al., 2010, Steeneveld 





Table 3.4.  Stochastic average milk loss (kg/d) due to specific infecting pathogens for a primiparous cow with first clinical mastitis 
case.  Stochastic averages were created by from a 10,000 iteration simulation from a PERT Alt. distribution fit to results presented by 











Other No Pathogen 
-4 -1.28 -2.12 -0.52 -1.77 -3.54 -4.62 -1.36 
-3 -0.57 -2.31 -0.46 -1.76 -3.31 -4.02 -1.20 
-2 -1.33 -1.53 -0.33 -1.72 -3.63 -3.64 -2.08 
-1 -1.08 -3.27 -0.93 -3.29 -4.38 -2.35 -2.13 
0 -2.61 -8.39 -6.66 -7.15 -7.17 -3.48 -7.64 
1 -1.71 -7.99 -4.71 -7.04 -5.32 -2.46 -4.93 
2 -2.04 -6.36 -4.85 -6.37 -4.57 -2.74 -4.68 
3 -2.07 -4.43 -5.04 -5.44 -3.34 -2.37 -3.87 
4 -1.76 -3.75 -2.80 -5.67 -3.89 -2.89 -4.99 
5 -1.76 -5.39 -2.82 -5.34 -6.05 -3.49 -4.33 
6 -1.44 -4.53 -3.41 -4.06 -3.87 -3.17 -7.06 
7 -0.84 -3.82 -2.73 -3.49 -3.10 -3.10 -6.84 
8 -0.76 -3.54 -2.40 -4.14 -2.89 -3.38 -5.70 
9 -0.65 -2.48 -1.81 -3.24 -2.12 -2.61 -5.77 
10 -0.58 -2.22 -2.09 -3.17 -2.42 -2.87 -5.54 
1Used in estimation for milk loss associated with Streptococcus uberis and Streptococcus dysgalactiae 




Table 3.5.  Stochastic means for milk loss (kg/d) due to specific infecting pathogens for a multiparous cow with first clinical mastitis 
case.  Stochastic averages were created from a 10,000 iteration simulation from a PERT Alt. distribution fit with results presented by 













-4 0.00 -0.87 0.00 -0.22 0.00 -1.91 0.00 
-3 0.00 -1.04 0.00 -0.17 0.00 -2.16 0.00 
-2 0.00 -0.77 0.00 -0.27 0.00 -1.24 0.00 
-1 -1.63 -1.24 -0.71 -0.83 -0.60 -1.60 -0.81 
0 -5.34 -5.48 -13.10 -4.51 -1.13 -7.07 -5.49 
1 -4.06 -3.65 -7.24 -3.54 -0.74 -4.46 -4.06 
2 -4.41 -3.32 -4.63 -2.83 -0.90 -4.31 -2.50 
3 -3.76 -3.60 -4.24 -2.16 -1.32 -2.35 -2.55 
4 -3.29 -3.82 -2.86 -1.85 -1.15 -2.20 -2.10 
5 -2.91 -4.31 -2.81 -1.78 -0.90 -1.90 -1.99 
6 -2.58 -3.25 -1.91 -1.46 -0.86 -1.94 -1.60 
7 -1.92 -2.57 -1.38 -1.26 -1.18 -1.62 -1.88 
8 -2.33 -2.47 -1.68 -0.99 -1.73 -1.20 -1.18 
9 -2.20 -2.78 -2.14 -1.22 -2.01 -2.15 -0.95 
10 -1.83 -1.82 -0.88 -0.90 -1.22 -1.38 -0.80 
1Used in estimation for milk loss associated with Streptococcus uberis and Streptococcus dysgalactiae 




Table 3.6.  Stochastic means for milk loss (kg/d) associated bacteria type for primiparous 
cows with their second CM case.  Stochastic means were developed from a 10,000 
iteration simulation from a PERT Alt. distribution fit with results adapted from Schukken 









0 -6.87 10.14 -4.89 
1 -6.83 10.58 -4.85 
2 -5.73 10.58 -4.23 
3 -6.35 -9.00 -1.89 
4 -6.43 -7.76 -1.70 
5 -7.01 -7.05 -1.29 
6 -7.98 -7.46 -2.12 
7 -3.68 -7.68 -2.37 
8 -1.73 -5.95 -3.97 
1Used in estimation for milk loss associated with Staphylococcus aureus, Streptococcus 
uberis, Streptococcus dysgalactiae, and CNS.  
2Used in estimation for milk loss associated with Escherichia coli and Klebsiella.  





Table 3.7.  Stochastic means for milk loss (kg/d) associated bacteria type for multiparous 
cows with their second CM case.  Stochastic means were developed from a 10,000 
iteration simulation from a PERT Alt. distribution fit with results adapted from  









0 -5.95 -13.23 -6.65 
1 -5.33 -14.33 -6.79 
2 -3.75 -9.92 -3.75 
3 -2.87 -6.21 -2.65 
4 -2.47 -3.31 -3.05 
5 -1.19 -1.76 -4.01 
6 -0.74 -1.60 -3.75 
7 -0.91 -0.56 -2.69 
8 -0.16 -0.05 -2.61 
1Used in estimation for milk loss associated with Staphylococcus aureus, Streptococcus 
uberis, Streptococcus dysgalactiae, and CNS.  
2Used in estimation for milk loss associated with Escherichia coli and Klebsiella.  





Table 3.8.  Costs for antibiotics, culturing, and labor used to create a PERT distribution, 
making costs a stochastic distribution.  A 10,000 iteration simulation was conducted on 
the distribution to estimate the costs spent of antibiotics, culturing, and labor when 
determining the infecting pathogen and treating a case of clinical mastitis with 2016 
market prices. 




Low $2.08 (DairyHealthUSA, 2016) 
Average $3.28 (DairyHealthUSA, 2016) 
High $4.72 (DairyHealthUSA, 2016) 
Culture 
Low $3.75 (Pinzon-Sanchez et al., 2011) 
Average $6.00 (Pinzon-Sanchez et al., 2011) 
High $8.38 (Swinkels et al., 2005b) 
Labor 
Low $8.00 (Pinzon-Sanchez et al., 2011) 
Average $13.00 (Pinzon-Sanchez et al., 2011) 






Table 3.9.  The costs associated with milk discarded for a 2-d, 5-d, and 8-d treatment regimen for an initial and recurring clinical 
mastitis case.  Authors assumed that milk would be discarded for an additional 3 days after completion of treatment and discarded 
milk would be fed to calves1.  The estimate of the cost of milk discard was modeled for an average cow in the average United States 
dairy herd by taking 3 days of milk production prior to treatment and multiplying losses by a stochastic milk price 10,000 times under 
2016 market conditions.   
1An average of $12.43 was alleviated per day by feeding discarded milk to calves. The cost of discarded milk when not fed to calves is 
located in Appendix Table 0.4. 
  Parity 
  1 2 ≥ 3 
Treatment Mastitis Case Mean1 5% 95% Mean 5% 95% Mean 5% 95% 
2-d 
1 $13.45 -$22.43 $49.98 $26.46 -$20.93 $71.02 $34.35 -$22.52 $84.44 
2 $11.64 -$24.54 $48.58 $21.24 -$27.21 $66.96 $27.99 -$30.65 $79.61 
5-d  
1 $21.46 -$35.83 $80.14 $42.06 -$34.05 $113.64 $54.66 -$36.70 $135.18 
2 $18.38 -$39.53 $77.51 $33.41 -$44.05 $106.54 $44.07 -$49.73 $126.51 
8-d  
1 $29.40 -$49.44 $110.04 $57.40 -$47.85 $156.24 $74.65 -$51.52 $185.77 




Table 3.10.  Retention pay-off values for an average cow in an average United States dairy herd during an initial mastitis case and 2 
recurring cases (+ 30 days in milk) and (+ 60 days in milk) from the original mastitis case for parities 1, 2, and ≥ 3.  Retention-pay off 
values were modeled stochastically using a 10,000 iteration simulation with 2016 market prices. 
 Parity 
 1 2 ≥ 3 
Mastitis Case Mean 5% 95% Mean 5% 95% Mean 5% 95% 
1 -$0.76 $398.23 $254.04 -$1.30 $572.70 $307.14 -$0.96 $680.91 -$0.76 
2 -$1.13 $231.34 $161.09 -$1.87 $391.92 $201.68 -$1.62 $483.85 -$1.13 






Table 3.11.  The average costs of milk loss associated with Staphylococcus aureus, streptococcus uberis, streptococcus dysgalactiae, 
E. coli, CNS, Klebsiella, other pathogens, and no pathogen for parities 1, 2, and ≥ 3.  Costs of milk loss were modeled stochastically 
by fitting a PERT distribution and a 10,000 iteration simulation was conducted to estimate milk yield losses presented by Grohn et al. 
(2004) and Schukken et al. (2009) multiplied by a stochastic milk price under 2016 market conditions. 
 
  Parity 
  1 2 ≥ 3 
Pathogen Mastitis Case Mean 5% 95% Mean 5% 95% Mean 5% 95% 
S. aureus 
1 $289.84 $87.91 $584.58 $237.47 $70.75 $477.42 $230.82 $64.72 $471.06 
2 $380.27 $132.82 $720.85 $235.61 $67.82 $478.11 $228.72 $59.74 $470.28 
S. uberis 
1 $81.14 $23.88 $177.05 $225.90 $68.24 $434.55 $220.25 $61.13 $425.96 
2 $201.11 $86.96 $356.66 $231.38 $71.55 $439.71 $225.41 $61.86 $433.57 
S. dysgalactiae 
1 $81.14 $23.88 $177.05 $225.90 $68.24 $434.55 $220.25 $61.13 $425.96 
2 $201.11 $86.96 $356.66 $231.38 $71.55 $439.71 $225.41 $61.86 $433.57 
E. Coli 
1 $255.96 $71.89 $499.37 $129.08 $46.11 $262.21 $125.76 $41.98 $256.40 
2 $557.16 $211.88 $923.27 $169.59 $84.01 $306.25 $165.84 $77.97 $299.56 
CNS 
1 $335.38 $82.97 $675.80 $142.08 $29.03 $329.41 $138.36 $24.90 $325.45 
2 $441.33 $145.83 $818.97 $168.89 $52.76 $359.39 $164.71 $46.30 $354.95 
Klebsiella 
1 $641.20 $149.73 $1,304.79 $115.94 $34.08 $228.46 $112.45 $31.47 $223.32 
2 $922.82 $302.10 $1,688.03 $167.24 $82.78 $285.71 $163.25 $76.73 $278.96 
Other 
1 $302.80 $75.39 $687.59 $169.07 $39.98 $384.81 $163.79 $35.16 $375.06 
2 $449.84 $128.47 $897.43 $298.17 $103.79 $564.91 $288.47 $84.85 $544.59 
No pathogen 
1 $390.67 $139.66 $704.99 $109.50 $33.77 $232.41 $106.61 $30.83 $227.74 




Table 3.12.  Average treatment cost for a case of mastitis caused by Staphylococcus aureus, streptococcus uberis, 
streptococcus dysgalactiae, E. Coli, CNS, Klebsiella, other pathogens, and no pathogen present after culturing when treated 
with a 2-d, 5-d, 8-d, no treatment (NT), or a culling of an initial clinical mastitis case (CM1) and the combination of treatments 
for CM1 followed by a clinical recurrence (CM2).  The model used was a stochastic decision tree under 2016 market 
conditions for the average dairy herd in the United States.   
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean 5% 95% Mean 5% 95% 
2-d $408.96 $188.53 $702.73 $289.30 $134.58 $485.40 $297.08 $126.69 $499.23 
2-d/2-d $630.10 $326.91 $981.76 $430.05 $221.14 $668.80 $444.37 $202.67 $699.64 
2-d/5-d $657.33 $337.64 $1,022.33 $463.88 $227.69 $724.85 $481.83 $206.49 $761.30 
2-d/8-d $693.56 $351.34 $1,079.19 $497.65 $233.04 $781.16 $518.84 $209.36 $823.95 
2-d/NT $583.33 $310.07 $910.51 $379.11 $213.89 $584.43 $387.23 $199.66 $603.97 
2-d/Cull $285.15 $159.90 $432.51 $327.47 $120.89 $593.94 $375.48 $114.01 $703.57 
5-d $439.26 $203.45 $744.92 $325.10 $145.69 $537.77 $337.08 $135.96 $557.86 
5-d/2-d $658.79 $340.87 $1,022.46 $466.33 $231.74 $725.23 $485.36 $211.69 $763.05 
5-d/5-d $689.54 $352.78 $1,068.52 $500.16 $237.66 $781.21 $522.82 $215.06 $825.82 
5-d/8-d $722.26 $364.07 $1,122.29 $533.93 $242.47 $839.06 $559.83 $217.36 $889.55 
5-d/NT $612.02 $325.29 $947.95 $415.40 $226.49 $637.48 $428.22 $210.55 $665.22 
5-d/Cull $313.85 $178.44 $466.30 $363.76 $134.69 $650.52 $416.46 $124.34 $769.28 
8-d $470.36 $216.55 $791.56 $360.88 $155.06 $591.93 $381.20 $145.88 $625.05 
8-d/2-d $687.41 $354.17 $1,064.01 $502.35 $241.30 $782.19 $526.03 $219.60 $827.98 
8-d/5-d $718.15 $365.67 $1,110.36 $540.30 $247.27 $846.52 $565.80 $222.67 $895.57 
8-d/8-d $750.87 $375.54 $1,164.57 $548.95 $242.63 $865.80 $589.11 $220.60 $938.58 
8-d/NT $640.64 $339.33 $987.46 $451.42 $237.41 $692.81 $468.89 $219.59 $727.67 
8-d/Cull $342.47 $194.65 $503.13 $399.78 $147.03 $707.32 $457.14 $133.11 $836.22 
NT $363.92 $164.94 $640.68 $236.21 $116.82 $409.32 $237.21 $110.59 $413.10 
NT/2-d $589.11 $308.14 $925.27 $376.05 $206.60 $586.81 $382.48 $191.60 $604.76 
NT/5-d $619.85 $321.83 $969.59 $409.88 $215.03 $639.24 $419.94 $197.58 $664.10 
NT/8-d $652.57 $334.91 $1,018.26 $443.65 $221.69 $694.21 $456.95 $201.52 $724.68 
NT/NT $542.34 $286.76 $858.75 $325.11 $191.72 $508.21 $325.34 $180.32 $514.90 
NT/Cull $244.16 $129.36 $393.12 $273.47 $98.65 $511.41 $313.59 $97.76 $605.18 




Table 3.13.  Average frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling 
treatment having the lowest average treatment cost for an initial and recurring case of 
mastitis caused by Staphylococcus aureus, streptococcus uberis, streptococcus 
dysgalactiae, Klebsiella, E. coli, CNS, other pathogens, and no pathogen.  The model 
used was a stochastic decision tree under 2016 market conditions for the average dairy 
herd in the United States.   
 
 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 98% 98% 97% 
2 97% 97% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 98% 96% 96% 
2-d v NT 
1 3% 4% 4% 
2 4% 5% 6% 
2-d v Cull 
1 15% 42% 50% 
2 4% 19% 29% 
5-d v 8-d 
1 98% 97% 97% 
2 97% 96% 96% 
5-d v NT 
1 3% 3% 3% 
2 3% 4% 5% 
5-d v Cull 
1 12% 34% 42% 
2 3% 11% 17% 
8-d v NT 
1 2% 3% 3% 
2 3% 4% 5% 
8-d v Cull 
1 10% 28% 35% 
2 2% 6% 11% 
NT v Cull 
1 31% 49% 57% 




Table 3.14.  Average costs of a case of clinical mastitis when modeled for the average United States dairy herd under 2016 market 
conditions.  The model used was a stochastic decision tree that selected for the least cost treatment option over 10,000 iterations, 
comparing the cost of the mastitis case when dairy producers cultured the case of mastitis or did not culture. 
 Parity 
 1 2 ≥ 3 
 Mean 5% 95% Mean 5% 95% Mean 5% 95% 
Culture  $164.60 $11.11 $409.17 $163.92 $63.37 $330.99 $164.01 $58.44 $334.18 




Figure 3.1.  An abbreviated version of the cost of mastitis decision tree used in a stochastic decision tree analysis.  Choices in 
the model are associated with a cost.  Circles represent chances in the model and are associated with a probability of an o an 
outcome.  One initial mastitis case and two recurring cases are modeled using the decision tree.  The initial mastitis case has 
the option to be treated with a 2-d, 5-d, 8-d, no treatment, or culling from the herd.  After the first recurrence the same 5 





Figure 3.1 (continued) 
$ = Cost associated with scenario above 
P = Probability of scenario above 
1The costs associated with culturing mastitis.  See Table 3.8. 
2The probability for each of the organisms above being the infecting pathogen.  See Table 
3.2. 
3The costs associated with milk loss due to each specific pathogen.  See Formula 3.7. 
4The costs associated with a 2-d IMM antibiotic treatment of the clinical mastitis case.  
See Formula 3.8. 
5The costs associated with a 5-d IMM antibiotic treatment of the clinical mastitis case.  
See Formula 3.9. 
6The costs associated with an 8-d IMM antibiotic treatment of the clinical mastitis case.  
See Formula 3.10. 
7The costs associated with culling a cow infected with a clinical mastitis case.  See 
Formula 3.11. 
8The probability of cure based on bacteria type and treatment decision.  See Table 3.3. 
9The probability of recurrence or non-recurrence based on cure status of the clinical 
mastitis case.  See Recurrence Rates. 
10Simulation continues for three clinical mastitis cases per parity.  Upon the third 




Figure 3.2.  Variation in the overall mean of a case of mastitis due to RPO value during CM1 (RPO1), RPO value during 
CM2(RPO2), d of infection (DOI), RPO value during CM3 (RPO3), the cost of milk loss associated with the second E. coli infection 
(ECML2), the cost of milk loss associated with the second infection where no pathogen was present (NPML2), the cost of milk loss 
associated with the first Klebsiella infection (KML2), the cost of milk loss associated with the first minor pathogen infection (OML1), 
the cost of milk loss associated with the first infection where no pathogen was present (NPML1), and the cost of milk loss associated 
with the second CNS infection (CNSML2) for parity 1 cows with a $164.60 baseline.  Variables listed were stochastic variables and a 
10,000-iteration simulation was conducted on the data to estimate a cost of CM under 2016 market prices. 
























Figure 3.3.  Variation in the overall mean of a case of mastitis due to the cost of milk loss associated with the first CNS infection 
(CNSML1), the cost of milk loss associated with the second CNS infection (CNSML2), to RPO value during CM1 (RPO1), RPO 
value during CM2(RPO2), the cost of milk loss associated with the second infection where no pathogen present (NPML2), d of 
infection (DOI), the cost of discarding milk associated with a 2-d antibiotic treatment for CM2 (CM2MD2), the cost of discarding 
milk associated with an 8-d antibiotic treatment for CM2 (CM2MD8), the cost of discarding milk associated with a 5-d antibiotic 
treatment for CM2 (CM2MD5), and the cost of discarding milk associated with an 8-d antibiotic treatment for CM1 (CM1MD8) for 
parity 2 cows with a $163.92 baseline.  Variables listed were stochastic variables and a 10,000-iteration simulation was conducted on 
the data to estimate a cost of CM under 2016 market prices. 
 





















Figure 3.4.  Variation in the overall mean of a case of mastitis due to the cost of milk loss associated with the first CNS infection 
(CNSML1), the cost of milk loss associated with the second CNS infection (CNSML2), to RPO value during CM1 (RPO1), RPO 
value during CM2(RPO2), the cost of milk loss associated with the second infection where no pathogen present (NPML2), the cost of 
discarding milk associated with an 8-d antibiotic treatment for CM2 (CM2MD8), the cost of discarding milk associated with a 5-d 
antibiotic treatment for CM2 (CM2MD5), the cost of discarding milk associated with a 2-d antibiotic treatment for CM2 (CM2MD2), 
the cost of discarding milk associated with a 5-d antibiotic treatment for CM1 (CM1MD5), and the cost of discarding milk associated 
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Mastitis is one of the most costly and common diseases in the dairy industry.  
Dairy producers around the world have management plans to limit the effects of both 
clinical (CM) and subclinical mastitis (SCM).  The goal of these plans is to limit the 
number of new mastitis cases and shorten the duration of any current mastitis case.  
These goals are accomplished in two ways; first, prevention of new cases through proper 
management techniques and second, proper treatment of occurring mastitis cases. 
Many studies have looked into the costs of a mastitis case (Halasa et al., 2009a, 
Pinzon-Sanchez et al., 2011, Steeneveld et al., 2011a) but few have tried to determine the 
on-farm costs of prevention methods, antibiotic treatment, and whether milk quality 
measured at the farm level has an impact on disease costs.  McInerney et al. (1992) 
explained that many prevention method costs are considered standard management costs 
(hygiene control measures or feed additives) but are implemented to control disease and 
should be considered in economic analysis.  McInerney et al. (1992) add that marginal 
criterion of economic analysis holds true to examining disease costs.  For example, if a 
dollar spent managing mastitis results in more than a dollar gained by producing higher 
quality milk, the management practice is worth investing in.   
Dufour et al. (2011) completed a literature review determining which 
management practices are associated with a lower bulk-tank somatic cell count 
(BTSCC).  Wearing gloves, using automatic take-offs, and applying post-milking teat 
disinfectant were important practices.  Barkema et al. (1998a) concluded that dairy 
producers that use post-milking teat disinfectant are 1.17 times more likely to have a 




using a wet pre-milking treatment.  Producers that used the minimal number of antibiotic 
treatments when treating CM were 2.35 times as likely to have a lower SCC. 
Both the effect of management decisions and their economic impact are important 
for dairy producers to understand.  Much research has been conducted on the effects of 
management practices on milk quality, but little has been done examining the costs of 
these management practices and how milk quality may affect them.       
The objectives of this study were, 1) to determine the amount producers spend on 
preventive and treatment measures for milk quality, 2) to determine whether milk quality 
measures affected the costs spent on treatment and preventive measures, and 3) to 
determine what dairy producers estimate as a cost of CM and SCM. 
MATERIALS AND METHODS 
Data Collection 
The Southeast Quality Milk Initiative is a collaborative project between six 
universities in the Southeastern United States.  The University of Tennessee, University 
of Kentucky, University of Georgia, University of Florida, Mississippi State University, 
and Virginia Tech formed a team to determine the reasons for high SCC in the Southeast 
and help producers yield higher quality milk. 
As a part of the Southeast Quality Milk Initiative, 283 farms across the 
Southeastern United States participated in farm visits assessing milk quality.  Personnel 
from four universities visited farms across four states: Tennessee (n = 88), Kentucky (n = 
94), Virginia (n = 94), and Mississippi (n = 7).  Representatives from each state visited 




breakdowns for each state are located in Table 4.1.  At each farm, owners or herdsmen 
completed a 175-question survey consisting of questions based on farm management and 
areas that may influence milk quality.  Questions analyzed in the current study focused 
on measures taken to prevent poor milk quality, for example, use of pre and post dip and 
vaccines, and costs of the practices ($/cow or $/unit).  Two questions in the survey were 
included to determine whether producers had an understanding of what mastitis cost 
them.  Those questions included 1) What do you estimate a case of CM costs you? and 2) 
What do you estimate a case of SCM costs you? 
Data Analysis 
Data from all four states were entered into Qualtrics (Qualtrics LLC, Provo, UT) 
compiling the data from all farm visits into one data set.  Variables of interest in an 
economic analysis included the cost spent on intramammary (IMM) antibiotics 
($/mastitis case), cost of pre- and post-milking teat disinfectant ($/cow per d), cost spent 
on vaccinations against coliform pathogens ($/vaccination protocol), and producer 
estimates for the cost of a case of CM and SCM. 
Cost of Intramammary Antibiotics 
Producers were asked to provide a list of drugs used to treat CM, how many doses 
of the drug were administered per d, the number of d the treatment was given, the 
percentage of mastitis cases drugs were used to treat, unit size purchased, and the cost of 
the unit purchased.  Using formula 4.1, the costs of antibiotics used to treat a mastitis 
case were calculated. 









TC = Treatment cost  
A = Antibiotic dose given per d 
D = Number of d dose was given 
P = Percent of cases said treatment regimen is used 
C = Cost per unit bought 
U = Number of doses per unit bought 
For producers that provided all the information needed to calculate antibiotic cost 
per CM case, except for the cost per unit, the average cost from those that did provide the 
information was used.  Treatment cost was slightly skewed with the median being higher 
than the average.  To normalize the data, antibiotic costs per mastitis case were log 
transformed.  A univariate analysis using PROC GLM in SAS 9.4 (SAS Institute Inc., 
Carry, NC) was performed on the transformed data to determine which variables had an 
effect (P < 0.05) on the cost of treatment.  Significant variables were added into a 
multivariate model.  Stepwise backward elimination was performed to remove any non-
significant variables from the model.  Model 4.1 was used as the final model in the GLM 
procedure of SAS 9.4 to determine variable effects on the cost of IMM antibiotic 
treatment. 




𝑌𝑖𝑗𝑘𝑙 =  𝑀𝑖 + 𝐴𝑗 + 𝑆𝑘 + 𝐶𝑙 + 𝐶𝐴𝑙𝑗 + ԑ𝑖𝑗𝑘𝑙 
Where: 
Y = Cost of antibiotic treatment 
M = change to management practices due to an increased bulk tank SCC, yes or no 
A = antibiotic treatment used 
S = herd average SCS 
C = look for a swollen quarter when checking for CM, yes or no 
CA = the interaction between checking for a swollen quarter and the antibiotic treatment 
used 
Cost of Pre and Post-Milking Teat Disinfectant 
To calculate the cost of pre and post-milking teat disinfectant, researchers used 
producer estimates for the size of the unit of pre and post-milking teat disinfectant 
purchased, the cost per unit, and approximately how long each unit lasted.  In order to 
make a cost comparison across different herds, researchers converted each length that the 
unit lasted into d and then simplified the cost of both pre and post-milking teat 
disinfectant to the cost per cow per d using Formula 4.2. 









C = Cost of pre and post-milking teat disinfectant per cow per d 
P = Cost per unit 
D = How long unit of teat disinfectant lasts in d 
H = Lactating herd size 
Both pre and post-milking teat disinfectant costs were slightly skewed with the 
median being higher than the average.  In order to normalize the data, researchers 
transformed pre and post-milking teat disinfectant costs using a log transformation.  A 
univariate analysis using PROC GLM in SAS 9.4 was performed on the transformed data 
to determine which variables had an effect (P < 0.05) on the cost of pre and post-milking 
teat disinfectant.  Significant variables were added into a multivariate model.  Stepwise 
backward elimination was performed to remove any non-significant variables from the 
model.  Model 4.2 was used as the final model in the GLM procedure of SAS 9.4 to 
determine variable effects on the cost of post-milking teat disinfectant. 
Model 4.2.  GLM model for the cost of post-milking teat disinfectant. 
𝑌𝑖𝑗 = 𝐴𝑖 + 𝑈𝑗 + 𝐴𝑈𝑖𝑗 + 𝜀𝑖𝑗 
Where: 
Y = Cost of post-milking teat disinfectant 
A= How pre-milking teat disinfectant is applied 
U = Are udders singed or clipped, yes or no 




AU = Interaction between pre-milking disinfectant application and clipping or singing of 
udders 
Cost of Vaccinations against Coliform Pathogens 
Producers were asked whether they used vaccines to prevent mastitis caused by 
coliform pathogens.  If so, they were asked to provide a vaccination protocol including 
number of injections, volume of injection, size of bottle that was purchased, and an 
estimate of the cost of the bottle.  To compare the cost of the vaccinations across different 
herds, researchers estimated the cost of the vaccination protocol.  Formula 4.3 was used 
to determine the cost of vaccination by protocol. 




∗ 𝑉 ∗ 𝐼 
Where: 
P = Cost of vaccination protocol per cow 
C = Cost of a bottle of vaccine 
B = Size of bottle 
V = Volume of injection 
I = Number of injections given per protocol 
Vaccination costs were slightly skewed with the median being higher than the 
average.  To normalize the data, researchers transformed the data using a log 




Carry, NC) was performed on the transformed data to determine which variables had an 
effect (P < 0.05) on vaccination costs.  Significant variables were then added into a 
multivariate model.  Stepwise backward elimination was performed to remove any non-
significant variables from the model.  Model 4.3 was used as the final model in the GLM 
procedure of SAS 9.4 to determine variable effects on the cost of vaccination protocols. 
Model 4.3.  GLM procedure for the cost of vaccination protocol. 
𝑌𝑖 = 𝑉𝑗 + ԑ𝑖𝑗 
Where: 
Y = Cost of vaccination protocol 
V = Volume of injection given 
ε = Residual error 
Producer Estimates for the Cost of Clinical and Subclinical Mastitis 
Producers were asked to give an estimate of what a case of CM and SCM cost 
them.  Estimates were slightly skewed for both, with the median being higher than the 
average.  A log transformation was used to normalize data.  A univariate analysis using 
PROC GLM in SAS 9.4 was performed on the transformed data, determining which 
variables effected (P < 0.05) the estimates for the cost of CM.  Significant variables were 
then added into a multivariate model.  Stepwise backward elimination was performed to 
remove any non-significant variables from the model.  Models 4.4 and 4.5 were used as 
the final model in the GLM procedure of SAS 9.4 to determine variable effects on 




Model 4.4.  GLM procedure for producer estimates for the cost of CM. 
𝑌𝑖 = 𝑀𝑖 + ԑ𝑖 
Where: 
Y = Producer estimate for the cost of CM 
M = Have management changes been made in the past 12 mo to manage SCC, yes or no 
Model 4.5.  GLM procedure for producer estimates for the cost of SCM. 
𝑌𝑖𝑗𝑘𝑙𝑚 = 𝑊𝑖 + 𝑇𝑗 + 𝑀𝑘 + 𝐹𝑙 + 𝑆𝑚 + 𝑊𝑆𝑖𝑚 + ԑ𝑖𝑗𝑘𝑙𝑚 
Where: 
Y = Producer estimate for SCM 
W = When producer starts IMM treatment 
T = Treat SCM, yes or no 
M = Have management changes been made in the past 12 mo the manage SCC, yes or no 
F = Feed additives used to manage SCC, yes or no 
S = Herd average SCS 
WS = Interaction between when producer starts IMM treatment and SCS 





RESULTS AND DISCUSSION 
Overall Means 
Dairy producers in KY (n = 96), TN (n = 83), VA (n = 96), and MS (n = 7) 
participated in a 175-question on-farm survey.  Mean (± SD) 2014 bulk tank SCC, 
obtained from all producers’ cooperatives, was 288,064.83 ± 121,411 cells/mL.  Herd 
size ranged from 32 to 2,500 lactating cows with a mean (± SD) of 228 ± 329 and median 
of 125 cows.  Among survey participants: 189, 106, 107, and 42 producers provided 
researchers with the information required to calculate the costs spent on IMM antibiotics, 
pre-milking teat disinfectant, post-milking teat disinfectant, and coliform mastitis 
vaccinations, respectively.  Descriptive statistics of the different cost estimates are 
displayed in Table 4.2.  If producers did not provide all of the information needed by 
researchers to calculate a cost, they were not included in the final analysis.  For example, 
209 producers indicated that they were using a coliform mastitis vaccine but of those, 
only 42 provided enough information to calculate the cost associated with the 
vaccination.  Fewer producers provided an answer for more specific questions, such as 
size of the bottle bought or cost of the bottle.  Lack of an answer may have been due to 
not knowing from memory or lack of accurate records for vaccination protocols.  Results 
were similar for other variables of interest: 240, 246, and 255 producers indicated using 
IMM antibiotics, pre-milking teat disinfectant, and post-milking teat disinfectant, 
respectively.  In addition to costs spent on prevention and treatment of mastitis, another 





Producers were asked to estimate the costs of CM and SCM.  Descriptive 
statistics of both estimates are located in Table 4.3.  The mean estimate (±SD) of a case 
of CM was $269.77 ± $380.62.  Estimates were similar to estimates developed in 
economic models for a case of mastitis (Swinkels et al., 2005b, Pinzon-Sanchez et al., 
2011, Steeneveld et al., 2011a).  Huijps et al. (2008) presented a similar cost estimate 
when asking producers of their perception of mastitis costs.  Dutch producers estimated 
costs of $216.14 (2007 USD).  Large standard deviations in the current analysis, ± 380.62 
and 304.43 for CM and SCM, respectively, suggest large variability in estimates by 
producers.  Estimates ranged from $0.00 to $2,000.00 and $0.00 to $3,000.00 for SCM 
and CM, respectively.  No estimation was the most common answer for both CM and 
SCM, suggesting that producers did not know how a case of mastitis affects the dairy 
economically.  Another possibility for vacant estimates was survey technique.  Surveyors 
for some states may have pressed for answers and others left the question blank. 
The third objective of the study was to determine how answers to other questions 
of the 175-question survey affected the costs producers spent on prevention and treatment 
of mastitis and producer estimates for the costs of CM and SCM on their farms.  Huijps et 
al. (2008) completed a similar analysis, but tried to determine how producer perception of 
mastitis costs effect economic factors associated with a case of mastitis.  In the current 
analysis, authors consider these factors in addition to the other questions in the survey. 
The Cost of Pre-Milking Teat Disinfectant 
A univariate analysis was performed to determine which variables in the survey 
would be included in the final analysis.  However, for pre-milking teat disinfectant, none 




diagnosed CM was a significant variable when examining the cost of pre-milking teat 
disinfectant.  
The Cost of Post-Milking Teat Disinfectant 
Descriptive statistics for variables included in the final model are presented in 
Table 4.5.  One possible reason for pre-milking teat disinfectant application being 
significant was some producers used the same pre and post-milking teat-disinfecting 
solution.  Producers using a sprayer or foamer to apply pre-milking teat disinfectant spent 
$0.08/cow per d on post-milking teat disinfectant.  Producers using a foamer or sprayer to 
apply teat disinfectant are potentially using more disinfectant per cow than a dip cup 
($0.04/cow per d), as the dip cup allows for more precise application.  Additional use of 
teat disinfectant may also be the reason producers that fail to routinely clip or singe 
udders have a higher cost per cow of post–milking teat disinfectant. 
Producers failing to singe or clip udder hair spent an additional $0.04/cow per d 
on post-milking teat disinfectant than producers practicing udder hair removal.  An 
increased cost was evident for each application type of pre-milking teat disinfectant, 
possibly suggesting that failing to clip or singe udder hair leads to more disinfectant used 
per cow.  
The Cost of a Vaccination against Coliform Pathogens 
 The only variable that was consistently significant (P < 0.05) through univariate 
and multivariate analysis was the volume of vaccine used.  As vaccination protocols 
called for 1 more mL of vaccine, the cost of the vaccination protocol increased by $0.01 




The cost of IMM Antibiotics 
Whether producers checked for a swollen quarter to recognize CM was not 
significant (P = 0.31).  However, the interaction between checking for a swollen quarter 
and the IMM antibiotic used to treat CM was significant.  Producers that used 
Spectramast (Zoetis, Madison, NJ) as their primary mastitis treatment spent an additional 
$4.00 per mastitis case than when treated with other IMM antibiotics (Table 4.4).  The 
average cost of IMM antibiotics was $18.65 ± 0.69 per clinical mastitis case.  Farmers 
that used Today (Boehringer Ingelheim, Ingelheim am Rhein, Germany) spent the least 
per mastitis case, spending $11.73 ± 0.44.   
Producers that made a management change due to bulk tank SCC (BTSCC) being 
higher than their goal spent more (P = 0.02) on IMM antibiotics.  Most (58.9%) of the 
producers took action when their BTSCC rose above 400,000 cells/mL.  Increased costs 
of antibiotics by producers that had made a management change to manage BTSCC may 
have been for a couple reasons, 1) producers are seeing more persisting CM cases and 
treating cases for a longer duration, and 2) producers tried to manage their heightened 
BTSCC by treating more aggressively.  A relationship between SCS and the amount 
spent on IMM antibiotics is further evidence that producers may be using antibiotics to 
help manage milk quality rather than prevention methods.  With every one score increase 
in a herd SCS, the average cost spent on antibiotics increased $1.07 per case.  A 
relationship between the cost of antibiotics and SCS may also indicate the understanding 
of SCM.  Only 32 of the producers indicated that they did not know what SCM was when 




Producer Estimates for the Costs of SCM    
Descriptive statistics of the significant variables are presented in Table 4.6.  Dairy 
producers (n = 9) that start therapy when a cow is visibly sick estimated a cost of SCM 
mastitis less (P < 0.05) than those that used other methods.  A possible explanation for 
this is that these producers may be treating these animals for their systemic symptoms 
rather than providing IMM therapy or producers are catching visual signs earlier.  
Producers that always treated SCM estimated the cost of SCM to be significantly higher 
than producers that treated SCM sometimes or never.  A possible reason for this may be 
that producers that always treated SCM may have understood the repercussions of SCM, 
leading them to treat all cases in the first place.  For this same reason, dairy producers 
that have made management changes to deal with mastitis and those that use feed 
additives to manage SCC estimated costs significantly higher.  A possible reason for the 
higher estimates may be that those producers adopted more management practices to 
prevent SCM, making them more aware of costs associated with SCM.  Somatic cell 
score was a significant variable in the SCM cost estimate.  For each increase in a SCS the 
cost estimate increased by $4.01.  The positive regression coefficient may suggest 
producers with a higher herd SCS may have understood how having poorer quality milk 
affected them economically or may have accounted for penalties put in place by the 
processor.  Valeeva et al. (2007) concluded that dairy producers are motivated to make 
management changes to improve milk quality when processors inforce a penalty. 
Producer Estimates for the Cost of CM  
Producers that made a management change to deal with mastitis estimated a 




management change ($130.44 ± 5.22) (Table 4.7).  Like SCM, producers that made 
management changes may have a better understanding of the cost of CM or have become 
more aware of management costs because of the changes they have made. 
Limitations to the Survey 
 Multiple people aided producers in filling out the survey.  Most of the questions 
were categorical and multi-choice but error may have occurred if surveyors presented 
questions differently.  Producers did not have the chance to see the survey beforehand 
and filled the survey out with a representative of the Southeast Quality Milk Initiative 
project.  This may have led to producers estimating answers instead of looking through 
records or receipts to find the most accurate information, making some answers 
unreliable.  Herds that did not provide enough information to calculate a cost were 
removed from the analysis. 
CONCLUSIONS 
Some costs showed no relevant relationship with other questions in the survey.  
Others showed a direct relationship with milk quality.  The relationship of producers 
making a management change to control mastitis and the cost of antibiotics and the 
positive regression of SCS with cost spent on antibiotics may suggest that dairy 
producers in the Southeast are trying to manage milk quality through antibiotic treatment 
rather than preventative practices.   
 Little research has been done on producer understanding of CM and SCM costs 
(Huijps et al., 2008)and what producer information might affect these estimates.  Dairy 




of answers was large, with many producers not providing an estimate at all.  Producers 
that made management changes in the past yr before the farm visit tend to estimate a 
higher cost of both CM and SCM.  Increased treatment and management of SCC also led 
to a higher estimate by dairy producers.  
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Table 4.1.  Percentile categories for bulk tank SCC (cells/mL) for dairy herds in Florida, 
Kentucky, Tennessee, Virginia participating in the Southeast Quality Milk Initiative 
survey and the overall average SCC of participating producers provided by milk 
processors as average SCC for 2014. 
 Percentile 
State 0 33rd 66th 100th 
Florida 136,600 272,727 376,364 711,667 
Kentucky 86,000 233,333 315,833 783,889 
Tennessee 67,778 302,500 398,333 1,081,944 
Virginia 98,250 205,000 298,000 1,433,333 






Table 4.2.  Mean and standard deviations (SD) of mastitis prevention and treatment costs 
calculated from answers of a 175-question survey taken by dairy producers in Kentucky, 
Tennessee, Virginia, and Mississippi participating in the Southeast Quality Milk Initiative 
farm visits. 
Variable Mean SD Minimum Maximum 
IMM antibiotics ($/case) $15.08 $8.81 $2.83 $52.82 
Coliform pathogen vaccination ($/protocol) $2.65 $1.18 $0.40 $6.20 
Pre-milking teat disinfectant ($/cow per d) $0.04 $0.03 $0.003 $0.16 






Table 4.3.  Mean and standard deviation (SD) of an estimate of the cost of clinical and 
subclinical mastitis provided by dairy producers in Kentucky, Tennessee, Virginia, and 
Mississippi participating in the Southeast Quality Milk Initiative farm visits. 
Variable Mean SD Minimum Median Maximum 
CM cost estimate $269.77 $380.62 $0.00 $180.00 $3,000.00 






Table 4.4.  Means ± standard errors (SE) of the cost spent on IMM antibiotics for producers in Kentucky, Tennessee, Virginia, and 
Mississippi participating in the Southeast Quality Milk Initiative farm visits that indicated they did or did not check for a swollen 
quarter when examining for CM, did or did not make a management change due to a BTSCC that was higher than their goal, and used 
Spectramast, Pirsue, Today, or another IMM antibiotic treatment when filling out a 175 question on farm survey. 
Variable  Ans.1 Variable Ans. Mean ± SE 
Check for swollen quarter when checking for CM? 
Yes   $14.05 ± 0.50 
No   $15.10 ± 0.68 
Made management change due to BTSCC higher than goal? 
Yes   $17.18 ± 0.93a 
No   $12.32 ± 0.31b 
Antibiotic used 
Spectramast   $18.65 ± 0.69a 
Pirsue   $14.78 ± 0.61b 
Other   $13.87 ± 1.15bc 
Today   $11.73 ± 0.44c 
Antibiotic used 
Spectramast 
Check for swollen quarter 
when checking for CM? 
Yes $17.74 ± 0.68a 
No $19.84 ± 1.15a 
Pirsue 
Check for swollen quarter 
when checking for CM? 
Yes $16.61 ± 0.82a 
No $13.28 ± 0.78a 
Other 
Check for swollen quarter 
when checking for CM? 
Yes $7.35 ± 0.67a 
No $21.37 ± 2.47b 
Today 
Check for swollen quarter 
when checking for CM? 
Yes $14.90 ± 0.57a 
No $9.21 ± 0.50b 
a, b, c Means for each variable significantly different (P  < 0.05) 





Table 4.5.  Means for the cost spent on post-milking teat disinfectant for dairy producers in Kentucky, Tennessee, Virginia, and 
Mississippi participating in the Southeast Quality Milk Initiative farm visits that indicated they used a foam, spray, or dip cup to apply 
pre-milking treat disinfectant, did or did not singe or clip udders, and the interaction between pre-milking teat disinfectant application 
and whether producers singed or clipped udders when filling out a 175-question on farm survey. 
Variable Answer Variable Answer Mean1 
Pre-milking teat disinfectant application 
  Foam $0.08a 
  Spray $0.08a 
  N/A $0.05ab 
  Dip $0.04b 
Are udders singed or clipped 
  Yes $0.04a 
  No $0.08b 
Pre-milking teat disinfectant application 
Foam Are udders singed or clipped? 
Yes $0.04a 
No $0.11b 
Spray Are udders singed or clipped? 
Yes $0.08ab 
No $0.08ab 
N/A Are udders singed or clipped? 
Yes $0.03b 
No $0.07ab 
Dip Are udders singed or clipped? 
Yes $0.04b 
No $0.05b 
1SE of the mean < $0.01) 




Table 4.6.  Means ± standard errors for the estimates of the cost of SCM by dairy producers in Kentucky, Tennessee, Virginia, and 
Mississippi participating in the Southeast Quality Milk Initiative farm visits that indicated they started IMM antibiotic therapy at 
different times, sometimes, always or never treated SCM, have made a management change in the past 12 mo to deal with mastitis, did 
or did not use feed additives to manage herd SCC, and the relationship between herd SCS and producer estimates for SCM when 
filling out a 175-question on farm survey. 
Categorical Variable Answer Mean ± SE 
When would producer start IMM antibiotic therapy for CM? 
Electrical conductivity $238.75 ± 56.28ab 
Few flakes present $281.16 ± 18.35a 
Moderate flakes present $187.72 ± 12.75b 
Thick stringy clots $252.94 ± 32.38ab 
Cow visibly sick $52.64 ± 9.52c 
Wait and see if signs continue $220.54 ± 36.72ab 
After culturing $209.51 ± 30.30ab 
Other $145.99 ± 14.46b 
Do producers treat SCM? 
Always $270.48 ± 28.30a 
Sometimes $157.21 ± 10.44b 
Never $138.85 ± 9.61b 
Have any management changes been made to deal with mastitis? 
Yes $218.24 ± 15.49a 
No $149.71 ± 9.89b 
Are feed additives used to manage SCC? 
Yes $261.12 ± 21.99a 
No $125.06 ± 7.06b 
Continuous Variable  Estimate 
SCS  $4.011 ± 1.14 
a, b, c Means for each variable are different (P  < 0.05) 





Table 4.7.  Means ± SE for estimates of the cost of CM by dairy producers in Kentucky, Tennessee, Virginia, and Mississippi 
participating in the Southeast Quality Milk Initiative farm visits that indicated they did or did not make a change to deal with mastitis 
in the past 12 mo when filling out a 175-question on farm survey. 
Variable Answer Mean ± SE 
Have any management changes been made to deal with mastitis? 
Yes $217.23 ± 10.40a 
No $130.44 ± 5.22b 





















Table 0.1.  Herd demographic measures used in stochastic modeling to determine culling 
and reproductive performance costs.  Adapted from (Liang et al., 2016). 
Variable  Value  Source  
Number of milking cows  193 DairyMetrics (2016) 
Heifers (0 to 12 months as a percent of total 
herd)  
43.3% DairyMetrics (2016) 
Heifers (≥ 13 months as a percent of total herd)  46.1% DairyMetrics (2016) 
Percent of herd in 1st parity  36.1% Dhuyvetter et al. (2007) 
Percent of herd in 2nd parity  26.0% Dhuyvetter et al. (2007) 
Percent of herd in 3rd parity  17.7% Dhuyvetter et al. (2007) 
Percent of herd in 4th parity  11.0% Dhuyvetter et al. (2007) 
Percent of herd in 5th parity  5.8% Dhuyvetter et al. (2007) 
Percent of herd in 6th (or greater) parity  3.4% Dhuyvetter et al. (2007) 
Days in milk designated do not breed (d) 300 Bewley et al. (2010) 
Cull milk yield (kg)  15.86 Bewley et al. (2010) 
Mature cow live weight (kg)  721.42 NRC (2001) 
Slaughter cow weight (kg)  621.91 Dhuyvetter et al. (2007) 
Calf birth weight (kg)  41.73 Kertz et al. (1997) 
Voluntary waiting period (d)  58.50 DairyMetrics (2016) 
Gestation Length (d)  280 Norman et al. (2009) 
Baseline culling rate (1st parity, all culls other 
than diseases)  
13.0% Bewley et al. (2010) 
Percent heifer calves  46.6% Del Río et al. (2007) 
Weaned heifer death rate  1.8% NAHMS (2007) 
Age at first calving (mo.)  26.20 DairyMetrics (2016) 
Days dry (d)  59.6 NAHMS (2007) 
Initial rolling herd average (kg)  10,255.72 DairyMetrics (2016) 
Heat detection rate  46.50% DairyMetrics (2016) 
Conception rate  49.48% DairyMetrics (2016) 
Butterfat%  3.90% DairyMetrics (2016) 
Protein%  3.20% DairyMetrics (2016) 





Table 0.2.  Cow demographics used in stochastic modeling to determine the effects of a 
mastitis case in an average United States dairy herd under optimum treatment decisions.  
Adapted from (Liang et al., 2016). 
 Mean SD 5% 95% 
Rolling average herd milk 
production (RHAM, kg/cow/yr.)  
10,255.72 1,929.40 7,082.39 13,427.24 
Age at first calving (AFC, mo.)  25.70 2.93 20.87 30.52 
Heat detection rate (HDR, %)  46.50% 17.74% 16.50% 76.49% 







Table 0.3.  Predicted market prices for the 2016 yr and mean market prices for yr 2006 to 
2016.  Adapted from (Liang et al., 2016). 
 2016 market prices Mean market prices for 2006 to 2016 
Milk ($ per kg)  $0.42 ± 0.05 $ 0.40 ± 0.07 
Feed ($ per kg)  $0.23 ± 0.04 $ 0.17 ± 0.04 
Replacement cow ($per cow)  $1,715.78 ± 209 $ 1,615 ± 226 




Table 0.4.  The costs associated with milk discard for a 2-d, 5-d, and 8-d treatment regimen for an initial and recurring clinical 
mastitis case.  Authors assumed that milk would be discarded for an additional 3 days after completion of treatment.  The estimate of 
the cost of milk discard was modeled for an average cow in the average United States dairy herd by taking 3 days of milk production 
prior to treatment and multiplying losses by a stochastic milk price 10,000 times under 2016 market conditions. 
  Parity 
  1 2 ≥  3 
Treatment Mastitis Case Mean 5% 95% Mean 5% 95% Mean 5% 95% 
2-d 
1 $77.55 $46.67 $112.09 $90.58 $45.76 $133.50 $98.45 $43.54 $147.68 
2 $75.74 $44.42 $110.67 $85.37 $39.48 $128.96 $92.09 $35.88 $143.13 
5-d  
1 $124.03 $74.56 $179.42 $144.66 $72.64 $213.43 $157.22 $69.02 $236.18 
2 $120.95 $70.80 $176.91 $136.01 $62.67 $205.61 $146.63 $56.82 $228.26 
8-d  
1 $170.42 $102.39 $246.58 $198.47 $99.08 $293.22 $215.67 $93.98 $324.79 
2 $165.97 $97.10 $243.09 $186.21 $85.49 $282.08 $200.60 $77.38 $312.64 






Table 0.5.  Mean treatment costs of Staphylococcus aureus mastitis for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial 
clinical mastitis case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with 
a stochastic decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment 
(CM1/CM2) 
Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $465.20 $261.29 $737.69 $381.49 $187.81 $627.35 $390.85 $178.72 $646.76 
2-d/2-d $690.67 $415.67 $1,025.78 $512.11 $283.76 $783.35 $524.82 $264.35 $812.73 
2-d/5-d $690.67 $415.67 $1,025.78 $545.10 $291.41 $836.16 $561.68 $269.23 $870.90 
2-d/8-d $760.37 $442.39 $1,134.07 $582.17 $294.10 $897.89 $600.65 $272.51 $937.45 
2-d/NT $649.82 $398.80 $965.96 $462.76 $273.78 $706.34 $468.96 $259.51 $722.92 
2-d/Cull $381.43 $243.18 $538.13 $361.60 $152.49 $628.68 $409.57 $145.09 $737.49 
5-d $494.17 $277.71 $776.18 $417.76 $200.02 $678.59 $431.77 $188.93 $705.60 
5-d/2-d $719.37 $431.88 $1,065.70 $548.40 $295.70 $836.40 $565.81 $274.84 $873.66 
5-d/5-d $747.42 $443.73 $1,102.86 $581.38 $301.97 $889.29 $602.67 $278.67 $934.08 
5-d/8-d $789.07 $456.21 $1,176.20 $618.45 $303.15 $954.05 $641.64 $281.09 $1,000.73 
5-d/NT $678.51 $415.41 $1,001.50 $499.04 $287.61 $756.27 $509.95 $272.24 $782.48 
5-d/Cull $410.13 $262.65 $572.42 $397.88 $167.24 $685.60 $450.56 $155.98 $803.54 
8-d $528.79 $289.64 $832.95 $455.24 $210.83 $735.19 $471.11 $198.28 $766.52 
8-d/2-d $747.98 $444.85 $1,106.30 $584.42 $305.97 $891.45 $606.48 $283.52 $936.45 
8-d/5-d $776.04 $457.45 $1,143.46 $617.40 $310.26 $946.38 $643.34 $286.49 $997.72 
8-d/8-d $817.69 $469.12 $1,218.10 $654.47 $312.22 $1,010.49 $682.31 $288.29 $1,064.93 
8-d/NT $707.13 $430.92 $1,042.09 $535.06 $300.08 $809.91 $550.62 $282.43 $842.47 
8-d/Cull $438.75 $279.66 $610.21 $433.90 $179.76 $743.13 $491.23 $165.28 $870.65 
NT $423.53 $237.42 $683.05 $327.31 $167.38 $551.74 $329.10 $160.54 $557.43 
NT/2-d $649.68 $395.84 $969.52 $458.11 $267.36 $705.80 $462.93 $251.31 $720.15 
NT/5-d $677.74 $410.35 $1,009.32 $491.10 $276.48 $756.09 $499.79 $259.29 $777.51 
NT/8-d $719.39 $425.80 $1,076.44 $528.17 $282.79 $814.96 $538.76 $262.91 $841.38 
NT/NT $608.83 $373.41 $912.82 $408.76 $247.28 $632.49 $407.07 $235.52 $636.03 
NT/Cull $340.44 $212.19 $499.03 $307.60 $127.38 $545.55 $347.68 $126.82 $638.37 




Table 0.6.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of 
Staphylococcus aureus mastitis when modeled with a stochastic decision tree with 10,000 
iterations for each parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 98% 98% 97% 
2 96% 96% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 98% 96% 96% 
2-d v NT 
1 3% 3% 4% 
2 5% 5% 6% 
2-d v Cull 
1 4% 24% 33% 
2 2% 11% 19% 
5-d v 8-d 
1 97% 97% 97% 
2 97% 96% 96% 
5-d v NT 
1 2% 3% 3% 
2 3% 4% 5% 
5-d v Cull 
1 3% 16% 24% 
2 1% 7% 12% 
8-d v NT 
1 2% 3% 3% 
2 3% 4% 5% 
8-d v Cull 
1 2% 12% 18% 
2 1% 5% 8% 
NT v Cull 
1 96% 11% 18% 







Table 0.7.  Mean treatment costs of Streptococcus uberis mastitis for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial clinical 
mastitis case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with a 
stochastic decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean 5% 95% Mean 5% 95% 
2-d $170.50 $88.04 $278.59 $338.04 $150.17 $561.01 $345.82 $139.54 $577.88 
2-d/2-d $360.15 $201.40 $544.27 $437.65 $214.33 $691.97 $449.56 $193.65 $715.57 
2-d/5-d $388.21 $211.29 $587.03 $471.07 $220.20 $747.45 $486.68 $196.62 $774.67 
2-d/8-d $418.37 $220.63 $637.57 $505.99 $225.98 $807.06 $524.46 $199.47 $837.67 
2-d/NT $316.57 $190.23 $474.35 $385.11 $209.50 $602.21 $391.70 $192.20 $619.27 
2-d/Cull $207.03 $93.70 $347.50 $325.29 $118.62 $592.67 $373.31 $112.02 $701.57 
5-d $198.93 $99.42 $318.20 $374.44 $163.65 $614.69 $386.62 $149.79 $637.28 
5-d/2-d $388.84 $212.00 $587.98 $473.93 $224.68 $748.00 $490.54 $203.01 $776.92 
5-d/5-d $416.91 $222.37 $632.01 $507.35 $230.69 $804.36 $527.67 $205.68 $838.64 
5-d/8-d $447.06 $231.32 $684.83 $542.28 $234.93 $864.44 $565.44 $207.22 $903.17 
5-d/NT $345.26 $202.87 $514.64 $421.40 $221.63 $655.69 $432.68 $202.52 $679.38 
5-d/Cull $235.72 $110.76 $380.43 $361.58 $132.45 $648.86 $414.29 $122.33 $768.12 
8-d $226.24 $106.85 $362.53 $410.88 $173.80 $671.39 $426.31 $158.07 $697.40 
8-d/2-d $417.46 $223.81 $632.10 $509.95 $234.92 $805.99 $531.22 $210.22 $841.52 
8-d/5-d $445.53 $232.77 $678.52 $543.37 $239.18 $862.31 $568.34 $212.14 $904.00 
8-d/8-d $475.68 $239.42 $730.50 $578.30 $243.65 $921.82 $606.12 $213.63 $968.52 
8-d/NT $373.88 $214.77 $555.57 $457.42 $232.13 $713.37 $473.36 $211.55 $740.79 
8-d/Cull $264.34 $126.09 $417.13 $397.60 $144.32 $705.58 $454.97 $131.11 $834.93 
NT $131.42 $69.61 $224.56 $283.36 $133.86 $480.78 $285.37 $123.95 $489.14 
NT/2-d $319.16 $186.33 $484.61 $383.65 $200.84 $608.57 $387.67 $183.21 $622.24 
NT/5-d $347.22 $197.88 $523.85 $417.07 $208.95 $660.69 $424.79 $188.76 $678.78 
NT/8-d $377.38 $207.90 $571.09 $451.99 $214.79 $718.33 $462.57 $192.28 $739.82 
NT/NT $275.58 $168.73 $420.86 $331.11 $188.21 $528.23 $329.81 $174.33 $531.69 
NT/Cull $166.04 $64.38 $308.86 $271.29 $97.18 $510.70 $311.42 $95.90 $604.14 




Table 0.8.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of 
Streptococcus uberis mastitis when modeled with a stochastic decision tree with 10,000 
iterations for each parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 98% 98% 97% 
2 98% 96% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 97% 96% 96% 
2-d v NT 
1 5% 3% 4% 
2 4% 5% 5% 
2-d v Cull 
1 43% 30% 40% 
2 6% 17% 26% 
5-d v 8-d 
1 97% 97% 97% 
2 97% 96% 96% 
5-d v NT 
1 3% 3% 3% 
2 3% 4% 5% 
5-d v Cull 
1 35% 23% 32% 
2 4% 11% 18% 
8-d v NT 
1 3% 3% 3% 
2 3% 4% 5% 
8-d v Cull 
1 30% 17% 24% 
2 4% 7% 12% 
NT v Cull 
1 55% 42% 52% 






Table 0.9.  Mean treatment costs of Streptococcus dysgalactiae mastitis for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial 
clinical mastitis case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with 
a stochastic decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $169.91 $87.65 $278.39 $338.25 $150.10 $561.97 $345.39 $139.97 $577.04 
2-d/2-d $361.44 $202.52 $546.73 $438.81 $213.76 $694.79 $450.31 $193.47 $716.68 
2-d/5-d $391.38 $210.60 $593.65 $473.82 $219.84 $752.66 $488.40 $196.37 $778.52 
2-d/8-d $419.31 $220.78 $639.36 $506.81 $226.22 $808.62 $524.96 $199.21 $838.65 
2-d/NT $320.48 $190.14 $483.00 $388.46 $208.07 $611.97 $393.82 $191.20 $625.04 
2-d/Cull $207.03 $93.70 $347.50 $325.29 $118.62 $592.67 $373.31 $112.02 $701.57 
5-d $197.52 $97.17 $318.91 $374.91 $163.87 $617.80 $385.59 $150.34 $636.53 
5-d/2-d $390.14 $212.59 $589.15 $475.09 $223.74 $751.51 $491.30 $202.69 $778.43 
5-d/5-d $420.08 $222.57 $638.81 $510.10 $230.17 $809.22 $529.39 $205.34 $841.30 
5-d/8-d $448.00 $230.86 $686.44 $543.10 $235.12 $866.56 $565.95 $207.17 $904.21 
5-d/NT $349.18 $203.09 $522.50 $424.74 $221.37 $664.45 $434.81 $201.80 $685.02 
5-d/Cull $235.72 $110.76 $380.43 $361.58 $132.45 $648.86 $414.29 $122.33 $768.12 
8-d $225.85 $106.51 $363.17 $411.06 $173.97 $672.14 $462.33 $174.11 $749.16 
8-d/2-d $418.76 $223.58 $634.32 $511.11 $233.88 $808.31 $531.97 $210.14 $842.94 
8-d/5-d $448.69 $232.22 $686.11 $579.12 $243.48 $924.11 $588.49 $214.21 $938.54 
8-d/8-d $476.62 $239.28 $732.47 $411.06 $173.97 $672.14 $515.43 $181.02 $832.57 
8-d/NT $377.80 $214.74 $563.51 $460.76 $230.85 $718.38 $475.49 $210.70 $745.90 
8-d/Cull $264.34 $126.09 $417.13 $397.60 $144.32 $705.58 $454.97 $131.11 $834.93 
NT $129.70 $68.15 $223.64 $283.95 $132.06 $485.38 $284.13 $122.59 $489.54 
NT/2-d $320.46 $186.87 $485.83 $384.80 $200.45 $612.61 $388.42 $183.05 $623.72 
NT/5-d $350.39 $198.57 $530.99 $419.82 $208.05 $667.21 $426.51 $188.21 $682.97 
NT/8-d $378.32 $207.86 $574.00 $452.81 $214.95 $720.75 $463.07 $192.32 $740.81 
NT/NT $279.49 $168.81 $427.66 $334.46 $185.94 $535.99 $331.94 $172.59 $537.74 
NT/Cull $166.04 $64.38 $308.86 $271.29 $97.18 $510.70 $311.42 $95.90 $604.14 




Table 0.10.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of 
Streptococcus dysgalactiae mastitis when modeled with a stochastic decision tree with 
10,000 iterations for each parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 97% 97% 97% 
2 97% 96% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 97% 96% 96% 
2-d v NT 
1 4% 3% 4% 
2 4% 5% 6% 
2-d v Cull 
1 43% 30% 40% 
2 6% 17% 26% 
5-d v 8-d 
1 98% 98% 97% 
2 98% 96% 96% 
5-d v NT 
1 3% 3% 3% 
2 3% 4% 5% 
5-d v Cull 
1 36% 24% 32% 
2 5% 11% 18% 
8-d v NT 
1 3% 3% 3% 
2 3% 4% 5% 
8-d v Cull 
1 30% 17% 24% 
2 4% 7% 12% 
NT v Cull 
1 56% 42% 52% 






Table 0.11.  Mean treatment costs of E. Coli mastitis for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial clinical mastitis 
case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with a stochastic 
decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $361.49 $164.98 $608.19 $280.10 $153.14 $440.71 $286.71 $148.68 $450.58 
2-d/2-d $766.60 $383.53 $1,159.42 $446.46 $272.79 $644.51 $457.92 $259.94 $669.12 
2-d/5-d $795.92 $395.53 $1,200.30 $479.28 $278.20 $700.49 $494.50 $263.90 $729.80 
2-d/8-d $823.84 $406.66 $1,241.33 $511.68 $285.30 $752.75 $530.64 $266.70 $791.95 
2-d/NT $723.14 $370.36 $1,096.76 $397.77 $264.63 $567.12 $402.76 $255.07 $578.03 
2-d/Cull $261.32 $142.76 $406.30 $387.02 $177.22 $658.58 $434.68 $170.85 $769.61 
5-d $390.67 $179.72 $648.52 $315.87 $164.19 $492.73 $326.98 $158.09 $510.83 
5-d/2-d $795.29 $397.16 $1,198.30 $482.75 $282.07 $702.97 $498.91 $268.34 $733.84 
5-d/5-d $824.62 $408.73 $1,239.97 $515.57 $288.20 $756.52 $535.49 $271.45 $796.21 
5-d/8-d $852.53 $419.56 $1,282.49 $547.97 $294.36 $812.78 $571.63 $273.96 $858.63 
5-d/NT $751.83 $382.92 $1,133.82 $434.05 $277.13 $619.88 $443.74 $266.70 $639.54 
5-d/Cull $290.01 $160.92 $440.55 $423.31 $189.93 $716.02 $475.67 $181.43 $835.07 
8-d $419.46 $193.10 $688.33 $351.71 $173.65 $548.27 $367.41 $165.96 $574.67 
8-d/2-d $823.91 $410.17 $1,237.12 $518.77 $291.72 $759.69 $539.58 $276.42 $799.78 
8-d/5-d $853.24 $422.17 $1,279.95 $551.59 $297.89 $815.82 $576.16 $278.85 $862.44 
8-d/8-d $881.15 $431.54 $1,324.57 $583.99 $303.30 $873.33 $612.30 $281.77 $925.86 
8-d/NT $780.45 $396.77 $1,175.17 $470.07 $287.99 $675.38 $484.42 $276.57 $702.52 
8-d/Cull $318.63 $176.41 $476.77 $459.33 $203.09 $771.48 $516.34 $190.15 $901.71 
NT $319.40 $140.27 $556.29 $227.24 $135.53 $365.09 $226.40 $131.58 $364.94 
NT/2-d $725.61 $366.37 $1,105.03 $392.46 $258.12 $562.67 $396.03 $247.94 $573.37 
NT/5-d $754.94 $378.09 $1,146.03 $425.28 $267.38 $612.76 $432.61 $254.90 $631.34 
NT/8-d $782.85 $390.87 $1,184.23 $457.68 $273.46 $665.23 $468.75 $259.54 $690.09 
NT/NT $682.15 $347.39 $1,042.58 $343.77 $238.59 $490.24 $340.87 $231.21 $488.97 
NT/Cull $220.33 $113.30 $368.84 $333.02 $155.46 $576.33 $372.79 $153.90 $671.25 




Table 0.12.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of E. Coli 
mastitis when modeled with a stochastic decision tree with 10,000 iterations for each 
parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 98% 98% 97% 
2 98% 96% 96% 
2-d v 8-d 
1 98% 98% 97% 
2 98% 96% 96% 
2-d v NT 
1 3% 3% 4% 
2 4% 5% 6% 
2-d v Cull 
1 10% 44% 52% 
2 1% 29% 40% 
5-d v 8-d 
1 98% 98% 97% 
2 97% 96% 96% 
5-d v NT 
1 2% 3% 3% 
2 3% 4% 5% 
5-d v Cull 
1 8% 36% 45% 
2 1% 20% 30% 
8-d v NT 
1 2% 3% 3% 
2 3% 4% 5% 
8-d v Cull 
1 6% 29% 37% 
2 1% 13% 21% 
NT v Cull 
1 14% 54% 62% 






Table 0.13.  Mean treatment costs of CNS mastitis for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial clinical mastitis case 
(CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with a stochastic decision 
tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $436.27 $187.58 $756.65 $217.75 $82.71 $410.77 $224.64 $73.53 $422.06 
2-d/2-d $334.17 $219.12 $458.47 $274.22 $111.65 $481.68 $310.85 $94.93 $573.35 
2-d/5-d $362.43 $233.66 $501.42 $308.43 $121.25 $541.90 $349.31 $100.33 $641.93 
2-d/8-d $390.01 $246.04 $547.31 $341.39 $130.35 $599.75 $386.23 $104.20 $709.29 
2-d/NT $292.34 $196.74 $398.98 $221.07 $98.38 $387.02 $249.82 $90.47 $460.12 
2-d/Cull $278.74 $151.12 $423.10 $248.02 $47.18 $510.88 $296.44 $39.33 $619.41 
5-d $467.44 $203.98 $800.15 $253.98 $92.48 $462.74 $265.23 $81.60 $480.39 
5-d/2-d $362.86 $235.45 $501.54 $310.51 $125.61 $540.39 $351.84 $105.98 $639.76 
5-d/5-d $391.12 $248.20 $547.82 $344.71 $135.05 $600.52 $390.29 $110.72 $709.13 
5-d/8-d $418.70 $259.16 $593.96 $377.67 $143.46 $658.56 $427.21 $114.64 $776.31 
5-d/NT $321.04 $215.66 $434.56 $257.36 $114.29 $441.89 $290.81 $102.15 $524.86 
5-d/Cull $307.44 $170.13 $456.84 $284.30 $60.75 $567.05 $337.43 $48.82 $684.25 
8-d $497.04 $217.89 $842.38 $289.99 $101.18 $516.20 $305.73 $89.22 $541.37 
8-d/2-d $391.48 $249.30 $547.15 $346.53 $138.68 $599.76 $392.51 $114.84 $707.65 
8-d/5-d $419.74 $260.93 $595.22 $380.73 $147.76 $660.04 $430.97 $119.86 $777.80 
8-d/8-d $447.32 $270.23 $641.92 $413.69 $154.09 $716.47 $467.89 $123.41 $844.77 
8-d/NT $349.66 $232.10 $475.11 $293.38 $128.03 $498.80 $331.48 $111.94 $590.29 
8-d/Cull $336.05 $186.64 $493.27 $320.32 $72.35 $623.72 $378.10 $57.17 $751.06 
NT $387.23 $165.23 $686.56 $163.92 $63.37 $330.99 $164.01 $58.44 $334.18 
NT/2-d $293.18 $194.47 $404.43 $220.22 $91.11 $398.61 $248.96 $81.28 $474.98 
NT/5-d $321.44 $211.59 $440.48 $254.43 $102.75 $453.96 $287.42 $87.64 $541.22 
NT/8-d $349.02 $226.35 $480.08 $287.39 $112.61 $509.67 $324.34 $93.02 $606.26 
NT/NT $251.35 $164.93 $360.77 $167.07 $72.42 $307.34 $187.94 $70.84 $365.88 
NT/Cull $237.75 $119.30 $382.23 $194.02 $25.61 $428.43 $234.56 $25.80 $520.79 




Table 0.14.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of CNS mastitis 
when modeled with a stochastic decision tree with 10,000 iterations for each parity 1, 2, 
and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3. 
2-d v 5-d 
1 98% 97% 97% 
2 98% 97% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 98% 97% 96% 
2-d v NT 
1 3% 4% 4% 
2 2% 4% 5% 
2-d v Cull 
1 8% 55% 62% 
2 10% 35% 42% 
5-d v 8-d 
1 98% 97% 97% 
2 98% 97% 96% 
5-d v NT 
1 2% 4% 4% 
2 2% 3% 5% 
5-d v Cull 
1 7% 48% 55% 
2 5% 8% 11% 
8-d v NT 
1 2% 3% 4% 
2 2% 3% 4% 
8-d v Cull 
1 5% 40% 48% 
2 3% 2% 2% 
NT v Cull 
1 11% 65% 71% 






Table 0.15.  Mean treatment costs of Klebsiella mastitis for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial clinical mastitis 
case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with a stochastic 
decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $719.67 $259.18 $1,342.32 $227.03 $103.99 $369.10 $235.63 $97.57 $385.17 
2-d/2-d $1,113.67 $499.15 $1,855.87 $390.86 $224.49 $572.36 $403.63 $209.46 $599.24 
2-d/5-d $1,147.50 $514.91 $1,902.27 $423.71 $229.51 $627.23 $440.15 $213.16 $661.19 
2-d/8-d $1,190.56 $529.55 $1,973.13 $456.14 $232.68 $682.58 $475.72 $214.94 $722.44 
2-d/NT $1,048.94 $474.37 $1,750.16 $342.07 $219.15 $490.83 $349.07 $208.19 $506.07 
2-d/Cull $289.65 $161.81 $441.10 $302.96 $99.50 $567.87 $351.08 $92.21 $677.08 
5-d $752.37 $278.47 $1,387.31 $262.61 $112.40 $422.91 $275.55 $105.46 $445.33 
5-d/2-d $1,142.36 $515.09 $1,893.15 $427.15 $233.51 $630.63 $444.62 $217.39 $665.17 
5-d/5-d $1,176.20 $528.74 $1,939.85 $460.00 $236.64 $685.13 $481.14 $220.28 $728.67 
5-d/8-d $1,219.25 $544.87 $2,012.29 $492.42 $240.02 $741.36 $516.71 $220.75 $790.57 
5-d/NT $1,077.63 $492.90 $1,788.47 $378.36 $230.62 $545.75 $390.06 $218.02 $569.39 
5-d/Cull $318.35 $180.23 $473.72 $339.25 $112.09 $623.51 $392.07 $101.55 $742.83 
8-d $790.84 $298.37 $1,446.04 $296.89 $121.50 $475.56 $313.52 $112.55 $505.31 
8-d/2-d $1,170.98 $530.88 $1,931.13 $463.16 $240.38 $689.24 $485.29 $224.49 $732.69 
8-d/5-d $1,204.82 $544.52 $1,976.78 $496.02 $244.70 $745.35 $521.81 $226.25 $796.72 
8-d/8-d $1,247.87 $559.83 $2,048.24 $528.44 $249.94 $802.72 $557.38 $228.11 $859.13 
8-d/NT $1,106.25 $507.73 $1,826.07 $414.38 $240.63 $601.28 $430.73 $225.85 $634.43 
8-d/Cull $346.97 $197.39 $510.61 $375.27 $124.08 $680.49 $432.75 $110.06 $809.40 
NT $662.73 $229.77 $1,255.55 $175.83 $89.81 $295.55 $178.02 $84.79 $300.77 
NT/2-d $1,072.68 $478.20 $1,797.63 $336.86 $210.96 $488.07 $341.74 $200.54 $500.83 
NT/5-d $1,106.52 $492.70 $1,850.83 $369.71 $219.27 $539.14 $378.26 $205.93 $559.30 
NT/8-d $1,149.57 $512.42 $1,919.24 $402.14 $224.39 $592.42 $413.83 $208.33 $619.04 
NT/NT $1,007.95 $457.21 $1,696.59 $288.07 $195.87 $413.47 $287.18 $188.24 $414.57 
NT/Cull $248.66 $129.88 $401.29 $248.96 $79.05 $486.38 $289.20 $78.46 $578.57 




Table 0.16.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of Klebsiella 
mastitis when modeled with a stochastic decision tree with 10,000 iterations for each 
parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 96% 98% 97% 
2 92% 97% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 98% 96% 96% 
2-d v NT 
1 3% 4% 4% 
2 3% 5% 6% 
2-d v Cull 
1 2% 55% 62% 
2 1% 21% 33% 
5-d v 8-d 
1 98% 97% 97% 
2 96% 96% 96% 
5-d v NT 
1 2% 3% 3% 
2 2% 5% 5% 
5-d v Cull 
1 2% 47% 55% 
2 1% 13% 23% 
8-d v NT 
1 2% 3% 3% 
2 2% 4% 5% 
8-d v Cull 
1 2% 40% 47% 
2 1% 7% 14% 
NT v Cull 
1 3% 65% 71% 






Table 0.17.  Mean treatment costs of minor pathogen mastitis case for 2-d, 5-d, 8-d, no treatment (NT), and culling of an initial 
clinical mastitis case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled with 
a stochastic decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $440.95 $202.43 $808.97 $306.21 $142.81 $537.96 $311.89 $135.93 $543.81 
2-d/2-d $677.26 $329.84 $1,125.72 $513.80 $243.67 $822.98 $520.66 $223.24 $830.18 
2-d/5-d $706.18 $339.93 $1,167.80 $547.35 $250.72 $875.06 $557.95 $226.29 $889.28 
2-d/8-d $734.76 $350.90 $1,208.04 $580.42 $254.91 $926.47 $594.66 $228.98 $948.23 
2-d/NT $629.96 $312.20 $1,055.99 $461.09 $238.06 $738.17 $462.10 $219.04 $737.36 
2-d/Cull $332.62 $195.05 $487.52 $362.50 $151.81 $626.38 $410.18 $145.04 $738.05 
5-d $470.19 $219.22 $847.31 $342.23 $154.04 $589.05 $352.41 $146.10 $600.68 
5-d/2-d $705.95 $342.58 $1,165.76 $550.08 $253.69 $876.03 $561.65 $231.06 $891.76 
5-d/5-d $734.87 $353.13 $1,209.45 $583.64 $259.51 $929.61 $598.94 $234.61 $950.85 
5-d/8-d $763.45 $364.07 $1,247.20 $616.70 $264.53 $982.19 $635.65 $237.65 $1,010.68 
5-d/NT $658.65 $327.76 $1,089.80 $497.37 $249.30 $790.49 $503.09 $229.58 $795.14 
5-d/Cull $361.32 $216.26 $521.68 $398.79 $167.22 $684.13 $451.17 $156.86 $803.80 
8-d $499.26 $234.60 $884.93 $377.99 $162.75 $638.88 $392.64 $154.59 $660.03 
8-d/2-d $734.57 $355.01 $1,205.52 $586.10 $262.36 $930.25 $602.32 $239.24 $953.33 
8-d/5-d $763.49 $366.84 $1,245.60 $619.66 $268.38 $984.20 $639.61 $242.74 $1,013.48 
8-d/8-d $792.07 $375.50 $1,286.93 $652.72 $272.62 $1,036.11 $676.32 $245.49 $1,074.19 
8-d/NT $687.27 $341.24 $1,125.81 $533.39 $259.15 $842.88 $543.76 $238.73 $855.56 
8-d/Cull $389.94 $233.25 $558.81 $434.81 $180.10 $742.15 $491.84 $166.12 $870.70 
NT $397.06 $176.22 $751.07 $253.72 $122.85 $464.87 $252.69 $116.92 $461.01 
NT/2-d $636.27 $309.71 $1,074.47 $459.80 $231.77 $744.69 $458.77 $211.58 $739.57 
NT/5-d $665.19 $323.71 $1,111.83 $493.35 $238.45 $793.91 $496.06 $217.22 $796.46 
NT/8-d $693.77 $334.26 $1,148.98 $526.42 $244.62 $845.50 $532.77 $221.68 $853.43 
NT/NT $588.97 $287.10 $1,005.52 $407.08 $220.33 $663.20 $400.21 $201.62 $650.67 
NT/Cull $291.64 $163.12 $445.99 $308.50 $127.46 $543.70 $348.29 $125.65 $639.13 




Table 0.18.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of mastitis 
caused by a minor pathogen when modeled with a stochastic decision tree with 10,000 
iterations for each parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥ 3 
2-d v 5-d 
1 98% 98% 97% 
2 98% 97% 96% 
2-d v 8-d 
1 98% 98% 97% 
2 98% 96% 96% 
2-d v NT 
1 3% 4% 4% 
2 3% 5% 5% 
2-d v Cull 
1 10% 41% 50% 
2 3% 11% 20% 
5-d v 8-d 
1 98% 98% 97% 
2 97% 96% 96% 
5-d v NT 
1 3% 3% 4% 
2 3% 4% 5% 
5-d v Cull 
1 8% 33% 42% 
2 3% 7% 13% 
8-d v NT 
1 2% 3% 3% 
2 3% 4% 5% 
8-d v Cull 
1 6% 26% 34% 
2 2% 5% 8% 
NT v Cull 
1 13% 51% 60% 





Table 0.19.  Mean treatment costs mastitis case with a negative culture result for 2-d, 5-d, 8-d, no treatment (NT), and culling of an 
initial clinical mastitis case (CM1) and the combination of treatments for CM1 followed by a clinical recurrence (CM2) when modeled 
with a stochastic decision tree with 10,000 iterations for each parity 1, 2, and ≥ 3. 
 Parity 
 1 2 ≥ 3 
Treatment (CM1/CM2) Mean 5% 95% Mean  5% 95% Mean 5% 95% 
2-d $507.72 $257.09 $811.03 $225.55 $105.93 $374.31 $235.70 $99.53 $390.52 
2-d/2-d $736.82 $364.07 $1,137.78 $426.47 $204.71 $658.77 $437.19 $182.28 $680.26 
2-d/5-d $776.37 $379.57 $1,200.41 $462.25 $210.43 $717.82 $475.98 $186.02 $744.12 
2-d/8-d $811.27 $393.80 $1,252.75 $496.60 $214.78 $774.20 $513.42 $188.86 $805.92 
2-d/NT $685.37 $347.71 $1,058.84 $374.58 $199.51 $571.81 $379.62 $181.60 $582.98 
2-d/Cull $323.39 $197.90 $468.96 $307.10 $101.71 $573.76 $355.23 $95.49 $683.83 
5-d $542.76 $271.94 $862.76 $258.97 $114.89 $423.66 $272.49 $107.38 $446.21 
5-d/2-d $765.52 $380.21 $1,178.09 $462.76 $214.89 $715.88 $478.18 $190.20 $744.85 
5-d/5-d $805.07 $394.79 $1,237.41 $498.53 $219.01 $775.04 $516.97 $193.76 $807.63 
5-d/8-d $839.97 $406.53 $1,294.89 $532.89 $224.22 $832.52 $554.41 $196.42 $872.10 
5-d/NT $714.06 $361.75 $1,098.34 $410.87 $209.98 $625.44 $420.61 $191.37 $645.92 
5-d/Cull $352.08 $215.83 $504.36 $343.38 $115.44 $630.13 $396.22 $105.43 $748.48 
8-d $575.41 $285.42 $912.16 $293.29 $122.77 $477.79 $310.57 $114.27 $505.94 
8-d/2-d $794.14 $395.75 $1,218.42 $498.77 $222.50 $772.83 $518.85 $197.94 $809.46 
8-d/5-d $833.69 $408.49 $1,277.28 $534.55 $226.50 $833.97 $557.64 $200.79 $873.84 
8-d/8-d $868.59 $419.43 $1,333.87 $568.91 $231.24 $893.35 $595.08 $203.12 $938.69 
8-d/NT $742.68 $376.37 $1,136.35 $446.88 $220.41 $682.47 $461.28 $198.94 $709.37 
8-d/Cull $380.70 $231.64 $541.10 $379.40 $128.21 $686.41 $436.89 $113.87 $816.41 
NT $460.26 $232.82 $744.72 $174.37 $89.70 $300.12 $177.96 $85.89 $307.79 
NT/2-d $695.84 $347.31 $1,080.67 $372.47 $192.18 $573.46 $375.30 $173.87 $583.22 
NT/5-d $735.39 $361.75 $1,143.43 $408.25 $198.92 $630.14 $414.09 $178.68 $645.20 
NT/8-d $770.29 $373.80 $1,192.03 $442.60 $205.96 $686.78 $451.53 $182.05 $706.60 
NT/NT $644.38 $326.49 $1,003.21 $320.58 $185.08 $494.70 $317.73 $168.19 $493.64 
NT/Cull $282.40 $168.30 $429.87 $253.10 $79.84 $489.46 $293.34 $79.67 $585.07 




Table 0.20.  Frequencies of a 2-d, 5-d, 8-d, no treatment (NT), and culling treatment 
having the lowest average treatment cost for an initial and recurring case of mastitis with 
no pathogen present after culturing when modeled with a stochastic decision tree with 
10,000 iterations for each parity 1, 2, and ≥ 3. 
  Parity 
Treatment  Mastitis Case 1 2 ≥  3 
2-d v 5-d 
1 98% 97% 97% 
2 96% 96% 96% 
2-d v 8-d 
1 98% 97% 97% 
2 98% 96% 96% 
2-d v NT 
1 3% 3% 4% 
2 4% 5% 5% 
2-d v Cull 
1 2% 55% 62% 
2 2% 13% 23% 
5-d v 8-d 
1 98% 97% 97% 
2 97% 96% 96% 
5-d v NT 
1 2% 3% 4% 
2 3% 4% 5% 
5-d v Cull 
1 2% 47% 55% 
2 2% 7% 15% 
8-d v NT 
1 2% 3% 3% 
2 2% 4% 5% 
8-d v Cull 
1 2% 40% 47% 
2 2% 4% 9% 
NT v Cull 
1 3% 64% 71% 
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